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ABSTRACT OF DISSERTATION 
 
COMPARATIVE CHONDROGENESIS OF INTERZONE AND ANLAGEN CELLS  
IN EQUINE SKELETAL DEVELOPMENT 
 
At the presumptive sites of future synovial joints during mammalian skeletogenesis, articular 
cartilage develops from interzone located between the cartilaginous anlagen of bones. Thus, 
two types of cartilaginous tissues differentiate in close proximity. While anlagen cartilage is 
transient, progressing through endochondral ossification to form bones, articular cartilage is 
stable and functions throughout life to facilitate both low friction movement and load 
distribution. Despite important life-long functional properties, articular cartilage has a very 
limited intrinsic ability to repair structural defects. On the other hand, structural lesions in 
bones generally heal well by forming a cartilaginous callus and recapitulating endochondral 
ossification to repair fractures and other defects. Therefore, understanding the comparative 
aspects of interzone and anlagen cell differentiation may provide novel insights into emergent 
cell-based therapies to support articular cartilage regeneration. The objective of this 
dissertation research was to compare patterns of gene expression between equine interzone 
and anlagen cells across multiple post-induction time points to test the hypothesis that 
chondrogenic differentiation of these two cell lines is directed to articular and hypertrophic 
developmental pathways, respectively. The first part of the study was conducted using 
microfluidic RT-qPCR to analyze a selected panel of 93 genes. The data provided evidence that 
genes involved in transcriptional regulation and signaling transduction are differentially 
expressed as early as 1.5 hours after the start of chondrogenic induction, followed at later 
time points by effector genes such as those encoding cartilage matrix proteins. Then, RNA 
sequencing was used to expand the analyses at selected time points to a whole transcriptome 
level. A pilot single cell RNA sequencing experiment further described the two chondrogenic 
pathways characterizing subpopulations of these skeletal cell lines. Taken together, the results 
demonstrated that interzone and analgen cells respond very quickly but in different ways to 
the same inductive signals. Important regulatory mechanisms are likely activated almost 
immediately, within a few hours, after chondrogenic induction. These differential regulatory 
responses progress to cell type-specific profiles of effector genes that result in the two 
different cartilaginous tissues. 
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Chapter 1. Introduction 
 
Articular cartilage and joint health 
Articular cartilage is a hyaline tissue lining the ends of bones on opposing surfaces in 
diarthrodial joints. Unlike other hyaline cartilage in the body, such as cartilage in the nose, 
larynx, trachea, or ribcage, articular cartilage is not covered by perichondrium; instead, it is 
encapsulated by a synovial membrane and surrounded by synovial fluid, from which nutrients 
are delivered to the tissue. The fibrous synovial joint capsule connects the perimeter articular 
surfaces on adjoining bone surfaces, anatomically delineating the total diarthrodial joint 
structure.  
 
On a broad component level, articular cartilage consists of 65 – 80% water, 10 – 25% 
extracellular matrix (ECM), and 10% cells—articular chondrocytes, which produce the ECM 
(Fisher et al., 2019). The composition of the ECM in dry matter is 50% collagens (primarily 
type II and type IX), and the other 50% is non-collagenous proteins such as proteoglycans (e.g., 
aggrecan) and glycosaminoglycans (e.g., cartilage oligomeric matrix protein and hyaluronan; 
Lane and Weiss, 1975). The cells and ECM in articular cartilage are organized in a zonal 
structure: 1) superficial tangential zone, 2) middle zone, and 3) deep zone in order from the 
surface towards the subchondral bone. The border between articular cartilage and the 




In the superficial zone, articular chondrocytes are flattened, somewhat smaller in size, 
and relatively densely arranged. Cells become round in shape and are sparsely distributed in 
the middle zone. Towards the deep zone, chondrocytes are stacked together, making short 
columns, and arranged perpendicular to the surface. Approaching the subchondral bone, 
chondrocytes become hypertrophic and calcify the ECM (Figure 1.1).  
 
 
Figure 1.1. Structure of articular cartilage. a) Collagen fiber architecture; b) Cellular 
organization across the zones of articular cartilage (Copyright, Ondrésik et al., 2017, 
reproduced with permission) 
 
The ECM is also arranged differently across the zones. Collagen fibrils, which make up a 
major part of the ECM content, are oriented parallel to the surface in the superficial zone and 
become isometrically distributed in the middle zone. Parallel to chondrocyte columns, 
collagen fibrils orient to a more vertical arrangement in the deep zone (Figure 1.1). At the 
same time, proteoglycan content becomes greater in the middle zone and the deep zone 
a)                                                                 b) 
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compared to the superficial zone. Aggrecan is the major proteoglycan in articular cartilage 
and is highly sulfated and heavily glycosylated, which gives it a net negative electrostatic 
charge. This protein binds to hyaluronan and captures water, creating osmotic swelling 
pressure, and its interaction with collagens endows colloidal properties. Altogether, the 
characteristics of the ECM provide tensile strength and compressive stiffness of articular 
cartilage. This smooth, tough tissue facilitates low friction movement, shock absorption, and 
weight load distribution. Articular cartilage is a stable tissue, which maintains its structure 
and functions throughout life. 
 
Despite its important biomechanical functions, traumatic injuries in articular cartilage 
often manifest as chronic arthritis and are the most prevalent joint diseases in various animals 
including humans, livestock animals, companion animals, and horses. Among the US equine 
population, chronic joint problems are the most common reason for lameness (20.9% of lame 
resident horses; USDA, 2017). Although the occurrence of articular cartilage degenerative 
diseases generally increases with age (USDA, 2017), these joint injuries are even more 
problematic in younger horses because their “product” usually centers on athletic 
performance. Horses, the primary patient population of interest in our laboratory, have 
several advantages as a model animal for these studies. In addition to the fact that the 
thickness of articular cartilage is comparable between horses and human (Sophia et al., 2009), 
several logistical challenges involving technical issues that would be present with small rodent 
models can be avoided with horses. The fetal limb buds are only a couple of millimeters in 
length even in horses, and isolating interzone and analgen cells from this small tissue is 
extremely difficult with smaller animal models and typically requires laser dissection 
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techniques and very limited cell yields. Also, horses are athletic individuals and therefore 
aspects of the data obtained from equine samples will be more relevant to the further 
translational experiments that address specific biomedical questions related to sport 
medicine. 
 
While articular cartilage degeneration is frequently seen in synovial joints, the tissue’s 
intrinsic ability to restore structural defects is very limited in mature mammals (Alford and 
Cole, 2005). Located in a hypoxic environment, this tissue is aneural, avascular, and 
alymphatic; these are the reasons why its degeneration is more troublesome. Because the 
tissue does not have any nerves, even though it is injured, the afflicted individual does not 
perceive pain directly from the articular cartilage. Nociceptive neurons would be located in 
the surrounding tissues such as the subchondral bone area or joint capsule. Furthermore, 
because this tissue does not have blood and lymph vessels, materials and factors needed for 
the tissue regeneration need to diffuse across large distances, which hinders the intrinsic 
tissue repair. Therefore, clinical interventions are challenged and efforts to support articular 
cartilage restoration met with limited success.  
 
For this purpose, emergent cell-based therapies in articular cartilage regenerative 
medicine are being commonly applied; mesenchymal stem cells with multipotent 
differentiation potential are treated with chondrogenic induction factors and transplanted 
into articular cartilage lesions. Clinical outcomes to date, however, continue to have 
frustratingly limited success. The repaired tissue is often fibrous (fibrocartilage), and 
chondrocytes in repaired cartilage may undergo hypertrophy, followed by calcification of the 
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ECM (Beris et al., 2005, Caldwell and Wang, 2015). Thus, repaired cartilage has inferior 
biomechanical function and durability compared to normal articular cartilage, and therefore, 
the performance of the animal would be deteriorated. Further research is still required to 
improve clinical approaches for supporting articular cartilage regeneration.  
 
Fetal limb skeletal development  
To advance current articular cartilage regenerative medicine, consideration of the normal 
developmental processes that generate limb skeletal elements may provide novel insights. In 
early embryonic stages, mesenchymal cells derived from the paraxial/lateral mesoderm 
aggregate together at a presumptive site of a limb. This mesenchymal condensation then 
undergoes chondrogenic differentiation forming a continuous, uninterrupted cartilaginous 
limb bud. Then, this cartilaginous tissue becomes properly segmented, resulting in several 
cartilaginous anlagen, which serve as templates for limb bones (Pitsillides and Ashhurst, 2008, 
Decker et al., 2014). 
  
Between those cartilaginous tissues, “interzone” tissue develops, and cells in this region 
change their morphology, becoming flattened and densely packed. This tissue is characterized 
by paused chondrogenesis. At early stages in fetal development, multiple synovial joint 
elements—ligament, joint capsule, synovial membrane as well as articular cartilage—develop 
from this layer of interzone cells. As synovial joint formation proceeds in mammals, the space 
between adjoining bone surfaces becomes cavitated. During these processes, a portion of 
interzone cells resume chondrogenic differentiation for articular cartilage formation (Figure 
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1.2). Once articular chondrocytes are differentiated, these cells are stable, maintaining 





At the same time, cartilaginous anlagen undergo terminal hypertrophic differentiation. 
Starting from the center of each anlage, chondrocytes rapidly proliferate, maturate, and start 
expressing hypertrophic ECM such as collagen type X. Then, the tissue becomes calcified, 
preventing the chondrocytes from approaching nutrients and in turn, resulting in apoptosis 
(Ham, 1952, Cameron, 1963). The cell death generates vacancy in the anlagen and allows 
blood vessels to invade the hypertrophic regions. The blood brings osteogenic factors and cells 
into the anlagen, establishing the primary ossification centers. Finally, the medullary cavity 
becomes enlarged, and hypertrophic cartilage is replaced by bone tissue in the normal process 
of bone formation, which is termed endochondral ossification (Figure 1.3). Thus, anlagen 
chondrocytes are transient. 
 
Figure 1.2. Synovial joint formation 
(Copyright: Moskalewski et al., 2013, 





Figure 1.3. Endochondral ossification. a) Mesenchymal condensation; b) Chondrocyte 
differentiation; from the center of the mesenchymal condensation, cells differentiate into 
chondrocytes; c) Chondrocyte maturation; chondrocytes at the center of the cartilaginous 
anlage undergo hypertrophy until terminal stages; d) Cartilage vascularization; blood vessels 
(red lines) invade the center of the hypertrophic zone, and vascular invasion leads to 
resorption of cartilaginous matrix and deposition of bone (black) within the medullary cavity 
(Copyright: Long and Ornitz, 2013, reproduced with permission). 
 
These two different developmental chondrogenic processes—one directed towards 
articular cartilage development and the other directed towards hypertrophic differentiation 
leading to bone formation—occur simultaneously and in close proximity. As a result of 
recapitulating developmental processes, fractured bones actually repair quite well, provided 
that the fracture is reduced, stabilized, and not compromised by infection or loss of blood 
























Interestingly, as demonstrated roughly a decade ago in our laboratory, some vertebrate 
species such as mature axolotl salamanders retain interzone-like tissue in their distal limb 
joints which provides this amphibia with the ability to restore even large articular cartilage 
defects (Cosden et al., 2011). Furthermore, this axolotl interzone-like tissue has the potential 
to generate an entirely new diarthrodial joint de novo within a skeletal microenvironment 
(Cosden-Decker et al., 2012). These axolotl studies demonstrated the potential of interzone 
cells, which do not undergo hypertrophic differentiation, to regenerate articular cartilage 
tissue. Taken together, this developmental biology and previous literature suggest that 
understanding developmental processes of limb skeletal elements and the comparative 
aspect of interzone and anlagen cells may well provide important information to advance 
therapeutic approaches for mammalian articular cartilage regeneration.  
 
Molecular mechanisms involved in limb skeletal development 
The homeobox (HOX) gene family of transcription factors is well-conserved across the 
species. These genes are widely involved in embryonic developmental processes and 
participate in axial patterning. Mammalian HOX paralogs (HOXA-D) are located on four 
separate chromosomes and their functional annotations are more similar to their own 
paralogs on the other chromosomes compared to their neighboring HOX genes on the same 
chromosome. The relative location within a chromosome defines their groups: anterior 
(HOX1-5), central (HOX6-8), and posterior (HOX9-13) clusters from the 3’ end to the 5’ end. 
While the HOX genes generally establish the anterior-posterior axis in the body, the posterior 
HOX genes (HOX9-13) are also involved in limb fields specification and appendicular skeletal 
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(limb) patterning (Mohanty-Hejmadi et al., 1992, Nelson et al., 1996, Pineault and Wellik, 
2014). Along a limb bud, from proximal to distal, the posterior HOX genes are collinearly 
expressed as their relative location on chromosomes; HOX9 and 10 patterns the stylopod, 
HOX11 patterns the zeugopod, and HOX13 patterns the autopod. In the earlier developmental 
stages, their expression gradually overlaps while it is collinear. However, the expression 
patterns become restricted in the specific regions within the limb as development progresses. 
 
At the presumptive sites of limbs, mesenchymal cells derived from the mesoderm come 
together in an aggregate structure to form limb buds, a process induced by FGF10 (Sekine et 
al., 1999). In an in vitro study, transforming growth factor beta 1 (TGF-1) treatment resulted 
in chondrogenic differentiation in limb mesenchymal cells preceding the condensation, 
suggesting TGF-1 may stimulate chondrogenesis during cartilage pattern formation (Leonard 
et al., 1991). The mesenchymal condensation and initial chondrogenesis are regulated by 
SOX9 expression and result in the production of a cartilaginous ECM, such as collagen type II 
and aggrecan core protein (Bi et al., 1999, Akiyama et al., 2002). This undisturbed cartilaginous 
tissue becomes subdivided into several anlagen, and each segment is strongly correlated with 
the spatially discrete domains of HOX9-13 expression (Nelson et al., 1996). Between these 
cartilaginous anlagen—at the future joint sites, cells begin expressing interzone marker genes 
(GDF5, WNT9A, and ENPP2) and stop expressing cartilaginous genes (Karsenty and Wagner, 
2002, Pacifici et al., 2005). A portion of these interzone cells resume chondrogenesis and 
differentiate into articular chondrocyte, however, the molecular and cellular mechanisms 




Some of the major cytokines that promote both chondrogenesis and hypertrophy in 
various cell lines are members of the transforming growth factor beta (TGF-β) family 
(Goldsmith et al., 2006, Dobaczewski et al., 2011, Wang et al., 2014). While multiple TGF-β 
ligands can bind to multiple TGF-β receptors, the downstream events are mediated by various 
combinations of receptors including, TGF-β receptor type I (ALK1, and ALK5), type II (TGFBR2), 
and type III (TGFBR3; Figure 1.4). Also, these downstream signals can have different effects on 
limb skeletal development (Wang et al., 2014). The two canonical SMAD-dependent pathways 
are transduced by TGFBR2 and ALK5 and by TGFBR2 and ALK1. On the other hand, the 
noncanonical SMAD-independent pathway is transduced by TGFBR3 and ALK5 (Iwata et al., 
2012). TGFBR3 not only transduces the noncanonical TGF-β pathway, but also facilitates the 
TGFBR2 and ALK5 mediated canonical TGF-β pathway by providing stable ligands (Shi and 
Massagué, 2003). The canonical TGF-β pathway mediated by ALK5 activates SMAD2 and 
SMAD3, which are transcription factors promoting production of collagen type II and aggrecan 
core protein. Articular cartilage phenotypes are induced and maintained by SMAD2/3 
signaling, which represses RUNX2-inducible MMP13 expression (Chen et al., 2012). Also, the 
noncanonical TGF-β pathway has been reported to interact with SMAD2/3 signaling 
(Watanabe et al., 2001). Yet, the canonical pathway mediated by ALK1 induces hypertrophic 
differentiation by activating Smad1/5/8 (Nishida et al., 2013). However, the roles of the 





Figure 1.4. TGF-β signaling pathways in cartilage formation and maintenance (Copyright: 
Wang et al., 2014, reproduced with permission). 
 
In summary, various genes and signaling pathways are involved in molecular and cellular 
mechanisms that regulate the process and sequence of limb skeletal development. Thus, 
investigating kinetics or interactions of gene expression during these processes should help to 
elucidate the molecular mechanisms of the binary decision that is made by chondrocytes 
within a fetal limb bud, in which one population of cells take a non-hypertrophic program to 
stable articular cartilage, while others progress through terminal hypertrophic differentiation 
leading to osteogenesis. An important knowledge gap is whether interzone and anlagen cells 
are intrinsically determined to become articular cartilage and hypertrophic cartilage, 
respectively. If so, critical questions arise regarding the identity of the molecular regulators 
and the plasticity in their commitment to these two developmental pathways. 
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Advances in technologies for gene expression evaluation 
As the intricacy of biology have become more revealed, molecular approaches 
investigating the expression of a greater number of genes with a larger sample numbers have 
been developed. Today, “high throughput” capabilities have become a priority for studying 
gene expression leading to a diverse set of powerful technologies. 
 
While conventional reverse transcription-quantitative polymerase chain reaction (RT-
qPCR) has enabled sensitive and reproducible measurements in gene expression, this method 
is quite labor-intensive and expensive, requiring a greater volume of samples and reagents. 
Overcoming the disadvantages of conventional RT-qPCR systems, microfluidic RT-qPCR 
technology has allowed gene expression measurements from a number of targeted gene loci 
with a smaller amount of starting materials (both reagents and samples). By channeling 
reagents and cDNA samples within a microfluidic chip, thousands of gene expression reactions 
are simultaneously measured, and the reaction volume is scaled down to a nanoliter scale 
compared to traditional systems requiring microliters of reaction volumes. The microfluidic 
RT-qPCR systems work well for experiments investigating a defined set of target transcripts of 
interest. 
 
On the other hand, gene expression can be assessed at the whole transcriptome level 
using next generation sequencing platforms. By profiling transcriptomic signatures, RNA-
sequencing (RNA-seq) evaluates expression of not only genes that have been conventionally 
considered biomarkers or biologically relevant to the research subjects, but also genes that 
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have not been identified in their roles or have received less scientific attention. While 
traditional, bulk RNA-seq systems measure overall gene expression from all cells existing in a 
sample, single cell RNA-seq can separately profile the transcriptome from individual cells 
within a sample. Since single cell RNA-seq is still emerging and is a relatively novel technology, 
the high expense can be a barrier to broad use. However, single cell methods are rapidly 
bringing to consideration new and novel opportunities in transcriptome research. 
 
Overview of the dissertation 
In this dissertation, chondrogenic divergence between equine fetal interzone and anlagen 
cell cultures was studied using various, advanced technologies for evaluating gene expression. 
The overall hypothesis tested in the present research project was that chondrogenic 
differentiation of interzone and anlagen cells is directed to articular and hypertrophic 
developmental pathways, respectively. In Chapter 2, using microfluidic RT-qPCR, the 
expression kinetics of 93 selected genes was evaluated at ten different time points during the 
336-hour in vitro chondrogenesis. The hypothesis tested in this first study was that 
chondrogenic divergence between the two fetal skeletal cell lines will become evident within 
an earlier time frame—within the first 24 hours—after initiating the chondrogenic induction. 
Then, five time points prioritized based on the data from Chapter 2, and the different 
chondrogenic pathways between interzone and anlagen cells were further investigated in 
Chapter 3 using traditional, bulk RNA-seq. This study tested the hypothesis that regulatory 
genes will differentially respond to the chondrogenic stimulation between the two skeletal 
cell cultures within the first 1.5 hours, and more distinctive transcriptomic characteristics will 
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accumulate as time passes during the 96-hour experimental period. In addition, a pilot single 
cell RNA-seq study is reported in Chapter 4. The hypotheses of this pilot study were that 
interzone and analgen cell pellet cultures will develop different levels of heterogeneity in cell 
subpopulations at 24h and 48h after inducing chondrogenesis, and these fetal cell lines will 
present cell type-unique traits as well as common chondrogenic characteristics. In closing, 
Chapter 5 summarizes the studies conducted for this dissertation project and indicates future 
research directions. Altogether, the new kinetics information on gene expression in interzone 
and anlagen cell cultures will not only enhance our understanding of these two 
developmental cell types, but also lay a foundation for future studies investigating novel 




Chapter 2. Kinetics of gene expression changes in equine fetal interzone and anlagen cells 
during 14 days of in vitro chondrogenesis 
 
Introduction 
During the early stages of limb formation, articular cartilage develops from interzone 
located at the presumptive sites of future synovial joints within the cartilaginous anlagen of 
bones. Therefore, two different types of cartilage differentiate in close proximity. While 
anlagen cartilage is transient, progressing through endochondral ossification to form bones, 
articular cartilage remains stable and functions throughout life to facilitate biomechanical 
load distribution and low friction movement between adjoining bone surfaces. Despite the 
important functional properties of articular cartilage, its intrinsic ability to restore structural 
defects is limited in mature mammals (Alford and Cole, 2005). Almost the polar opposite is 
true regarding the potential for bone tissue regeneration. Fractured bones repair quite well 
by recapitulating endochondral ossification; provided the fracture ends are brought together, 
stabilized, and not compromised by infection or loss of blood supply. Thus, research on the 
comparative cell biology between interzone and anlagen cells, as well as their developmental 
chondrogenic pathways may provide novel information relevant to improving mammalian 
articular cartilage regenerative treatments.  
 
In an effort to understand the biology of fetal interzone and anlagen cells, their 
chondrogenic potential was measured and compared after 21 days in three dimensional pellet 
culture and continuous stimulation with a chondrogenic induction medium containing 
transforming growth factor beta 1 (TGF-β1; Adam et al., 2019). The results demonstrated that 
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interzone and anlagen cultures respond differently to chondrogenic stimulation based on 
expression of cartilaginous marker genes, such as aggrecan core protein (ACAN) and collagen 
type II alpha 1 chain (COL2A1). Also, the cell pellets showed distinguishing histological 
characteristics, including proteoglycan amount and distribution, as well as cellular 
morphology and arrangement. In other research studies, the protocol for in vitro 
chondrogenic differentiation has also been reported after 21 days, with the expression of 
extracellular matrix (ECM) genes measured at the mRNA or protein level used as targeted 
functional outcomes (McCarthy et al., 2012, Rakic et al., 2018). However, gene expression 
changes induced by TGF-β, a well-established chondrogenic factor, start as early as 30 minutes 
to 1 hour after treating TGF-β in culture (Franco et al., 2010, Aomatsu et al., 2011). Molecular 
details of these early responses are not fully understood, so an important gap of knowledge 
is whether there are qualitative or quantitative differences of gene expression kinetics over 
time in these two chondrogenic cell cultures.  
 
By comparing a timed sequence of the cellular response to TGF-β1 induced 
chondrogenesis between interzone and anlagen cell cultures, the present study was designed 
to answer the following questions: 1) how do gene expression patterns change over time and 
2) when do the differential pathways of the two cell types start to diverge in this in vitro 
chondrogenesis model? The hypothesis tested in this study is that divergent chondrogenic 
differentiation pathways in interzone and anlagen cultures will be evident within the first 24 
hours after in vitro chondrogenic induction. 
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Materials and Methods 
Cell culture and sample collection 
Equine fetal interzone cells, anlagen cells, and dermal fibroblasts (a negative control) were 
previously harvested from seven 45-days-old fetuses (Adam et al., 2019), and the cells were 
frozen and stored at passage 2 (P2). Using standard protocols, frozen cells were thawed and 
cultured in T-75 polystyrene flasks with high glucose Dulbecco's modified Eagles medium 
(DMEM; cat No. 10569044; Gibco) supplemented by 10% (v/v) fetal bovine serum (heat 
inactivated; cat No. S11150H; Atlanta Biologicals) and 1% (v/v) penicillin/streptomycin (P/S; 
cat No. 15070063; Gibco) and termed ‘complete medium’ in this study. When the cell 
monolayers reached approximately 80% confluence, the adherent cells were lifted by 0.25% 
Trypsin-EDTA solution (cat No. 25200056; Gibco) and split into new flasks (seeding density of 
10,000 cells/cm2). Cell viability in the suspension of >95% was confirmed by trypan blue dye 
exclusion test.  
 
When P4 monolayers reached >80% confluence, a portion of the cells were used to collect 
total RNA. The cells were harvested in a guanidinium thiocyanate solution (1ml/T-75 flask; 
QIAzol Lysis Reagent; cat No. 79306; Qiagen), immediately snap-frozen, and stored at –80°C 
until total RNA isolation. The rest of P4 monolayers were lifted by trypsin digestion, and 
chondrogenic cell pellets were established at P5 as previously described (Adam et al., 2019). 
Each cell pellet was comprised of 500,000 viable cells and maintained in chondrogenic 
induction medium (high glucose DMEM + 1% P/S + bovine serum albumin, 12.5 mg/ml + 
ascorbic-2-phosphate, 50 µg/ml + TGF-β1 (Transforming Growth Factor-β1 human; cat No. 
T7039-50UG; Sigma-Aldrich), 10 ng/ml + 1% insulin-transferrin-selenium-sodium pyruvate + 
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Dexamethasone, 100 nM + 1% nonessential amino acid) for the full culture period. 
 
Aliquots of pellet cultures were collected at ten different time points: baseline (0h), 1.5, 
3, 6, 12, 24, 48, 96, 168, and 336 hours after the initiation of the chondrogenic induction. 
These time points were selected based on a literature review (Ranganathan et al., 2007, Rudini 
et al., 2008, Franco et al., 2010, Aomatsu et al., 2011, Koyama et al., 2013, Nejadnik et al., 
2015, Yokota et al., 2014, Yamazaki et al., 2015) to assess the kinetics of gene expression over 
time after the TGF-β1 treatment in the cell pellet cultures. At each time point, the collected 
pellets were washed with phosphate-buffered saline (PBS), snap-frozen (3 pellets/vial), and 
stored at –80°C until total RNA isolation.  
 
Total RNA isolation 
Thawed cell monolayers and pellets (3 pellets per 1 ml of the guanidinium thiocyanate 
solution) were homogenized using a PowerGen homogenizer (Model 125; Fisher Scientific). 
Total RNA was then extracted and purified using a spin-column based RNeasy Mini kit (cat No. 
74106; Qiagen) followed by ethanol precipitation. The quantity of RNA was determined using 
a Qubit™ RNA Broad Range Assay Kit (cat No. Q10211; Life Technologies) with a Qubit® 3.0 
Fluorometer (cat No. Q33216; Life Technologies), and the 260/280 and 260/230 ratios were 
measured by a Nano Drop ND 1000 spectrophotometer (Thermo Fisher Scientific). Finally, 
RNA integrity numbers (RIN) were determined using a Bioanalyzer 2100 (Agilent Technologies) 
with an Agilent RNA 6000 Pico kit (cat No. 5067-1513; Agilent Technologies) to assess the 
quality of the RNA samples. The monolayer RNA samples resulted in 260/280 ratios of 2.0 – 
2.1, 260/230 ratios of 2.3 – 2.7, and RINs of 8.7 – 10, except for one sample that showed a RIN 
19 
 
of 6.8. A substantial majority of cell pellet RNA samples had 260/280 ratios of 1.8 – 2.1, 
260/230 ratios of 1.8 – 2.7, and RINs of 6.4 – 10. Out of 210 cell pellet RNA samples, ten 
samples had 260/230 ratios outside of this range, but gene expression patterns were 
consistent with experimental group averages so the data were retained. Any potential 
genomic DNA contamination was removed with dsDNase (cat No. K1672; Thermo Fisher 
Scientific) during reverse-transcription protocol using the Maxima First Strand cDNA Synthesis 
Kit for RT-qPCR (cat No. K1672; Thermo Fisher Scientific). The cDNA samples were then stored 
at –20°C pending qPCR analysis. 
 
Quantitative polymerase chain reaction (qPCR)  
1) Targeted gene loci 
Three prospective endogenous control genes, B2M, GUSB, and RPLP0 (Mienaltowski et 
al., 2008) were evaluated in a preliminary RT-qPCR analysis conducted on a subset (n=2) of 
the entire sample set. Ninety-three genes (Table 2.1) of interest were selected for analysis 
based on equine cartilaginous tissue RNA-seq data generated in the MacLeod lab (Adam et 
al., in preparation) and a literature review. The earlier data or published reports from these 
genes were either 1) differentially expressed between interzone and anlagen tissue samples 
at three developmental ages (day-45 fetuses, day-60 fetuses and neonatal foals), 2) 
functionally annotated to include fetal developmental processes, 3) known to be involved in 





These 96 gene loci were studied with commercially available (59 assays) and customized 
(37 assays) equine-specific TaqMan® primer-probe sets (Thermo Fisher Scientific; Table 2.1). 
Where possible, the primer-probe sets were designed to span two exons (88 assays), with 
eight assays designed within a single exon.   
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Ec07025737_s1 104 Single exon 
23:5298376 -
5298260 
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AREPT7J 138 Single exon 
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TLR2 Toll-Like Receptor 2 Ec03818334_s1 87 Single exon 
2:80314660-
80314562 
































aCommercially available primer-probe sets. ThermoFisher catalogue IDs start with ‘Ec’ and 
their catalogue number is 4448892. Catalogue IDs for custom designed primer-probe sets 
start with ‘A’ and their catalogue number is 4441114. 






2) Positive control RT-qPCR assessments 
Prior to conducting the main microfluidic RT-qPCR analysis, a preliminary assessment was 
conducted using a robotic ViiA™ 7 Real-Time PCR System (Thermo Fisher Scientific) in order 
to verify 1) amplification of two endogenous controls (GUSB and RPLP0) in all 231 cDNA 
samples (7 biological replicates × 3 cell lines × 11 time points, plus P4 monolayer samples) and 
2) amplification of all 96 targeted gene loci by the TaqMan® primer-probe sets in a positive 
control sample. The positive control sample was prepared by pooling equal parts of 1) a 
pooled total RNA sample composed of 43 different equine tissue/cell sources (Hestand et al., 
2015), and 2) a 35-days-old equine fetus homogenate. In these test analyses, negative controls 
included a no-reverse transcription sample and a no-template sample to confirm the absence 
of contaminating genomic DNA or RNA in individual samples or the system. The entire 231 
samples (10 ng of cDNA/reaction) expressed GUSB (cycle threshold (Ct) values of 21.44 ± 0.06) 
and RPLP0 (Ct values of 18.21 ± 0.06). In addition, the positive control sample demonstrated 
amplification in 95 of the targeted gene loci (Ct values of 17.68 – 30.85). The one exception 
was primers specific for COL10A1 (Ct value of 35.92).  
 
3) Microfluidic RT-qPCR 
The 231 cDNA samples were prepared at a concentration of 10 ng/ul and divided into 
three 96 well-microfluidic chips (96 × 96 Fluidigm Dynamic Array; Fluidigm). Seven 3-fold 
dilution series (125, 41.67, 13.89, 4.63, 1.54, 0.51, and 0.17 ng/ul) of the positive control 
sample were added onto each chip to evaluate PCR efficiency and to also function as an inter-
plate control. The plates were then shipped to the Roy J. Carver Biotechnology Center, a 
genomics core at the University of Illinois at Urbana-Champaign (Urbana, IL, USA). To 
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quantitate steady state mRNA levels for the targeted 96 gene loci in all experimental samples, 
a microfluidic RT-qPCR system (Biomark HD high throughput amplification system, Fluidigm) 
was utilized and operated with manufacturer-recommended protocols (Fluidigm Corporation, 
2018). After 14-cycles of pre-amplification, steady state mRNA levels were measured with this 
microfluidic RT-qPCR system and the data processed using the Fluidigm Real-Time PCR 
Analysis software.  
 
Data analyses and statistics 
The two most stable endogenous controls (GUSB and RPLP0) across the sample set (Figure 
2.1) were used for the gene expression normalization within a sample (ΔCt = Ct of a gene of 
interest – average Ct of GUSB and RPLP0). Then, the ΔCt of each target gene was calibrated 
with ΔCt of the same target gene in the positive control sample (ΔΔCt = ΔCt in a sample – ΔCt 
in the positive control). Finally, ΔΔCt values were converted to relative quantity (RQ=2-ΔΔCt; 
fold changes based on expression in the positive control; Livak and Schmittgen, 2001). To 
determine statistical differences between the data points (targeted gene × cell type × time 
point), the fold change data were log-transformed and analyzed using SAS statistical software, 
version 9.3 (SAS Institute Inc., Cary, NC). One-way multivariate analysis of variance was 
conducted with Tukey's honest significance test for multiple comparison adjustments. The 






Figure 2.1. Steady state mRNA levels (Ct, mean ± SEM) of three prospective endogenous 
controls (B2M, GUSB, and RPLP0) across the 336-hour experimental period. GUSB and RPLP0 





Genes processed in data analyses 
Of the 93 targeted genes of interest, six loci were not processed for further data analyses; 
five genes (ARHGEF15, CHODL, NPY, RET, and STAB1) had little or no relative expression based 
on the control sample (RQs of <0.02), and IGF2 had low fluorescent intensity in two out of 
three microfluidic chips which resulted in loss of 5 – 6 biological replicates. Thus, data from 
87 genes were analyzed further. 
 
These 87 genes were categorized into three groups based on their established functional 
annotation: 1) 15 genes regulating transcription, 2) 51 genes involved in signal transduction, 
and 3) 23 genes involved in ECM biology. Two genes (MASP1 and NEFL) were not categorized 
into any of the three annotation groups. Four genes were included in two of the three 
annotation groups; ENTPD1, ENTPD2, and LEF1 in both the transcription and signaling groups, 
and THBS4 in both the signaling and ECM groups. 
 
Kinetics of gene expression changes by cell type 
Time point differences in steady state levels of mRNA for individual gene loci were 
assessed by comparing values to baseline at 0h within a cell type. Significant upregulation and 
downregulation events were noted (Figure 2.2). At the first time point, 1.5 hours, the 
significant changes observed were all upregulation. The time points from 3 hours on had 
instances of both upregulation and downregulation. Among the total of 261 gene × cell type 
combinations (87 genes × 3 cell types), 110 combinations showed upregulation (Figure 2.2.a), 
83 combinations showed downregulation (Figure 2.2.b), 22 combinations showed mixed 
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patterns of upregulation and downregulation (Figure 2.2.c). Steady state mRNA levels were 













Figure 2.2. Changes in steady state mRNA levels in response to the chondrogenic stimulation 
relative to the 0h time point. IZ = interzone cell; ANL = anlagen cell; FB = fibroblast. a) 
Upregulated genes, b) downregulated genes and c) genes with mixed patterns of upregulation 





1) Monolayer vs. 0h 
To assess the effect of trypsin digestion and centrifugation required for establishing cell 
pellets from monolayers, steady state mRNA levels in P4 cell monolayers were compared to 
that of P5 0h cell pellets. Among the 87 targeted loci, only four genes (APLNR, GDF5, S1PR3, 
and TLR2) had significantly lower expression levels in monolayer cultures compared to 0h cell 
pellets in one or more cell types (P<0.05; Figure 2.3). These genes are all categorized in the 
signal transduction. Interestingly, GDF5 and S1PR3 subsequently displayed consistent up-





Figure 2.3. Genes with significantly different steady state mRNA levels between passage 4 
monolayer cultures and passage 5 cell pellet cultures at 0h. IZ = interzone cell; ANL = anlagen 
cell; FB = fibroblast. 
aThe reference point (baseline) for comparison was 0h for the same sample.  
 
2) Timing of initial differential expression relative to 0h within a cell type 
Eighty-six out of the 87 targeted genes displayed a significant change with at least one 
timepoint in response to the chondrogenic induction protocol. The lone exception was 
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GALNT14, in which steady state mRNA levels did not change significantly at any time point in 
either of the three cell types (Figure 2.2.d). Comparing the three functional annotation 
categories, percentages of loci displaying their first onset of change (gene × cell type 






Figure 2.4. Histogram of percentages of the first response to the chondrogenic stimulation in 
new gene × cell type combinations within each of the three functional annotation groups.  
Table 2.2. Timing of the first response to the chondrogenic induction protocol in new gene 
× cell type combinations within each of the three functional annotation groups. Data are 
reported as the percent (%) of gene loci within the annotation group with significant 
changes.  
 Time point 
Annotation 
group 
1.5h 3h 6h 12h 24h 48h 96h 168h 336h 
Transcription 
regulation 
7.0 34.9 16.3 25.6 11.6 2.3 2.3 0.0 0.0 
Signal 
transduction 
3.3 18.9 21.3 9.8 9.8 13.1 12.3 3.3 8.2 
Extracellular 
matrix 
0.0 18.2 12.7 20.0 12.7 9.1 12.7 7.3 7.3 
Total 3.3 20.9 18.6 14.9 10.2 10.7 11.2 3.7 6.5 
37 
 
In the transcription regulation group, the first half (58.1% of the total) of gene × cell type 
combinations showed their first chondrogenic responses within the first 6 hours, with the 
mode observed at 3h (34.9% of the total). The other 41.9% of gene × cell type combinations 
first responded to the chondrogenic stimulation between 12 – 96h. Only 4.6% of gene × cell 
type combinations responded between 48 – 96h, and these were observed solely in fibroblast 
cultures. It is interesting to note that in interzone and anlagen cell cultures, steady state mRNA 
levels for all of the genes with transcription regulation functional annotation had changed 
significantly within the first 24 hours following chondrogenic induction (Table 2.3). No 
transcription regulating genes displayed their first change later than 96h in any cell type.  
 
By comparison to the transcription regulation group, genes involved in signaling cascades 
showed slightly delayed responses. Roughly half (53.3%) of the gene × cell type combinations 
changed significantly within the first 12 hours. Genes in the signaling group also showed 
relatively slower responses in fibroblast cultures.  
 
Response to the chondrogenic induction protocol was more delayed for genes encoding 
ECM proteins or involved in ECM metabolism. Indeed, no differences were observed in this 
functional annotation group at the 1.5h time point. The first half (50.9%) of gene × cell type 
combinations were observed between 3 – 12h (Table 2.3).  
 
In the negative control dermal fibroblasts, responses to chondrogenic induction were 
delayed compared to interzone and anlagen cells. Transcriptional regulatory genes all showed 
their first responses within 24 hours in the chondrogenic cells, compared to some initial 
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changes delayed until 96h in fibroblast cultures. In the signal transduction group, 8.3% or 2.1% 
of the first responses were recorded at the last time point (336h) in interzone cell cultures 
and anlagen cell cultures, respectively, while 15.4% of those was recorded at 336h in 
fibroblast cultures. Also, the majority of first reactions in the ECM group were at 3h (23.5%) 
and 12h (23.5%) in interzone cultures, 12h (28.6%) in anlagen cultures, and 96h (23.5%) in 




Table 2.3. Timing of the first response to the chondrogenic induction protocol within 
functional annotation group  
 
(% of gene loci with significant changes) 
Annotation group Time point 
Transcription 
regulation 1.5h 3h 6h 12h 24h 48h 96h 168h 336h 
Interzone cell 6.7 33.3 20.0 26.7 13.3 0.0 0.0 0.0 0.0 
Anlagen cell 7.1 28.6 14.3 28.6 21.4 0.0 0.0 0.0 0.0 
Fibroblast 7.1 42.9 14.3 21.4 0.0 7.1 7.1 0.0 0.0 
 
Signal 
transduction 1.5h 3h 6h 12h 24h 48h 96h 168h 336h 
Interzone cell 0.0 27.8 19.4 5.6 13.9 11.1 11.1 2.8 8.3 
Anlagen cell 4.3 17.0 25.5 14.9 6.4 17.0 10.6 2.1 2.1 
Fibroblast 5.1 12.8 17.9 7.7 10.3 10.3 15.4 5.1 15.4 
 
Extracellular 
matrix 1.5h 3h 6h 12h 24h 48h 96h 168h 336h 
Interzone cell 0.0 23.5 5.9 23.5 17.6 11.8 5.9 11.8 0.0 
Anlagen cell 0.0 19.0 14.3 28.6 4.8 9.5 9.5 4.8 9.5 
Fibroblast 0.0 11.8 17.6 5.9 17.6 5.9 23.5 5.9 11.8 
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Relative differences between cell types at each time point 
Steady state mRNA levels at each time point were compared in pairwise comparisons 
between cell types, and the results categorized into four groups (Table 2.4; Figure 2.5). While 
14 – 18 genes were already differentially expressed at 0h in the comparisons between cell 
types, most genes (69 – 73 genes among the 87 targeted loci) did not show differences initially. 
The focus of this study is on relative differences between interzone and anlagen cells.  
 

















IZ vs. ANL 11 genes 3 genes 47 genes 26 genes 
IZ vs. FB 14 genes 0 gene 41 genes 32 genes 
ANL vs. FB 18 genes 0 gene 47 genes 22 genes 
Common 
genes in all 
comparisons 





IZ and ANL 
cultures 






















Figure 2.5.a) Genes that were differentially expressed in the indicated pairwise cell type comparison at baseline (0h) and also retained differences 
after inducing chondrogenesis 
 
 
Figure 2.5.b) Genes that were differentially expressed in the indicated pairwise cell type comparison at baseline (0h) but lost differences after 
inducing chondrogenesis 
 
Upregulated in interzone cell culture ***, P<0.0001
Upregulated in anlagen cell culture **, P<0.01
Upregulated in fibroblast culture *, P<0.05
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Figure 2.5.c) Genes that were not differentially expressed in the indicated pairwise cell type comparison at baseline (0h) but responded 







Upregulated in interzone cell culture ***, P<0.0001
Upregulated in anlagen cell culture **, P<0.01
Upregulated in fibroblast culture *, P<0.05
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(continued Figure 2.5.c) Genes that were not differentially expressed in the indicated pairwise cell type comparison at baseline (0h) but 
responded differently to the chondrogenic stimulation 
 
Comparison between interzone and 
anlagen cell cultures
(Time point, h)
Comparison between interzone cell 
and fibroblast cultures
(Time point, h)
Comparison between anlagen cell 
and fibroblast cultures
(Time point, h)
Genes 0 1.5 3 6 12 24 48 96 168 336 Genes 0 1.5 3 6 12 24 48 96 168 336 Genes 0 1.5 3 6 12 24 48 96 168 336
SNAI2 *** *** GALNT14 *** ENTPD2 *** ***
CLU *** *** FGFR3 ** *** PDLIM1 *** ***
CDH13 *** *** RUNX2 ** ** SNAI2 *** ***
ENTPD2 *** ** FRZB * * ANGPTL4 *** ***
ASS1 ** *** IGFBP7 *** CDH13 *** ***
TGFBI ** *** ANGPTL4 ** GDF6 *** ***
S100A4 ** *** APLNR ** PANX3 *** *
SGMS2 ** FGF18 * APLNR ** ***
WNT9A * *** TLR2 * COL1A1 ** ***
SNAI1 * BMPR1A **
ALPK3 *** ABI3BP **
CREB5 *** ADGRG1 * **
ANGPTL4 *** CREB5 ***
AQP1 *** NTRK2 ***
TSPAN15 *** TLR2 ***
COL1A1 *** IGFBP7 **
TIMP2 *** ITGAV **
CTGF ** TSPAN15 **







Upregulated in interzone cell culture ***, P<0.0001
Upregulated in anlagen cell culture **, P<0.01
Upregulated in fibroblast culture *, P<0.05
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Figure 2.5.d. Genes that were not differentially expressed in the indicated pairwise cell type 
comparison at baseline (0h) and also were not different after the chondrogenic stimulation 
 
Comparison between 
interzone and anlagen 
cell cultures  
Comparison between 
interzone cell and 
fibroblast cultures  
Comparison between 
anlagen cell and 
fibroblast cultures 
Genes  Genes  Genes 
ENTPD1  ALPK3  ALPK3 
OSR2  CREB5  GLI3 
ADGRG1  OSR2  RUNX2 
APLNR  PDLIM1  ABCC9 
FAM132A  SNAI2  ADGRG2 
GDF5  SP7  BMP2 
IGFBP5  ADGRG2  FRZB 
IGFBP7  BMP2  IBSP 
PLAT  BMPR1A  KCNJ8 
ADGRG2  BOC  LOC100630171 
BMP2  CDH13  MET 
CDON  CDON  PLVAP 
FRZB  DIO2  PRKG2 
FZD1  GDF6  PTCH2 
ITGAV  ITGAV  S1PR3 
KCNJ8  KCNJ8  COL10A1 
LOC100630171  LOC100630171  GALNT14 
NTRK2  NTRK2  OMD 
PTCH2  PANX3  SPARCL1 
ALPL  PLVAP  THBS4 
DCN  PTCH2  TGFBI 
MMP2  S100A1  NEFL 
SPARCL1  TNFRSF21   
COL10A1  TSPAN15   
GALNT14  COL10A1   
NEFL  COL1A1   
  ITGA7   
 
 OMD   
  SMPD3   
  SPARCL1   
  TIMP2   
  MASP1   
 
Figure 2.5. Four patterns of differential gene expression before and after inducing in vitro 
chondrogenesis. Each pattern is shown in a), b), c), and d), respectively. 
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1) Genes with differential expression levels prior to the chondrogenic stimulation  
Among the cell type pairwise comparisons, there were three common genes (DLX5, LEF1, 
and RUNX3) that had different initial expression levels at 0h and showed unique cell type 
specific properties to the chondrogenic induction protocol. Specific to the comparison 
between interzone and anlagen cultures, five genes (GDF6, MGP, OMD, PDLIM1, and RUNX2) 
started with different expression levels and also retained differential profiles following the 
chondrogenic induction (Table 2.4; Figure 2.5.a). 
 
If initial mRNA levels of a gene were different in the comparisons to fibroblast cultures, 
the gene also showed different expression levels after inducing chondrogenesis. However, 
between interzone and anlagen cell cultures, three genes (COL2A1, COMP, and DIO2) with 
different initial mRNA levels lost differences across all post-chondrogenic induction time 
points (Table 2.4; Figure 2.5.b).  
 
2) Genes with no differential expression levels prior to the chondrogenic stimulation 
Among the 69 – 73 genes that initially had not different expression levels in pairwise cell-
type comparisons, 41 – 47 genes developed significant steady state mRNA differences after 
inducing chondrogenesis. Between interzone and anlagen cultures, there were 47 genes in 
this category, and only nine (ALPK3, ASS1, AQP1, CTGF, FAM20A, FGF1, ITGA7, PLVAP, and TLR4) 
that were specific to the comparison between these two chondrogenic cell lines (Table 2.4; 
Figure 2.5.c). 
 
On the other hand, 22 – 32 genes still did not change in pairwise cell-type comparisons, 
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seven of which showed no difference in any cell type comparison: ADGRG2, BMP2, COL10A1, 
KCNJ8, LOC100630171, PTCH2, and SPARCL1. Among these seven genes, there was no gene 
involved in transcription regulation. In addition, twelve genes were commonly regulated 
under the chondrogenic stimulation specifically between interzone and anlagen cultures: 
ADGRG1, ALPL, APLNR, DCN, ENTPD1, FAM132A, FZD1, GDF5, IGFBP5, IGFBP7, MMP2, and 





3) Individual gene loci demonstrate clear examples of cell type specific differences  
Cartilage biomarkers (COL2A1 and COMP) were upregulated in the chondrogenic cell lines 
at later time points (Figure 2.6). While their steady state mRNA levels were also increased in 
fibroblast cultures towards the end of the experimental period, the relative levels compared 
to the chondrogenic cell cultures were consistently lower in non-chondrogenic cell cultures 
(COL2A1, from 24h to 336h; COMP, at all post-chondrogenic induction time points; Figure 
2.5.a and c). 
 
 
Figure 2.6. Steady state mRNA levels of classic cartilaginous biomarkers across the 
experimental period. Fold changes were calculated based on the positive control sample 
(pooled equine adult tissue and fetus RNA). Mean ± SEM (n=7); a) COL2A1; b) COMP 
 
There were examples of genes that resulted in unique regulation patterns in either 
interzone or anlagen cell cultures compared to the other two cell types over the time course. 
Changes in steady state mRNA levels of ABI3BP showed a clear example of downregulation 
(Figure 2.7.a), and those of PRKG2 showed an example of minimal expression (Figure 2.7.b) 
specifically in interzone cell cultures during the experimental period. In contrast, PANX3 was 
upregulated only in anlagen cell cultures toward the later time points while its mRNA levels 
a)          b)  
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Figure 2.7. Steady state mRNA levels of example genes that were differentially regulated in 
interzone cell cultures compared to the other cell types across the experimental period. Fold 
changes were calculated based on the positive control sample (pooled equine adult tissue and 
fetus RNA). Mean ± SEM (n=7); a) ABI3BP was downregulated and b) PRKG2 was not expressed 
only in interzone cell cultures. 
 
 
Figure 2.8. Steady state mRNA levels of an example gene that was differentially regulated in 
anlagen cell cultures compared to the other cell types across the experimental period. Fold 
changes were calculated based on the positive control sample (pooled equine adult tissue and 
fetus RNA). Mean ± SEM (n=7); PANX3 was upregulated only in anlagen cell cultures towards 
later time points. 













The present study was conducted to test the hypothesis that divergent chondrogenic 
pathways in interzone and anlagen cell cultures will be evident within the earlier time frame—
within the first 24 hours after inducing in vitro chondrogenesis. In all three cell types including 
the negative control fibroblasts, changes in steady state mRNA levels in a subset of the 
targeted genes started as early as 1.5 hours after initiating the chondrogenic induction. All 
genes that showed responses at 1.5h had functional annotation categorized in regulatory 
events such as transcription or signal transduction. Moreover, initial responses in transcription 
regulatory events in the two chondrogenic cell lines occurred within the first 24 hours, while 
delayed responses were observed in the negative control (Table 2.3). The earlier changes in 
these regulatory genes likely diverge chondrogenic pathways in interzone and anlagen cell 
cultures, and differences may provide insight into divergent aspects of their chondrogenic 
fate. From the pairwise comparisons between interzone and anlagen cell cultures at each time 
point, starting mRNA levels of 73 genes were not significantly different. For the 47 genes that 
differentially responded to the TGF-1 chondrogenic induction at some point in the 336-hour 
of experimental period, 12 significantly changed within the first 24 hours (Table 2.4; Figure 
2.5.c). Thus, the results support the hypothesis tested in this study. 
 
Relationship between early and delayed gene expression changes  
The first responses to the chondrogenic induction measured at 1.5h were involved in 
either transcription regulation or signal transduction while no ECM related genes changed 
their mRNA levels at the first collection point. The majority of first responses were observed 
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within the first 24 hours in all three annotation groups: at 3h in the transcription group, 6h in 
the signaling group, and 12h in the ECM group. Most of the initial changes in transcription 
regulatory category occurred within a day (0 – 24h), while about 40% of the first responses in 
the signaling group and the ECM group occurred after 24 hours. In fact, no gene loci in the 
ECM related genes had no response at the first collection point in any cell cultures (Table 2.2; 
Figure 2.4). Taken together, the results demonstrate a sequence whereby genes encoding 
proteins functionally annotated in transcription, signaling events, and ECM are expressed in 
roughly that order: altered transcriptional events leading to subsequent changes in signaling 
cascades and finally the effector genes involved in ECM biology. 
 
The model derived from this observation is that transcription regulating genes might be 
primary genes required for secondary changes in downstream signaling events and ECM 
accumulation. To define “(early) primary” and “(delayed) secondary” genes from a 
perspective of cell biology, an experiment designed to include protein synthesis inhibitors 
must be performed (Yamamoto and Alberts, 1976). If a gene changes its expression levels 
under the presence of protein synthesis inhibitors, it can be called “primary” response 
because it does not require de novo protein synthesis to change its expression levels. 
Therefore, to further elucidate these relationships and identify if the responses were either 
primary or secondary, a mechanistic experiment will be required. 
 
It is interesting to note that, all changes in mRNA levels observed at 1.5h (Table 2.2) were 
upregulation compared to the baseline (Figure 2.2.a and c). On the other hand, 
downregulation started to be detected by 3h. This may confirm that degradation of 
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transcripts requires more time than de novo synthesis (Eser et al., 2014). Regulatory genes 
may have relatively faster decay rates in order to rapidly alter signal transduction; all the 
genes that showed their first responses as downregulation between 3 – 6h were involved in 
either transcription or signaling events, except for two cases (Figure 2.2.b and c). 
 
There were only a few genes that showed changes at the 0h time point compared to P4 
monolayer cell cultures, indicating little subsidiary effects of the chondrogenic induction 
protocol besides the chondrogenic stimuli treatment (Figure 2.3). These genes are generally 
involved in cell migration and adhesion (Hashimoto et al., 2005, Scott et al., 2007, Zeng et al., 
2007, Shwartz et al., 2016, Ogle et al., 2017), and thus the results may suggest that being 
lifted from monolayers and spun down to form pellets might require the cells to alter gene 
expression regulating these biological processes regardless of cell types. 
 
Differential gene regulation between cell types 
Differences between chondrogenic and non-chondrogenic cell cultures 
From the observations made in individual cell types over the time course, delayed 
responses in all functional annotation categories were observed in the fibroblasts compared 
to the either interzone or anlagen cells (Table 2.3). While this may well be attributed to 
chondrogenic potential of the cell types and relative sensitivity to the induction medium, it is 
important to note that the targeted gene loci were selected based in part on established 
annotations related to chondrogenesis and expression in skeletal tissues. As such, there is a 




Consistent with their established functional annotations, COL2A1 and COMP, encoding 
major cartilaginous ECM proteins, were significantly upregulated in the interzone and anlagen 
cell pellets at later time points. The results with these biomarker effector genes confirmed 
their chondrogenic potential (Figure 2.5.a and c; Figure 2.6).  
 
Differences between interzone and anlagen cell cultures 
Interzone and anlagen tissues in equine fetuses at day-45 of gestation are readily 
distinguished morphologically with a dissecting microscope. Along with the morphogenic 
distinction, 14 out of the 87 gene loci targeted started with different mRNA levels at 0h. 
Among the 14 genes, 11 genes still expressed different profiles after inducing chondrogenesis 
(Table 2.4; Figure 2.5.a) and five of them showed the differential patterns only between 
interzone and anlagen cultures but not in the negative control fibroblasts. OMD and RUNX2 
were upregulated in anlagen cell cultures after the chondrogenic induction, and their known 
annotation is related to ECM production in the bone (Ninomiya et al., 2007, Mevel et al., 2019). 
Thus, the results may confirm that anlagen cultures under chondrogenic stimulation 
progressed towards the pathways leading to bone formation. On the other hand, MGP and 
GDF6 were upregulated in interzone cultures, and their reported functional annotations are 
inhibiting ectopic tissue calcification (Luo et al., 1997) and diarthrodial joint formation (Settle 
et al., 2003), respectively. In addition, mRNA levels of PDLIM1, a transcription coactivator gene, 
were greater in interzone cell cultures at the latest time points. From a previous RNA-seq 
dataset generated in the MacLeod lab, this gene was not differentially expressed between 
interzone and anlagen tissue lineages from 45-day-old equine fetuses and neonatal foals, but 
the expression of PDLIM1 was 3.41 fold greater (P<0.0001) in interzone tissue compared to 
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cartilaginous anlagen from 60-day-old fetuses (Adam et al., in preparation). The present 
results and the previous data may suggest that this transcription regulatory gene might 
become upregulated in interzone at a later stage during articular cartilage development. 
Taken together, expression patterns of these genes in the culture model are consistent with 
the articular and hypertrophic cartilaginous tissue outcomes of interzone and anlagen cells 
respectively. 
 
Interestingly, three genes that started with different steady state mRNA levels in interzone 
and anlagen cells, lost those differences after inducing chondrogenesis across the entire 
experimental period (Table 2.4; Figure 2.5.b). Two of the three, COL2A1 and COMP, are major 
cartilaginous ECM genes. These data are consistent with the induction medium driving both 
cell lines to produce common cartilaginous ECM under the same chondrogenic stimulation.  
 
As noted above, steady state mRNA levels for 73 of the 87 targeted gene loci were not 
significantly different at the initial 0h time point. In comparing cell types, gene expression 
either diverged or changed in a similar way. Forty seven genes differentially responded to the 
chondrogenic induction (Table 2.4; Figure 2.5.c), but only nine of these were specific to the 
comparison between interzone and anlagen pellets. FGF1 was upregulated early (6h) in 
anlagen cultures and justifies further investigation. For the other 26 genes, the changes 
displayed profile similarities after the chondrogenic induction (Table 2.4; Figure 2.5.d). GDF5 
is an established interzone biomarker (Bi et al., 1999, Hyde et al., 2007), but in this in vitro 
model using primary cells derived from day 45 equine fetuses, its mRNA profiles were not 
different between interzone and anlagen cultures at both pre- and post-chondrogenic 
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induction time points. The discrepancy between the current data and the previous findings in 
other species may be due to differences in developmental age. Similarly, while ALPL is known 
to be involved in bone mineralization (Golub and Boesze-Battaglia, 2007), its mRNA levels 
were not different between the two chondrogenic cell cultures. This may not be surprising 
given that the culture system was not intended to model osteogenesis.  
 
Several gene loci displayed clear cell type-specific expression profiles. Example of unique 
steady state mRNA levels in interzone cell cultures were ABI3BP and PRKG2 (Figure 2.7). 
ABI3BP is a novel ECM gene and is required to switch the cellular status from proliferation to 
differentiation in mesenchymal stem cells (Hodgkinson et al., 2013). The mRNA levels of this 
gene were initially greater in interzone cell cultures compared to the other cell lines (Figure 
2.5.a), started to decrease by 96h (Figure 2.2.b), and became as low as the other cell lines at 
the last time point. In literature, this gene was differentially upregulated in articular cartilage 
compared to hypertrophic growth plate both in vivo and in vitro (Hissnauer et al., 2010). In 
contrast, mRNA levels of PRKG2 were minimal and remained unchanged over time in 
interzone cell cultures (Figure 2.2.d) while this gene became upregulated in the other two cell 
lines at later time points (Figure 2.2.a). PRKG2 is known to be involved in mammalian skeletal 
development, and its null mutation resulted in 23 – 30% decreased length of limb bones 
(Pfeifer et al., 1996) due to impaired chondrocyte hypertrophy (Kawasaki et al., 2008). Thus, 
the present data indicate that interzone cell cultures had less hypertrophic potential 
compared to the other two cell types.  
 
PANX3 was a locus specifically upregulated in anlagen cell cultures compared to the other 
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cell cultures (Figure 2.8). This gene is expressed in cartilaginous anlagen of a developing limb 
(Bond et al., 2011), and when PANX3 was knocked down, hypertrophic differentiation was 
delayed and attenuated (Oh et al., 2015). Consistent with its functional annotation, the 
patterns of its mRNA levels across the experimental period confirmed the greater 
hypertrophic potential in anlagen cell cultures. 
 
In summary, results demonstrated that while interzone and anlagen cells are both 
chondrogenic, they display some clear differences in response to the same TGF-β1 
chondrogenic induction signal. Data from this in vitro model had several gene expression 
profiles broadly consistent with well-established developmental fates of interzone and 
anlagen cells within limb buds. 
 
Future direction 
Although the current study reports interesting time point differences and examples of 
genes that may render interzone and anlagen cell cultures unique, there are important 
questions remaining: 1) how would the kinetics of gene expression change at a transcriptome 
level and 2) what would be the key regulator(s) of differential chondrogenic pathways 
between these cell lines? 
 
The present study focused on the 93 selected genes that have differential gene expression 
levels between interzone and anlagen tissues or functional annotations related to fetal 
skeletal development. However, there are more than 20,000 structurally annotated protein 
coding gene loci in mammals. Therefore, whole-transcriptome analyses at critical time points 
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may also reveal important regulator or effector genes that have conventionally received less 
attention. By conducting pathway analyses on the transcriptomic data, critical signaling 
mechanisms that regulate divergent chondrogenic differentiation pathways may be identified.  
 
Conclusion 
In conclusion, the results confirmed the chondrogenic potential of interzone and anlagen 
cells, but they also documented distinct functional responses to the same chondrogenic 
stimulation. The new information elucidated by this study centers on expression kinetics of 
the targeted genes with established functional annotation relevant to chondrogenesis, 
cellular responses to TGF-β1, and the regulation of cellular differentiation. Overall, 
transcription regulatory responses preceded the other responses in signal transduction or 
ECM maintenance, and effector genes involved in ECM biology showed relatively delayed 
responses compared to regulatory genes. The data demonstrated that ‘(early) primary’ 
regulatory gene expression changes start as early as 1.5 hours after inducing chondrogenesis, 
followed by changes in expression profiles of ‘(delayed) secondary’ effector genes at later 
time points. Further investigation is required at a transcriptome level to identify key 
regulators and pathways that drive differential chondrogenesis in interzone and analgen cells 




Chapter 3. Transcriptomic divergence between equine fetal interzone and anlagen cells 
during in vitro chondrogenic induction 
 
Introduction 
Different chondrogenic pathways are involved in developmental processes of limb 
skeletal elements in mammals starting early in fetal development and continuing through 
gestation and even into the postnatal period (Shimizu et al., 2007, Pitsillides and Ashhurst, 
2008). The initial chondrogenesis occurs in the mesenchymal condensation of a limb bud 
resulting in cartilaginous tissue formation. In developing limb tissues, SOX9 is expressed from 
the proliferating chondrocytes (Ng et al., 1997) and promotes expression of cartilaginous 
marker genes, COL2A1, ACAN, and COMP (Bi et al., 1999, Akiyama et al., 2002). Then, this 
continuous—uninterrupted—cartilaginous anlage becomes segmented into several units, 
which serve as templates of limb bones, separated by a different developmental tissue called 
the interzone which develops into all of the structures and tissue types present in synovial 
joints. Early developmental events of interzone are characterized by the decreased 
expression of chondrogenic biomarkers such as SOX9, COL2A1, and ACAN, and increased 
expression of interzone markers such as GDF5, WNT9A, CHRD, and ENPP2 (Bi et al., 1999, 
Karsenty and Wagner, 2002, Pacifici et al., 2005). While chondrocytes in anlagen progress 
through hypertrophic differentiation during endochondral ossification, a subset of the cells in 
interzone tissue that paused chondrogenic differentiation resume chondrogenesis and 
differentiate into articular chondrocytes. Even though several key marker genes in these 
processes have been reported in the literature, details related to the kinetics of gene 
expression have not been fully understood. 
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Beyond understanding developmental processes of skeletogenesis, the importance of 
comprehending comparative cell biology of interzone and anlagen cells likely has relevance 
to stark differences in the intrinsic ability of articular cartilage and bone tissue to repair 
structural defects. While bone fractures repair well by recapitulating the developmental 
process, articular cartilage has a very limited capacity to heal lesions. To study the cell biology 
of equine interzone and anlagen, primary cell cultures derived from fetal limb tissues 
collected at day 45 of gestation were studied before and 21 days after the in vitro induction 
of chondrogenesis (Adam, in preparation). In this previous RNA-seq study, transcriptomic 
profiles of interzone and anlagen cell cultures were relatively similar at the start of the 
experiment, but substantially diverged 21 days after being grown under the exact same 
chondrogenic induction conditions. 
 
In a follow-up set of experiments to understand the biology of these chondrogenic cell 
lines, as reported in Chapter 2 of this thesis, the kinetics of gene expression profiles of 93 
selected genes in equine fetal interzone and anlagen cell pellets grown in a chondrogenic 
medium were evaluated by RT-qPCR at 10 time points, specifically 0, 1.5, 3, 6, 12, 24, 48, 96, 
168, and 336 hours after inducing in vitro chondrogenesis. The results confirmed that both 
cell lines are chondrogenic, but showed clear differences in expression profiles of certain 
regulatory genes starting even with the first 1.5h sample, as well as those encoding ECM 
components at subsequent time points. The new information obtained from the experiments 
in Chapter 2 further elucidated the kinetics of gene expression in these cell cultures during 
the 336-hour experimental period, although the findings were based on a finite number of 
the targeted genes. Thus, comparing steady state RNA levels between interzone and analgen 
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cells on a fully transcriptomic scale would provide additional knowledge of individual gene 
loci and functional ontologies while providing the opportunity for a much more rigorous 
assessment of important chondrogenic and other cell biology pathways. 
 
Therefore, the objective of the present study was to elaborate chondrogenic divergence 
between interzone and anlagen cell cultures at a whole transcriptome level under the same 
chondrogenic induction conditions. By analyzing transcriptomic data, potential candidate 
regulators that diverge the chondrogenic pathways between these two skeletal cell lines 
might be identified. The hypothesis tested in this chapter was that chondrogenic divergence 
between interzone and anlagen cell cultures will be initiated by differentially expressed 
regulatory genes within the first 1.5 hours, and more distinctive characteristics represented 
by the activation of different pathways and acquisition of distinguishing ECM profiles will 
accumulate as time passes in culture. 
 
Materials and Methods 
Cell culture  
Interzone cells, anlagen cells, and dermal fibroblasts (negative control) from day-45 
equine fetuses were previously harvested (Adam et al., 2019) and used for chondrogenic 
differentiation experiments as reported in Chapter 2 of this thesis. A subset of these RNA 
samples were used for the present transcriptomic analysis. Briefly, three-dimensional cell 
pellet cultures were established at passage 5 and treated with a chondrogenic induction 
medium containing TGF-1 (10 ng/ml). Then, cell pellets were collected at 10 different time 
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points during the 336-hour experimental period, followed by total RNA extraction for gene 
expression analyses. The subset of these samples were analyzed further in the current chapter, 
specifically six biological replicates at each of five collection points (0, 1.5, 3, 12, and 96h). 
Including the baseline, these time points were prioritized based on the study results reported 
in Chapter 2. By 1.5h, regulatory genes started to respond to the chondrogenic stimulation. 
At 3h, the major peak of overall first gene expression responses was observed. A second major 
peak of first responses of transcription regulatory genes was observed at 12h. Finally, most 
effector genes involved in ECM maintenance were exhibiting changes in steady state RNA 
levels by 96h after initiation of chondrogenic induction. More detailed procedures are 
described in the Materials and Methods section in Chapter 2. 
 
RNA sample preparation 
For bulk RNA-seq, any potential genomic DNA contamination in the total RNA isolates was 
removed using an RNase-Free DNase kit (cat No. 79254; Qiagen). The post-DNase step 
concentration of RNA was measured by a Qubit® 3.0 Fluorometer (cat No. Q33216; Life 
Technologies) with a Qubit® RNA Broad Range Assay Kit (catalog No. Q10211; Life 
Technologies). Both purity and RNA structural integrity was assessed using a Bioanalyzer 2100 
(Agilent Technologies) with an Agilent RNA 6000 Pico kit (catalog No. 5067-1513; Agilent 
Technologies). All samples resulted in RIN values >8. The samples were diluted with nuclease-
free water to 20 ng/ul and frozen at –80 °C. Then, 1,000 ng of each sample was shipped to the 
Roy J. Carver Biotechnology Center (University of Illinois at Urbana-Champaign, Urbana, IL, 




Bulk RNA sequencing 
Construction of cDNA libraries from the RNA samples was conducted using a TruSeq 
Stranded mRNA kit (cat #. 20020595, Illumina). In the protocol, the samples were purified 
using poly-T oligo-attached magnetic beads and fragmented into smaller pieces (average 
library fragment size of 440 bp) by divalent cations under increasing temperature. The strand 
orientation was distinguished using Actinomycin D. In turn, Illumina Read 1 adaptors (P5) were 
ligated to the antisense strands, and Read 2 adaptors (P7) including sample-specific barcoding 
sequences (i7 index) were added to the sense strands. After the adaptor ligation step, the 
libraries were amplified by PCR for 14 cycles and quantitated by qPCR. The amplified individual 
libraries (100 ng/each) were pooled. The pool was diluted to 5nM, and 9 ul of the pool was 
loaded into an S4 lane on a NovaSeq 6000 (Illumina) for the sequencing. The cDNA libraries 
were sequenced for 151 cycles from each end of the fragments (total 302 cycles) with 
NovaSeq S4 reagents (cat. # 20027466; Illumina). The sequence Fastq files were generated 
and demultiplexed with the bcl2fastq v2.20 Conversion Software (Illumina). Quality scores 
were accessed by FastQC v0.11.9. 
 
Data analysis pipeline 
Once the resulting Fastq files were transferred to the University of Kentucky from the Roy 
J. Carver Biotechnology Center, adaptor sequences were trimmed out by Trim Galore v0.6.5. 
The trimmed reads were mapped onto the latest equine reference genome (EquCab 3.0, 
GCA_002863925.1; Kalbfleisch et al., 2018) using Tophat (v2.0.8) and quantified with an 
ENSEMBL equine gene structure annotation database (v98) through the Cufflinks (v 2.2.1) 
pipeline (Trapnell et al., 2012). Read counts were normalized to the fragments per kilobase of 
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transcript per million mapped reads (FPKM) unit. 
 
Differential expression analysis 
Using the CuffDiff function in Cufflinks (v 2.2.1), differentially expressed genes (DEGs) 
were evaluated with focuses on 1) profiling kinetics of steady state mRNA changes within a 
cell type, 2) identifying common chondrogenic traits of interzone and anlagen cells relative to 
fibroblasts, and 3) characterizing differences between the two chondrogenic cell lines during 
in vitro chondrogenesis. The thresholds defining differential expression were log2 fold change 
(FC)>|1| and the false discovery rate (FDR) adjusted P-value<0.05. The DEGs were visualized 
in a heatmap or a volcano plot using R packages (gplot, Warnes et al., 2015; EnhancedVolcano, 
Blighe et al., 2019). 
 
Gene ontology enrichment analysis 
Gene ontology (GO) enrichment analyses were conducted with DEGs by the Functional 
Annotation Tool from DAVID Bioinformatics Resources (v6.8; https://david.ncifcrf.gov; Huang 
et al., 2009)) to systemically describe the DEGs with a focus on biological processes. The 
results were either listed in tables or visualized using GOplot (Walter et al., 2015). 
 
Hub gene analysis 
Hub gene analyses were conducted using an R package, WGCNA (Weighted gene co-
expression network analysis, v1.66), to identify modules of highly correlated genes with the 
time sequence within a cell type. Gene significance (GS) of a gene was assessed based on the 
correlation of the gene with the trait (in this case, the time course). Module eigengene (ME) 
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groups were defined by module-trait relationship scores ranged from -1 to 1, and the module-
trait score closest to 1 represents the most correlated features with the trait. Module 
membership (MM) of a gene was determined by the correlation of its expression profile with 
each ME group. Genes that have GS>0.8 and MM>0.9 with the most significant ME group 
were used to build a gene co-expression network within a cell type (Cytoscape, v2.8.3).  
 
Upstream pathway prediction 
Upstream regulators identified computationally as having an increased potential of being 
responsible for differential gene expression profiles 1) between two consecutive time points 
within a cell type and 2) between interzone and anlagen cell types at each time point were 
predicted using the Ingenuity Pathway Analysis (IPA) software (Qiagen). The differential 
expression data input cutoffs for this analysis were log2FC>|0.3| and FDR adjusted P-
values<0.05. From the analysis results, when a P-value of overlap was less than 0.05 and an 
activation z-score was greater than or equal to |2|, the predicted genes were likely to be 
upstream regulators which distinguished between two conditions being compared: 1) a time 
point vs. its previous time point within a cell type or 2) interzone cell cultures vs. anlagen cell 





Sequencing depth of all samples (90 samples total, reflecting 3 cell types × 5 time points 
× 6 biological replicates) ranged from 29 – 45 million paired-reads per sample (average of 35 
million paired-reads/sample; Table 3.1). Phred scores were greater than 30 at all base 
positions in all 90 samples (base call accuracy > 99.9%; Figure 3.1). With an average mapping 
efficiency of 95.0%, the sequencing of the entire sample set resulted in well-balanced 
mapping rates onto the latest version of the equine reference genome (EquCab 3.0; 
Kalbfleisch et al., 2018; Table 3.2).  
 
 
Figure 3.1. Phred scores of the 90 samples assessed by FastQC v0.11.9. Each green line 
represents each sample.  
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Table 3.1. Sequencing depth of all samples, million paired-reads/sample 
 Interzone cell cultures Anlagen cell cultures Fibroblast cultures 
Time point 
Biological replicate 
0h 1.5h 3h 12h 96h 0h 1.5h 3h 12h 96h 0h 1.5h 3h 12h 96h 
H1 31 40 36 34 35 39 34 36 34 33 29 33 45 35 40 
H2 34 35 35 37 37 35 40 30 34 35 32 38 32 36 38 
H5 32 34 33 38 33 38 40 37 37 32 33 35 39 40 35 
H6 35 35 32 42 36 34 43 37 33 33 34 35 33 34 32 
H9 32 39 38 34 32 37 37 32 34 37 36 40 35 39 37 
H11 39 38 43 39 40 34 36 35 32 34 34 38 31 30 36 
  
Table 3.2. Mapping efficiency of all samples, % 
 Interzone cell cultures Anlagen cell cultures Fibroblast cultures 
Time point 
Biological replicate 
0h 1.5h 3h 12h 96h 0h 1.5h 3h 12h 96h 0h 1.5h 3h 12h 96h 
H1 95.2 95.1 95.0 95.1 95.1 95.1 94.8 94.9 95.0 95.1 95.6 95.3 95.3 94.9 94.6 
H2 95.2 95.4 95.4 95.0 95.2 95.2 95.4 95.5 95.4 95.0 95.2 95.4 95.2 95.0 94.7 
H5 95.5 94.9 95.1 95.4 94.7 95.4 95.2 95.4 95.4 95.0 94.4 95.3 95.3 94.7 94.9 
H6 94.6 94.7 94.9 95.0 94.4 94.0 95.0 94.9 94.7 94.9 95.2 95.1 94.5 94.4 94.6 
H9 95.4 95.3 95.4 95.2 95.1 95.3 95.1 94.5 95.3 95.0 95.1 95.3 94.1 94.8 94.8 
H11 95.2 95.2 95.1 95.0 94.9 93.2 94.8 95.0 94.9 94.5 95.1 94.7 95.4 94.6 94.7 
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Kinetics of gene expression profiles within a cell type 
Differentially expressed genes were evaluated between paired time point comparisons 
(0h vs. 1.5h; 1.5h vs. 3h; 3h vs. 12h; 12h vs. 96h) within a cell type. The numbers of DEGs 
determined at a given time point compared to a previous time point are shown in Table 3.3.  
 
The following subsections describe the kinetics of gene expression profiles in each cell 
type evaluated by diverse analyses. First, expression patterns of total DEGs across the entire 
experimental period were visualized. Also, GO enrichment analysis was conducted, and the 
five most overrepresented biological process terms in each subsequent time comparison are 
presented. Hub genes and their co-expression network were defined based on gene 
expression patterns over time. Finally, upstream regulators were predicted in each time 
sequence comparison. 
 
Table 3.3. Number of differentially expressed genes (DEGs) within cell type when compared 
to previous time point 
 Cell type Interzone cell Anlagen cell Fibroblast 
Total unique DEG entities across 
the entire experimental perioda  
2,822 3,784 3,212 
Regulation pattern  
Time point comparison 
UP Down UP Down UP Down 
1.5h based on 0h 141 29 110 16 96 10 
3h based on 1.5h 304 207 234 133 289 118 
12h based on 3h 858 696 1,031 965 988 838 
96h based on 12h 691 742 1,091 1,304 830 1,027 
Total unique DEG entities across 
the entire experimental period 
in each regulation patternb 
1,861 1,532 2,242 2,252 2,026 1,861 
aThe numbers include both upregulated and downregulated DEGs 





1) Interzone cell analyses 
1-a) Expression patterns of DEGs during the experimental period 
Along the time course, interzone cell cultures resulted in 2,822 DEGs: 1,816 genes were 
upregulated, 1,532 genes were downregulated, and 538 genes changed relative directional 
orientation (up- or downregulation) over the experimental period. While the gene expression 
pattern changes between the baseline and the first collection point (1.5h) were not separated, 
a clear distinction of transcriptomic patterns started to be observed by 3h (Figure 3.2.a). Some 
genes that were expressed at a higher level during earlier time points became downregulated 
at later time points, and the opposite was also observed. By 96h, the differential gene 
expression profiles became almost reversed from the baseline. Towards the later time points, 
a greater number of genes were differentially expressed at a time point compared to its 
previous time point (Figure 3.2.b and c). Chronologically closer time comparisons shared more 
common DEGs (Figure 3.2.b and c). 
 
1-b) Gene enrichment analysis 
The five most upregulated and downregulated overrepresented biological processes for 
each time comparison are listed in Table 3.4 and 3.5, respectively. At the earlier time 
sequences, transcription regulatory events were most significantly represented by the profiles 
of both upregulated and downregulated DEGs. Towards the later time points, biological 






1-c) Hub genes and co-expression network 
The most significant gene correlated with the time course was FOLR2 (GS=0.99; P-
value=2.2E-24), and the top ten genes that were highly correlated with the time sequence are 
listed in Table 3.6. All of the ten most significant genes were categorized into the Turquoise 
group by ME identification. Among the 27 ME groups evaluated by WGCNA, the Turquoise 
group had the greatest module−trait relationship (0.96; P-value=1E-17) with the time course 
in interzone cell cultures (Figure 3.3). The co-expression network of the genes, which were 
highly correlated with the Turquoise group, is exhibited in Figure 3.4. The gene that had the 
highest MM with the Turquoise group was OLFML3 (MM=0.98; P-value=7.1E-22). Based on 
existing knowledge, however, interactions of OLFML3 with the other members in the 
Turquoise group were not demonstrated, therefore not shown in Figure 3.4. 
 
1-d) Upstream regulator prediction 
 During the first 1.5 hours, a smaller number of upstream regulators were predicted in 
both activation and inhibition status (Figure 3.5). The greatest number of computationally 
predicted upstream regulators were observed between 3h and 12h. It is interesting to note 
that TGFB1 was predicted to be an upstream regulator from the baseline to 1.5h (z-score=4.95; 
P-value=2.8E-39) while the major chondrogenic factor that was used in the experiment was 






Figure 3.2. Differentially expressed 
genes (DEGs; n= 2,822) over time 
within interzone cell cultures. a) 
DEGs plotted in a heatmap. On the 
right side, time points (#h) and 
biological replicates (H#) are 
labeled. b) UpSet figure of 
upregulated DEGs (n=1,816) 
between time points. c) UpSet 
figure of downregulated DEGs 
(n=1,532) between time points. 
The set size graphs of the UpSet 
figures represent the number of 
DEGs in each time point 
comparison. Note that each 
comparison has a different set 
size. 
b) Upregulated DEGs 
c) Downregulated DEGs  
a) Heatmap  
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Table 3.4. Top five biological process gene ontology (GO) terms of differentially upregulated 
genes in interzone cell cultures during time courses 
Time 
course 
GO ID Term 
P-
valuea 
Differentially expressed genes from the dataset 
0h vs 1.5h 
GO:0000122 
Negative regulation of 
transcription from RNA 
polymerase II promoter 
7.51E-
07 
DLX2, PLK3, EZR, IRF2BPL, NRARP, SMAD7, 
EFNA1, RELB, NR4A2, LMCD1, PER1, FOXC2, 
ID3, SOX9, JUNB, HIC1 
GO:0045944 
Positive regulation of 
transcription from RNA 
polymerase II promoter 
1.92E-
06 
IL6, RELB, F2RL1, CCNL1, NFKBIA, NR4A1, DLL1, 
FADD, SOX9, JUNB, IL11, LIF, ADRB2, IRF2BPL, 
VEGFA, ZC3H12A, PER1, SERTAD1 
GO:0043410 




LIF, TNFRSF1B, ADRB2, IL6, RELT, PDGFB, IL11 
GO:0045892 





GCLC, CRY2, CEBPB, PDGFB, CCDC85B, KLF10, 
RELB, IRF1, ID3, SOX9 
GO:1900745 




GADD45G, ZC3H12A, GADD45B, GADD45A 
1.5h vs 3h 
GO:0006954 Inflammatory response 
4.67E-
05 
TLR10, CCL2, ELF3, TNFRSF25, CSF1, RELB, 
AFAP1L2, NFKB1, TGFB1, CALCB, S1PR3, 






NOTCH1, HEYL, WNT11, ZFPM1, GJA5 
GO:0007219 Notch signaling pathway 
1.22E-
03 







HEYL, WNT11, ZFPM1, PLXND1, GJA5 
GO:0071407 
Cellular response to 
organic cyclic compound 
1.87E-
03 
ALPL, RGS20, CCL2, GLI2, TGFB1 
3h vs 12h 
GO:0060021 Palate development 
5.51E-
04 
MEF2C, DHRS3, SATB2, WDPCP, MEOX2, 
HAND2, DLX5, ARID5B, INSIG1, IFT172, SNAI2 
GO:0050680 





MEF2C, MTSS1, IFT122, CDKN2B, IFT172, GDF5, 
MCC, TINF2 
GO:0071498 




MEF2C, MTSS1, PTGS2, HAS2 
GO:0007155 Cell adhesion 
6.13E-
03 
HAPLN2, HAPLN1, HAPLN4, ICAM5, POSTN, 
NCAM1, ITGA9, COMP, TGFBI, CNTN2, ACAN, 






FLRT3, ASPN, STAT4, IL22RA1, LRRC4B, EPOR, 
DCN, LRRC15, GHR 






BMP4, CSGALNACT1, FGF18, DLX5, COL2A1, 
MMP16, MMP13, SCX 
GO:0070374 
Positive regulation of 
ERK1 and ERK2 cascade 
1.47E-
06 
BMP4, FGF18, BMP2, CCL2, F2RL1, CHI3L1, 
CCL19, FGF10, CD74, CCL11, SPRY2, ARRB1, 






BMP4, BMP2, WNT5B, OSR2, GDF5, COL2A1, 
COL11A2, SCX 
GO:0032331 





BMP4, RARG, GDF5, NKX3-2, SNAI2, GREM1 
GO:0090090 
Negative regulation of 




NKD1, NOG, AMER1, BMP2, WNT5B, DACT1, 
PRICKLE1, SNAI2, FRZB, WWTR1, GREM1, GLI3, 
GLI1 




Table 3.5. Top five biological process gene ontology (GO) terms of differentially 
downregulated genes in interzone cell cultures during time courses 
Time 
course 
GO ID Term 
P-
valuea 
Differentially expressed genes from the dataset 
0h vs 1.5h 





0.018 EGR1, SIX1, CITED2, ZNF2 




0.044 SPRY1, SIX1 
GO:0043407 
Negative regulation 
of MAP kinase 
activity 
0.049 SPRY1, RGS2 
1.5h vs 3h  
GO:0035914 








of transcription from 




MEF2C, ATF7IP, SATB2, FGF9, EDN1, KLF11, NR4A2, 
CBX4, NR4A3, GLI3, DLX2, OSR2, REL, IRF2BPL, 













INHBA, COL9A3, FGF9, ARID5B, BCL2, KITLG, LHX9, 
CITED2 
GO:0060021 Palate development 
1.28E-
05 
MEF2C, INHBA, SATB2, OSR2, ARID5B, CSRNP1, 
COL2A1, GLI3 
3h vs 12h  
GO:0043066 
Negative regulation 
of apoptotic process 
1.82E-
05 
IER3, IL6, EGR3, ACTC1, LIMS2, NUAK2, SOCS3, 
SMAD6, BTC, ASNS, GLI2, IGF1R, ATF5, SPRY2, 
STK40, PTK2B, ID1, CHST11, THOC6, AVEN, RARA, 
MYC 
GO:0030335 




FLT1, WNT5B, PDGFB, LYN, TGFBR1, FAM110C, 
EDN1, MYADM, CCL26, CCL11, IGF1R, NOTCH1, 
SEMA3E, CEMIP, PLAU 
GO:0035994 










SGK1, SOCS2, LYN, NUAK2, SPSB1, TGFBR1, PRKAG2, 
PRKCI, CXCL8, PRKCG, RPS6KA5, HUNK, RASSF5, 
STAC, TIAM2, CDC42BPA, GUCY1A2, SH2B3, RGS7, 






TNFRSF21, TLR10, IL6, CCL2, ELF3, LYN, IL18, CSF1, 
TLR1, ACKR1, ANXA1, CXCL8, NFKB1, BDKRB1, 
CCL26, CCL11, TNFRSF1B, CCL20, RELT 
12h vs 96h 
GO:0001666 Response to hypoxia 
2.17E-
06 
CAV1, CRYAB, EGLN3, TGFB3, SMAD3, EGLN1, DDIT4, 
VEGFC, HSP90B1, LONP1, MYOCD, VEGFA, LOXL2, 
ALKBH5 
GO:0006096 Glycolytic process 
2.57E-
05 
GPI, TPI1, ALDOC, PGAM1, HK1, PGK1, GAPDH, ENO1 
GO:0007155 Cell adhesion 
1.22E-
04 
B4GALT1, ATP1B1, ACHE, ICAM5, PCDH10, ITGA1, 
ACKR3, ITGA3, TINAGL1, ADGRG1, ITGAX, ITGA8, 
SULF1, CNTN2, GP1BA, CNTN4, THBS2 
GO:0002931 Response to ischemia 
1.33E-
04 
HYOU1, CAV1, UCHL1, CAMK2A, FAIM2, CIB1 
GO:0007507 Heart development 
1.47E-
04 
PDGFB, FOXJ1, SOD2, GATA2, ACVR2B, ADAP2, ECE1, 
ADM, OSR1, JMJD6, GYS1, EPOR, LOX, BCOR 




Table 3.6. Ten most highly correlated hub genes with time course in interzone cell cultures 
during entire experimental period 




FOLR2 Turquoise 0.988 2.19E-24 0.954 3.80E-16 
ITGA10 Turquoise 0.983 5.42E-22 0.942 7.88E-15 
PRELP Turquoise 0.981 1.45E-21 0.967 4.23E-18 
LOXL4 Turquoise 0.981 1.50E-21 0.931 8.56E-14 
KCNN4 Turquoise 0.977 1.95E-20 0.955 2.87E-16 
FMOD Turquoise 0.976 4.26E-20 0.944 5.52E-15 
COL24A1 Turquoise 0.975 6.34E-20 0.972 3.31E-19 
PODNL1 Turquoise 0.971 4.93E-19 0.955 2.26E-16 
GABRE Turquoise 0.971 7.01E-19 0.960 5.97E-17 
AEBP1 Turquoise 0.969 1.32E-18 0.958 8.74E-17 
aME, Module eigengene 




Figure 3.3. Module eigengene (ME) groups 
with module−trait relationship scores in 
interzone cell cultures over time. P-values 
are shown in the parentheses. The higher 
relationship score represents the greater 
correlation between a ME group and the 




Figure 3.4. Hub gene co-expression network in interzone cell cultures during 96 hours of in 





Figure 3.5. Upstream regulators predicted by Ingenuity Pathway Analysis (IPA) between subsequent time points in interzone cell cultures. 
The activation status thresholds were activation z-score>|2| and P-value of overlap<0.05. Only genes that have log2 fold change (FC)≥|1| in 
the dataset were presented in the figure. Positive z-scores represent activated upstream regulators, and negative values indicate inhibition. 
When a predicted activation status (activation or inhibition) matched the regulation pattern analyzed from the dataset (positive 
log2FC=upregulation; negative log2FC=downregulation), the prediction was accepted. aOthers include enzymes, kinases, and others. bSignal 
transduction includes growth factors, ligands, receptors, and cytokines. 
*CPMX1 and MEOX2 are also hub genes in interzone cell cultures whose expression patterns are highly correlated with the time course. 
**In the data, log2FC of TGFB1 from 0h to 1.5h was 0.94.   
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2) Anlagen cell analyses 
2-a) Expression patterns of DEGs during the experimental period 
Over the entire experimental period, 3,784 DEGs were observed in analgen cell cultures: 
2,242 genes were upregulated, 2,252 genes were downregulated, and 710 genes were 
overlapped between the lists of upregulated and downregulated DEGs. The transcriptomic 
profiles were not discriminative from the baseline until 3h (Figure 3.6.a). Of note, one 
biological replicate (Horse #6) at 0h and 1.5h had gene expression patterns more closely 
clustered to those of its own at 3h than those of the other biological replicates at 0h and 1.5h. 
Except for this case, the overall gene expression profiles were clustered by time point. A clear 
distinction of the transcriptomic characteristics was observed by 12h, and the initial gene 
expression patterns became almost opposite by 96h. Similar to interzone cell cultures, more 
common DEGs were recorded between chronologically closer time point comparisons, and 
fewer common DEGs were shared between time point comparisons with greater time gaps 
(Figure 3.6.b, and 6.c).  
 
2-b) Gene enrichment analysis 
The five most overrepresented biological processes at each time sequence analyzed from 
the upregulated and downregulated DEGs in anlagen cell cultures are listed in Table 3.7 and 
3.8, respectively. Only 3 biological processes were found to be over-represented from the 
downregulated DEGs at 1.5h based on 0h. During the first 1.5 hours, transcription regulatory 
events were most significantly upregulated. Regulatory processes in signaling cascades were 
observed during the entire experimental period. Finally, biological processes related to ECM 
metabolism were overrepresented in the last time comparison (between 12h and 96h). 
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2-c) Hub genes and co-expression network 
The most significant hub gene correlated with the time sequence in analgen cell cultures 
was SEMA6A (GS=0.99; P-value=6.4E-25), with the top ten listed in Table 3.9. The ME 
identification categorized these ten genes into the Brown group, and this group had the 
highest module−trait relationship (0.96; P-value=2E-17) with the time course in anlagen cell 
cultures (Figure 3.7). The co-expression network of the hub genes that were greatly correlated 
with the Brown group is shown in Figure 3.8. The gene that showed the highest MM with the 
Brown group was GXYLT2 (MM=0.99; P-value=1.6E-24), however, interactions of this gene 
with the other members in the Brown group are unknown. FMOD had the second highest MM 
with the Brown group (MM=0.99; P-value=3.2E-23) and centered in the co-expression 
network, interacting with 9 members in the Brown group. 
 
2-d) Upstream regulator prediction 
 Similar to interzone cell cultures, greater upstream regulators were predicted towards the 
later time sequences in both activation and inhibition status (Figure 3.9). Also, TGFB1 was 
predicted to be an activated upstream regulator during the first 1.5 hours (z-score=4.19; P-
value=9.4E-36). However, during the last time sequence (12h – 96h), inhibition of TGFB1 was 






Figure 3.6. Differentially expressed 
genes (DEGs; n=3,784) over time 
within anlagen cell cultures. a) 
DEGs plotted in a heatmap. On the 
right side, time points (#h) and 
biological replicates (H#) are 
labeled. b) UpSet figure of 
upregulated DEGs (n=2,242) 
between time points. The set size 
graph represents the number of 
DEGs in each time point 
comparison. c) UpSet figure of 
downregulated DEGs (n=2,252) 
between time points. The set size 
graphs of the UpSet figures 
represent the number of DEGs in 
each time point comparison. Note 
that each time comparison has a 
different set size. 
 
b) Upregulated DEGs 
c) Downregulated DEGs  
a) Heatmap  
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Table 3.7. Top five biological process gene ontology (GO) terms of differentially upregulated 
genes in anlagen cell cultures during time courses 
Time 
course 
GO ID Term 
P-
valuea 
Differentially expressed genes in the dataset 
0h vs 1.5h 
GO:0000122 
Negative regulation of 
transcription from RNA 
polymerase II promoter 
2.21E-
06 
DLX2, PLK3, IRF2BPL, NRARP, SMAD7, EFNA1, 
NR4A2, LMCD1, PER1, FOXC2, ID3, SOX9, JUNB, 
HIC1 
GO:0045892 





CRY2, CEBPB, PDGFB, ELF3, CCDC85B, KLF10, IRF1, 
ID3, SOX9, SOX8 
GO:0045944 
Positive regulation of 
transcription from RNA 
polymerase II promoter 
1.48E-
05 
CRTC1, NFKBIA, NR4A1, DLL1, FADD, SOX9, SOX8, 
JUNB, IL11, LIF, IRF2BPL, VEGFA, ZC3H12A, PER1, 
NFATC1 
GO:1900745 




GADD45G, ZC3H12A, GADD45B, GADD45A 
GO:0043153 
Entrainment of 




CRY2, PER1, BHLHE40, SIK1 
1.5h vs 3h 
GO:0071456 




PDGFB, HMOX1, VEGFA, FAM162A, AQP1, 
ANGPTL4 






ZNF566, PPARG, HR, ZNF175, ABCG1, ZNF2, 
RGS20, ZNF691, JMJD6, ZSCAN20, HEYL, ZNF404, 




0.007 CHST11, CHST3, CHSY1 
GO:0043536 




0.012 PDGFB, VEGFA, ANGPTL4 






FLRT3, ASPN, IL22RA1, LRRTM1, LRRC4B, GP1BA, 
EPOR, DCN, LRRC15, GREM2, CISH, GHR 
GO:0046426 




FLRT3, ASPN, LRRTM1, LRRC4B, GP1BA, DCN, 
LRRC15, CISH 
GO:0006469 
Negative regulation of 
protein kinase activity 
0.003 
FLRT3, ASPN, LRRTM1, LRRC4B, TRIB3, GP1BA, 
DCN, LRRC15, CISH, TRIB2 
GO:0035023 




PLEKHG4, DLC1, OBSCN, PLEKHG1, ARHGEF26, 
ARHGEF25, TIAM1, PLEKHG5, ARHGEF9, EPS8L1, 
FGD4 
GO:0007507 Heart development 0.003 
ZFP36L1, ADAP2, ADM, FOXJ1, TRPS1, COL3A1, 
ACAN, GYS1, NFATC4, EPOR, CACNA1C, CXADR, 
SOD2 






CTSK, MMP9, MMP16, CTSS, MMP14, MMP13, 
MMP2 
GO:0032331 





CHADL, RARG, GDF5, NKX3-2, GLI2, SNAI2, SOX9, 
GREM1 
GO:0090090 
Negative regulation of 




NOG, BMP2, FOXO1, RGS19, LEF1, SOX9, GREM1, 







MPZL3, EGFL6, MMP9, OLFML2B, ADAMTSL4, 
POSTN, SOX9, CSGALNACT1, SMOC2, TNFRSF11B, 






NOG, WNT4, HIF1A, LEF1, LOXL3, SOX9 




Table 3.8. Top five biological process gene ontology (GO) terms of differentially 
downregulated genes in anlagen cell cultures during time courses 
Time course GO ID Term 
P-
valuea 
Differentially expressed genes in the 
dataset 
0h vs 1.5h 
GO:0035914 




FOS, EGR2, CITED2 
GO:0070373 
Negative regulation of 
ERK1 and ERK2 cascade 
0.028 SPRY1, DUSP6 
GO:0007179 
Transforming growth 
factor beta receptor 
signaling pathway 
0.034 FOS, CITED2 
1.5h vs 3h 
GO:0035914 




EGR1, FOS, ATF3, EGR2, BTG2, MYF5, 
ANKRD1 
GO:0008543 












HES1, EGR1, HHEX, EGR3, EGR2, MEOX2, 





0.008 CEBPB, PTGER4, DUSP10, TRIB1 
GO:0045444 Fat cell differentiation 0.009 EGR2, ARID5B, NR4A2, KLF4 






CCNE2, CCNE1, CDC45, MCM7, POLA2, 
MCM2, MCM3, MCM10, MCM4, MCM5, 
MCM6 
GO:0030335 




WNT5B, FLT1, PDGFB, LYN, FAM110C, 
TGFBR1, EDN1, F2RL1, FER, CCL26, IGF1R, 
NOTCH1, SEMA3E, SEMA3D, ADRA2A, 
CEMIP, HAS2, PDGFC, PDGFD, PLAU, F2R 
GO:0045740 




IGF1R, DNA2, PDGFB, PCNA, FGF10, KITLG, 
PDGFC, AREG, GLI2 
GO:0006364 rRNA processing 
7.45E-
04 
DIS3, EBNA1BP2, CCDC86, RRP1B, RRP9, 
BOP1, GTF2H5, MDN1, MRTO4 
GO:0032870 
Cellular response to 
hormone stimulus 
0.001 
CGA, NPFFR2, ADRA2A, OXTR, JUNB, SLIT2, 
SLIT3 
12h vs 96h 
GO:0071456 




P4HB, EPAS1, PTGS2, PINK1, PMAIP1, 
NPEPPS, RORA, PRKCE, HYOU1, HMOX1, 
VEGFA, MDM2, FAM162A, NDRG1, ANGPT4 
GO:0000070 




CEP57, PLK1, CENPA, SPAG5, NEK2, ZWINT, 






CENPN, KIF11, NEK2, NEK10, BIRC5, 
KNSTRN, BRCA1, ESCO2, SPC25, HJURP, 






KIF14, KIF23, KIF22, KIF4A, KIF3A, KIF11, 
KIF15, KIF18A, KIF18B, CENPE, DNAH2, 






NCAPH, NCAPG, NUSAP1, CDCA5, NCAPD3, 
NCAPD2, SMC4 







Table 3.9. Ten most highly correlated genes with time course in anlagen cell culture during 
entire experimental period 




SEMA6A Brown 0.989 6.36E-25 0.977 3.22E-20 
ANKRD35 Brown 0.981 1.33E-21 0.952 5.83E-16 
PODNL1 Brown 0.979 8.50E-21 0.932 7.30E-14 
AEBP1 Brown 0.978 1.44E-20 0.950 1.20E-15 
ENSECAG00
000022553 
Brown 0.978 1.45E-20 0.962 2.22E-17 
PLEKHA4 Brown 0.972 4.80E-19 0.935 4.03E-14 
COMP Brown 0.971 5.05E-19 0.962 2.77E-17 
MAPK7 Brown 0.970 1.15E-18 0.948 2.07E-15 
CHST6 Brown 0.968 2.15E-18 0.980 3.82E-21 
LTBP3 Brown 0.968 2.39E-18 0.951 8.04E-16 
aME, Module eigengene 
bMM, Module membership 
  
Figure 3.7. Module eigengene (ME) groups 
with module−trait relationship scores in 
anlagen cell cultures over time. P-values 
are shown in parentheses. The higher 
relationship score represents the greater 
correlation between a ME group and the 





Figure 3.8. Hub gene co-expression network in anlagen cell cultures during 96 hours of in 




Figure 3.9. Upstream regulators predicted by Ingenuity Pathway Analysis (IPA) between subsequent time points in anlagen cell cultures. The 
activation status thresholds were activation z-score>|2| and P-value of overlap<0.05. Only genes that have log2 fold change (FC)≥|1| in the 
dataset were presented in the figure. Positive z-scores represent activated upstream regulators, and negative values indicate inhibition. 
When a predicted activation status (activation or inhibition) matched the regulation pattern analyzed from the dataset (positive 
log2FC=upregulation; negative log2FC=downregulation), the prediction was accepted. aOthers include enzymes, kinases, and others. bSignal 
transduction includes growth factors, ligands, receptors, and cytokines. 
*NKX3-2 is also a hub gene in anlagen cell cultures whose expression pattern is highly correlated with the time course. 
**In the data, log2FC of TGFB1 from 0h to 1.5h was 0.93.
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3) Fibroblast analyses 
3-a) Expression patterns of DEGs during the experimental period 
In the fibroblast negative control group 3,212 DEGs were measured over time: 2,026 genes 
were upregulated, 1,861 genes were downregulated, and 675 genes switched their regulation 
patterns during the 96 hours. Similar to the other cell cultures, gene expression patterns were 
less distinctive between the baseline and the first collection point (1.5h), and gradually 
changed until 3h after the initiation of in vitro chondrogenesis (Figure 3.10.a). Notable 
transcriptomic changes were accumulated towards the later time points. Fibroblast cultures 
also had a greater number of common DEGs between closer time point comparisons, and 
fewer DEGs were overlapped between distant time point comparisons (Figure 3.10.b and c).  
 
3-b) Gene enrichment analysis 
With an approach similar to the other cell types, overrepresented biological processes in 
each time sequence were analyzed from upregulated and downregulated DEGs in fibroblast 
cultures, and the five most significant GO terms are listed in Table 3.10 and 3.11, respectively. 
Due to the small size of the downregulated DEG list (n=9) in the comparison between 0h and 
1.5h, no downregulated biological processes were identified in this time sequence. Overall, 
similar biological processes were overrepresented in fibroblast cultures to the chondrogenic 
cell cultures: transcription regulatory events were observed at earlier time points, and 
processes related to signaling transduction happened during the whole experimental period. 
Also, the profiles of downregulated DEGs represented skeletal muscle cell and fat cell 
differentiation processes between 1.5h and 12h, and these terms were also observed in 
interzone and anlagen cell cultures between 1.5h and 3h (Table 3.5 and 3.9). 
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3-c) Hub genes and co-expression network 
The hub gene that was most correlated with the time sequence in fibroblasts was NEB 
(GS=0.99; P-value=4.6E-26), and the ten most correlated genes with the time course are 
shown in Table 3.12. The ME identification categorized nine genes out of these ten genes into 
the Turquoise group, which had the highest module−trait relationship (0.98; P-value=1E-21) 
with the time sequence (Figure 3.11). The other, ITGA10, was identified as a member of the 
Red group with the second highest module-trait relationship (0.76; P-value=1E-06). The co-
expression network of hub genes that were closely correlated with the Turquoise group is 
shown in Figure 3.12. The gene showed the highest MM with the Turquoise group was HTRA1 
(MM=0.99; P-value=1.9E-23), interacting with two hub genes, VCAM and BGN in the co-
expression network. 
 
3-d) Upstream regulator prediction 
Predicted upstream regulators in fibroblast cultures during the experimental period are 
shown in Figure 3.13. In common with the chondrogenic cell cultures, activation of TGFB1 was 
predicted (z-score=4.04; P-value=4.7E-28) during the first 1.5 hours. Activation of KLF3 
between 3h and 12h and SAA1 between 12h and 96h was observed as a common prediction 
in all cell types. On the other hand, sixteen genes were predicted to be commonly inhibited 
in the chondrogenic cell lines and the negative control at a point during the experiment: KITLG, 





Figure 3.10. Differentially expressed 
genes (DEGs; n=3,212) over time 
within fibroblast cultures. a) DEGs 
plotted in a heatmap. On the right 
side, time points (#h) and biological 
replicates (H#) are labeled. b) UpSet 
figure of upregulated DEGs 
(n=2,026) between time points. The 
set size graph represents the 
number of DEGs in each time point 
comparison. c) UpSet figure of 
downregulated DEGs (n=1,861) 
between time points. The set size 
graphs of the UpSet figures 
represent the number of DEGs in 
each time point comparison. Note 
that each time comparison has a 
different set size. 
b) Upregulated DEGs 
c) Downregulated DEGs  
a) Heatmap  
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Table 3.10. Top five biological process gene ontology (GO) terms of differentially 
upregulated genes in fibroblast cultures during time courses 
Time 
course 
GO ID Term 
P-
valuea 
Differentially expressed genes in the dataset 
0h vs 1.5h 
GO:0030335 




IRS2, PDGFB, FAM110C, ADRA2A, HAS2, SNAI1 
GO:0045892 




CRY2, CEBPB, PDGFB, CCDC85B, KLF10, RELB, 
IRF1 
GO:1900745 
Positive regulation of 
p38mapk cascade 
0.002 GADD45G, ZC3H12A, GADD45B 
GO:0032922 
Circadian regulation of 
gene expression 
0.002 CRY2, RELB, PER1, BHLHE40 
GO:0006357 
Regulation of 
transcription from RNA 
polymerase II promoter 
0.002 MAFF, ETS2, RELB, RFX2, RUNX3, ELMSAN1, ETV3 
1.5h vs 3h 
GO:0006954 Inflammatory response 
1.99E-
04 
IRAK2, TNFRSF21, S1PR3, TLR10, TNFRSF1B, 
HRH1, PTGIR, TNFRSF11A, CYP26B1, RELB, 
NFKB1, AFAP1L2 
GO:0048167 
Regulation of synaptic 
plasticity 
0.001 HRH1, HRH2, BAIAP2, ITPKA 
GO:0045892 




ZNF263, WNT4, CRY2, PDGFB, RELB, HR, LIMD1, 






ZNF566, SOX13, HR, ZFP3, ZNF175, ZNF2, AHRR, 
RGS20, NOTCH1, ZNF235, ZSCAN20, ZNF404, 
HEYL, LHX4, LIMD1, RFX3, ZNF436 
GO:0001666 Response to hypoxia 0.006 VEGFA, EGLN3, SMAD3, LIMD1, CBFA2T3, DDIT4 






KCNMA1, HCN2, NEDD4, GRIK3, ATP1A4, 
POPDC3, SLC26A10, KCNH3, SLC26A11, CHRNE 
GO:0007155 Cell adhesion 0.002 
HAPLN2, HAPLN4, ACHE, ICAM5, ITGAE, PCDH10, 
COL15A1, FERMT1, FES, PRKCE, COL5A1, NCAM1, 
ITGA9, COMP, TGFBI, LMLN, HRC 









SEMA5A, SEMA6C, SEMA4G, SEMA6D, SEMA4B, 
SEMA4A 
12h vs 96h 
GO:0030335 




BMP2, WNT5B, F2RL1, SPHK1, LRRC15, MMP14, 
SNAI2, AQP1, CCL26, SEMA5A, SEMA6D, 
SEMA3G, SEMA3E, PDGFRA, CEMIP, PDGFC, 






CTSK, MMP9, CTSS, MMP14, MMP13, MMP2, 
MMP11 
GO:0014068 





PTPN6, WNT16, F2RL1, PDGFC, ANGPT1, DCN, 
PDGFD, NRG1, F2R 
GO:0070374 
Positive regulation of 
ERK1 and ERK2 cascade 
5.39E-
04 
NOX4, BMP2, C5AR2, CCL2, F2RL1, FGF10, CD74, 
CCL26, SPRY2, PDGFRA, ANGPT1, PDGFC, PDGFD, 
PLA2G5, F2R 
GO:0006954 Inflammatory response 
7.71E-
04 
C5AR2, RARRES2, BMP2, CCL2, IL2RA, TSPAN2, 
TNFRSF25, TLR1, PTGS1, SPHK1, CXCL8, PTGFR, 
CCL26, S1PR3, AGTR2, TNFRSF11B, CCR7, 
BMPR1B 




Table 3.11. Top five biological process gene ontology (GO) terms of differentially 
downregulated genes in fibroblast cultures during time courses 
Time 
course 
GO ID Term P-valuea 
Differentially expressed genes in the dataset 
0h vs 1.5h No biological processes identified due to a small size of the DEG list (n=9) in this comparison 
  























0.015 RND3, RASL11A, RND1, RAB30, RGL1, ARL4A 





EGR1, HLF, FOS, NOTCH1, ATF3, BTG2, HIVEP3, 





ATF5, SGPL1, KMT2A, BCL2, TGFBR1, CSRNP1, 











regulation of DNA 
replication 
2.93E-04 IGF1R, DNA2, PDGFB, FGF10, KITLG, PDGFC, AREG 
GO:0030335 
Positive 
regulation of cell 
migration 
3.05E-04 
WNT5B, PDGFB, FAM110C, TGFBR1, F2RL1, EDN1, 
CCL26, IGF1R, CORO1A, NOTCH1, DAB2, SEMA3E, 







SLC8A3, P4HB, EPAS1, PTGS2, PINK1, NPEPPS, 






CAV1, CRYAA, EGLN3, SMAD3, EGLN1, DDIT4, 
VEGFC, HSP90B1, LONP1, MYOCD, VEGFA, P2RX2, 
RYR2, LOXL2, ALKBH5 
GO:0006096 Glycolytic process 2.82E-05 







PRKCZ, EML1, CRMP1, MAP1A, CNTN2, NEFH, 






6.48E-04 P4HB, P4HA1, EGLN3, EGLN1 






Table 3.12. Ten most highly correlated genes with time course in anlagen cell culture during 
entire experimental period 




NEB Turquoise 0.991 4.60E-26 0.983 4.07E-22 
OLFML2B Turquoise 0.989 1.26E-24 0.963 1.70E-17 
GSTA4 Turquoise 0.984 1.24E-22 0.955 2.77E-16 
NAAA Turquoise 0.982 8.12E-22 0.969 1.30E-18 
OMD Turquoise 0.982 9.56E-22 0.973 2.38E-19 
HTRA1 Turquoise 0.982 1.06E-21 0.986 1.87E-23 
SLC29A1 Turquoise 0.979 6.44E-21 0.960 5.07E-17 
IL1R1 Turquoise 0.979 8.39E-21 0.948 1.76E-15 
ITGA10 Red 0.978 1.10E-20 0.944 5.48E-15 
AMDHD2 Turquoise 0.978 1.38E-20 0.983 4.38E-22 
aME, Module eigengene 
bMM, Module membership 
  
Figure 3.11. Module eigengene (ME) 
groups with module−trait relationship 
scores in fibroblast cultures over time. P-
values are shown in parentheses. The 
higher relationship score represents the 
greater correlation between a ME group 





Figure 3.12. Hub gene co-expression network in fibroblast cultures during 96 hours of in 




Figure 3.13. Upstream regulators predicted by Ingenuity Pathway Analysis (IPA) between subsequent time points in fibroblast cultures. The 
activation status thresholds were activation z-score>|2| and P-value of overlap<0.05. Only genes that have log2 fold change (FC)≥|1| in the 
dataset were presented in the figure. Positive z-scores represent activated upstream regulators, and negative values indicate inhibition. 
When a predicted activation status (activation or inhibition) matched the regulation pattern analyzed from the dataset (positive 
log2FC=upregulation; negative log2FC=downregulation), the prediction was accepted. aOthers include enzymes, kinases, and others. bSignal 
transduction includes growth factors, ligands, receptors, and cytokines. 
*In the data, log2FC of TGFB1 from 0h to 1.5h was 0.38.
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Common chondrogenic characteristics of interzone and analgen cell cultures 
Differentially expressed genes in the interzone and anlagen experimental groups relative 
to the negative fibroblasts were evaluated at each time point (interzone cell cultures vs. 
fibroblast cultures and anlagen cell cultures vs. fibroblast cultures). The number of 
upregulated and downregulated DEGs are listed in Table 3.13. Then, DEGs that were 
commonly observed in both chondrogenic cell cultures compared to the negative control at 
each time point are identified (Table 3.13) and processed through gene enrichment analysis 
using the DAVID Functional Annotation Tool (v6.8; Huang et al., 2009; Table 3.14). 
 
In this section, the DEGs were further classified; when a DEG’s expression was measured 
in a condition (either chondrogenic cell lines or negative control) but not at all in the other 
condition, this gene was considered as a candidate switch being turned on or off depending 
on a condition. The numbers of common chondrogenic molecular switches at each time point 




Table 3.13. Number of differentially expressed genes (DEGs) in interzone and anlagen cell 
cultures compared to the negative control at each time point 
Upregulated 
Time point 
Interzone cell cultures 
Common DEGs in 
chondrogenic cell lines 
Anlagen cell cultures 
0h 450 [274] 769 
1.5h 436 [239] 779 
3h 434 [242] 708 
12h 470 [274] 629 
96h 645 [366] 617 
Downregulated 
Time point 
Interzone cell cultures 
Common DEGs in 
chondrogenic cell lines 
Anlagen cell cultures 
0h 611 [447] 850 
1.5h 662 [471] 864 
3h 664 [472] 868 
12h 895 [590] 921 
96h 793 [550] 877 
The numbers in the square brackets ([ ]) represent the number of commonly upregulated 
or downregulated DEGs observed in both interzone and analgen cell cultures at each time 
point. These numbers are included in the numbers of DEGs in each chondrogenic cell line 
in the same row. 
 
Table 3.14. Number of overrepresented biological process gene ontology (GO) terms 
identified in the chondrogenic cell cultures compared to fibroblast cultures 
 0h 1.5h 3h 12h 96h Total unique GO terms 
Upregulated  26 33 28 58 70 128 
Downregulated  43 33 59 48 50 133 
 
Table 3.15. Number of differentially expressed genes (DEGs) and candidate molecular 
switches in the chondrogenic cell cultures compared to fibroblast cultures  
Upregulated 
 0h 1.5h 3h 12h 96h 
Total DEGs 247 239 242 274 366 
Molecular switches [1] [1] [2] [1] [3] 
Downregulated 
 0h 1.5h 3h 12h 96h 
Total DEGs 447 471 472 590 550 
Molecular switches [9] [7] [3] [7] [10] 
The numbers in the square brackets ([ ]) represent the number of genes whose expression 
was exclusively turned on or off in the chondrogenic cell cultures. These numbers are 




Candidate molecular switches exclusively turned on in chondrogenic cell lines 
Compared to fibroblast cultures, there were 4 common genes that were only expressed 
in interzone and anlagen cell cultures at the same time points (Table 3.16). At the base line, 
there were no common genes exclusively expressed in the chondrogenic cell cultures. After 
inducing chondrogenesis, GSC expression was turned on in both chondrogenic cell lines by 
1.5h and until the last collection point (96h). Expression of a novel gene, 
ENSECAG00000040027, was turned on by 3h. Exclusive expression of another novel gene, 
ENSECAG00000034476, and HOXD13 was observed at 96h in the chondrogenic cell cultures. 
 
Table 3.16. Genes that were exclusively expressed in both interzone and anlagen cell 
cultures at the same time points while not expressed in fibroblast cultures 







  GSC  GSC 






Candidate molecular switches exclusively turned off in chondrogenic cell lines 
While expressed in fibroblast cultures, 19 genes were not expressed in both chondrogenic 
cell cultures at the same time points (Table 3.17). These genes include four of the Homeobox-
containing transcription factor genes in cluster B (HOXB4, HOXB5, HOXB8, and HOXB9). More 
candidate molecular switches were turned off in the chondrogenic cell cultures towards the 
baseline and the last time point (96h). 
 
Table 3.17. Genes that were not expressed exclusively in both interzone and anlagen cell 
cultures at the same time points while expressed in fibroblast cultures 














HOXB5 HOXB5 HOXB9 HOXB5 
ENSECAG 
00000039182 
HOXB8 NTM  HOXB9 
ENSECAG 
00000043423 
HOXB9 RBFOX1  SERPINB10 HOXB5 
NTM SIM1  SIM1 HOXB9 
OLFM3 ZIC4  ZIC4 MMP26 
RBFOX1    TLX3 
ZIC4    TNFSF4 






Upregulated DEGs in chondrogenic cell lines 
The profiles of commonly upregulated chondrogenic DEGs, including the switches, 
resulted in 128 significant biological processes across the entire experimental period by gene 
enrichment analysis (Table 3.14). A greater number of upregulated biological processes were 
identified at later time points. Among the five collection time points, three GO terms were 
consistently observed as significantly overrepresented biological processes in interzone and 
analgen cell cultures compared to the negative control (Table 3.18). These processes are 1) 
anterior/posterior pattern specification, 2) embryonic skeletal system morphogenesis, and 3) 
positive regulation of chondrocyte differentiation. 
 
Downregulated DEGs in chondrogenic cell lines 
The commonly downregulated DEGs as well as the turned-off molecular switches in the 
chondrogenic cell cultures presented 133 significant biological processes throughout the 
whole experimental period (Table 3.14). The profiles of downregulated DEGs in the 
chondrogenic cell lines relative to fibroblast cultures continuously overrepresented four 
biological processes at the all collection points (Table 3.19). These processes are 1) 
anterior/posterior pattern specification, 2) immune response, 3) negative regulation of cell 





Table 3.18. Upregulated overrepresented biological processes in the chondrogenic cell lines 
compared to fibroblast cultures at all time points 
GO:0009952a, Anterior/posterior pattern specification 




HOXD9, HOXA5, HOXA11, HOXA6, HOXA7, HOXA10, 
HOXD13, HOXD10 
1.67E-05 
  1.5h HOXA11, HOXA6, HOXA7, HOXA10, HOXD10 4.99E-03 
  
3h 
HOXD9, HOXA5, HOXA11, HOXA6, HOXA7, HOXA10, 
HOXD10 
1.69E-03 
  12h HOXA11, HOXA6, HOXA7, HOXA10, HOXD13, HOXD10 1.13E-04 
  96h RARG, HOXA5, HOXA11, HOXA10, HOXA9, GLI3, HOXD10 2.87E-03 
GO:0048704, Embryonic skeletal system morphogenesis 
 Time point Genes in the process P-Value 
 0h HOXD9, HOXA5, HOXA6, HOXA7, HOXD10 1.84E-04 
  1.5h GSC, HOXA6, HOXA7, HOXD10 1.81E-03 
  3h HOXD9, GSC, HOXA5, HOXA6, HOXA7, HOXD10 2.98E-03 
  12h GSC, HOXA6, HOXA7, HOXD10 1.19E-05 
  96h GSC, HOXA5, GLI3, HOXD10 2.97E-02 
GO:0032332, Positive regulation of chondrocyte differentiation 
 Time point Genes in the process P-Value 
 0h HOXA11, SOX5, SOX6 1.20E-02 
  1.5h HOXA11, SOX5, SOX6, SOX9 5.22E-04 
  3h HOXA11, SOX5, SOX6, SOX9 2.76E-05 
  12h HOXA11, GDF5, SOX5, SOX6, SOX9 5.14E-04 
  96h HOXA11, SOX5, SOX6, SOX9, GLI3 7.55E-05 
aGO:#, gene ontology ID 








Table 3.19. Downregulated overrepresented biological processes in the chondrogenic cell 
lines compared to fibroblast cultures at all time points 
GO:0009952a, Anterior/posterior pattern specification 
 Time point Genes in the process P-valueb 
 0h 
HOXB3, HOXC8, HOXC9, HOXB2, HOXC4, HOXB5, HOXB6, EMX2, 
HOXB9 
4.95E-04 
  1.5h 
HOXB3, HOXC6, HOXB4, HOXC8, HOXC9, HOXC4, HOXB5, HOXB6, 
EMX2 
7.33E-04 
  3h HOXB4, HOXC8, HOXC9, HOXC4, EMX2, HOXB9 2.29E-05 
  12h 
HOXB3, HOXB4, HOXC8, HOXC9, HOXB2, HOXC4, HOXD3, HOXB5, 
HOXB6, EMX2, HOXB9, ZBTB16 
4.60E-02 
  96h HOXC8, HOXB2, HOXC9, HOXC4, HOXD3, EMX2, HOXB9, ZBTB16 2.17E-03 
GO:0006955, Immune response 
 Time point Genes in the process P-Value 
 0h C7, IL18, TGFBR3, OAS1, COLEC12, FAS, OAS2, TINAGL1, BMP6, B2M 2.07E-02 
  1.5h 
C7, HRH2, TGFBR3, OAS1, COLEC12, FAS, OAS2, TINAGL1, TNFAIP3, 
BMP6, B2M, TNFSF8 
4.01E-03 
  3h 
TNFRSF21, C7, HRH2, IRF8, TGFBR3, OAS1, COLEC12, FAS, TNFAIP3, 
BMP6, B2M 
3.74E-02 
  12h 
TNFRSF21, C7, IL18, IRF8, OAS3, OAS1, TNFRSF14, COLEC12, NGFR, 
TNFAIP3, BMP6 
1.13E-02 
  96h 
CCL11, C7, TNFSF10, TNFSF4, HRH2, IL18, TNFRSF8, TGFBR3, 
COLEC12, FAS, BMP6, TNFSF8, B2M 
1.14E-02 
GO:0008285, Negative regulation of cell proliferation 
 Time point Genes in the process P-Value 
  0h 
CEBPA, ATF5, CDKN1A, PODN, PTGES, PTH1R, TFAP2B, PTPRU, 
SLC9A3R1, SKAP2, SLIT3, DPT 
7.96E-03 
  1.5h 
ATF5, CDKN1A, PODN, PTGES, BCL11B, PTH1R, TFAP2B, PTPRU, 
SLC9A3R1, SKAP2, SLIT3, TP53INP1, DPT 
4.58E-03 
  3h 
CEBPA, PODN, PTH1R, KLF11, FGF10, PTPRU, SLC9A3R1, SKAP2, 
SLIT3, ATF5, CDKN1A, PTGES, BCL11B, DPT, TP53INP1 
8.20E-03 
  12h 
CEBPA, PODN, PTH1R, FGF10, ZBTB16, PTPRU, PROX1, CDH5, SLIT3, 
RERG, ATF5, PTK2B, BCL11B, KLF4 
5.18E-04 
 96h 
NOX4, B4GALT1, PODN, ADARB1, ZBTB16, CBFA2T3, SKAP2, SLIT3, 
SPRY2, SPRY1, PTGES, PTK2B, BCL11B, SFRP4, ASPH, WNT9A 
6.22E-04 
GO:0030334, Regulation of cell migration 
 Time point Genes in the process P-Value 
 0h LAMA2, LAMA1, PLXNC1, PLXNA4, PLXNA2, AMOT 4.35E-03 
  1.5h LAMA2, LAMA1, PLXNC1, PLXNA4, PLXNA2, AMOT 5.59E-03 
  3h LAMA2, LAMA1, PLXNC1, PLXNA4, PLXNA2, AMOT 1.24E-02 
  12h LAMA2, PLXNC1, PLXNA4, LAMA3, PLXNA2, DOCK10 5.59E-03 
  96h LAMA2, PLXNC1, PLXNA4, AMOT, NTN1 4.18E-02 
aGO:#, gene ontology ID 





Distinct traits between interzone and anlagen cell cultures  
Differential gene expression was evaluated at each time point between interzone and 
anlagen cell cultures (Figure 3.14). More DEGs were observed at the earlier time points (772 
– 710 genes between 0h and 3h), and less DGEs were counted towards the later time points 
(543 – 551 genes between 12h and 96h; Table 3.20). Then, the DEGs were further categorized 
if they were expressed exclusively in one type of cell culture while not expressed at all in the 
other (Table 3.21). The ten most upregulated DEGs in interzone cell cultures and analgen cell 
cultures compared to each other at each time point are listed in Table 3.22 and 3.23, 
respectively. Gene enrichment analysis was conducted to identify overrepresented biological 
processes that were upregulated in each cell type (Figure 3.15 and Table 3.24). Finally, 
upstream regulators between the two chondrogenic cell cultures at each time point were 
predicted by Ingenuity Pathway Analysis (IPA; Qiagen; Figure 3.16). 
 
Table 3.20. Number of differentially expressed genes (DEGs) between interzone and 
analgen cell cultures at each time point  
0h 1.5h 3h 12h 96h 
Total DEGs between interzone and anlagen cell cultures 772 770 710 543 551 
Upregulated in interzone cell cultures 416 406 356 316 275 
Exclusively expressed in interzone cell cultures [1] [1] [2] [2] [1] 
Upregulated in anlagen cell cultures 356 364 354 227 276 
Exclusively expressed in anlagen cell cultures  [2] [0] [1] [2] [2] 
The numbers of exclusively expressed genes in the square brackets ([ ]) are also included 































Figure 3.14. Differentially expressed genes (DEGs) between interzone and anlagen cell 
cultures at each time point plotted in volcano plots. Differential expression was determined 
using fold change (FC) and statistical significance thresholds, log2FC>|1| and false discovery 
rate (FDR) adjusted P-value<0.05, respectively. Note that -log10 P-values defining an FDR<0.05 
threshold in each graph are different. The DEGs are shown in red dots. Exclusively expressed 
genes in a cell type with infinite FC are not displayed in the volcano plots (continued on the 
next page).   
Upregulated in  
anlagen cell cultures 
Upregulated in 
interzone cell cultures 
Statistical significance 
threshold 

































(Figure 3.14 continued) Upregulated DEGs in interzone cell cultures are expressed in positive 
log2FC while upregulated DEGs in anlagen cell cultures are expressed in negative log2FC. a) 0h, 
n=769 DEGs; b) 1.5h, n=769 DEGs; c) 3h, n=707 DEGs; d) 12h, n=539 DEGs; e) 96h, n=548 DEGs.  
HOXA13 
d) 12h 




Candidate molecular switches exclusively expressed in one cell type 
<Exclusively expressed genes in interzone cells> 
From the baseline until 3h, ENSECAG00000037611 was only expressed in interzone (FDR 
adjusted P-value=0.001; Table 3.21). At 3 and 12h, LY6G6C and C7H11orf52 were turned on 
(FDR adjusted P-value=0.001), respectively while there was no expression in anlagen cell 
cultures. Then, expression of ZIC3 was observed at 12h as well as at the last collection point 
(FDR adjusted P-value=0.001). 
 
<Exclusively expressed genes in anlagen cells> 
Before inducing chondrogenesis, HOXB2 (FDR adjusted P-value=0.001) and H4C9 (FDR 
adjusted P-value=0.003) were only expressed in analgen cell cultures (Table 3.21). Between 
1.5h and 3h, HOXB2 expression was also detected in interzone cell cultures, but it was turned 
off again by 12h and at 96h. Expression of ENSECAG00000038392 (FDR adjusted P-value<0.01), 
HOXB3 (FDR adjusted P-value=0.001), and PLAC8B (FDR adjusted P-value=0.001) was 
exclusively measured in analgen cell cultures at 3h, 12h, and 9h, respectively.  
 
Table 3.21. Exclusively expressed genes in either interzone or analgen cell cultures 

















HOXB2   HOXB3 PLAC8B 
The expression levels in the fragments per kilobase of transcript per million fragments 
mapped read (FPKM) format, and false discovery rate adjusted P-values are shown in Table 




Differentially expressed genes between interzone and anlagen cell cultures 
The ten most upregulated genes in interzone and anlagen cell cultures are listed in Table 
3.22 and 3.23, respectively. Gene enrichment analysis was conducted with the total DEGs 
between the two chondrogenic cell cultures at each time point. Then, the ten most 
overrepresented biological processes from the profiles of the DEGs between interzone and 
analgen cell cultures at each time point were plotted into a circle plot (Figure 3.15 and Table 
3.24). From the baseline until 3h, upregulated DEGs in anlagen cell cultures dominated in 
greater numbers of the significant overrepresented biological processes. However, at the last 
time point, only one process among the ten most significant processes was dominated by 




Table 3.22. Ten most upregulated differentially expressed genes in interzone cell cultures 




Expression levels, FPKMa 
log2FCb adj. P-valuec 
Interzone Anlagen 
0h 
ENSECAG00000037611 2.94 0.00 infd 0.001 
SLC13A4 81.98 0.84 6.60 0.001 
COL9A3 5.40 0.09 5.88 0.001 
CADPS 14.00 0.24 5.88 0.001 
COL11A2 2.62 0.06 5.52 0.013 
ZIC2 8.69 0.22 5.29 0.024 
HAPLN1 5.99 0.17 5.15 0.001 
COL2A1 17.18 0.62 4.80 0.001 
CLEC3A 5.96 0.25 4.60 0.001 
ABI3BP 87.94 3.67 4.58 0.001 
1.5h 
ENSECAG00000037611 2.59 0.00 inf 0.002 
CLEC3A 0.59 0.00 7.25 0.044 
SLC13A4 68.66 0.70 6.61 0.001 
CADPS 14.81 0.26 5.85 0.001 
COL9A3 2.65 0.06 5.44 0.001 
ZIC2 7.00 0.20 5.11 0.001 
SFRP4 0.57 0.02 4.81 0.025 
ABI3BP 88.27 3.75 4.56 0.001 
GCNT2 2.26 0.10 4.54 0.006 
CCDC3 3.43 0.17 4.36 0.003 
3h 
ENSECAG00000037611 2.28 0.00 inf 0.004 
LY6G6C 1.23 0.00 inf 0.001 
SLC13A4 50.92 0.91 5.81 0.001 
RPL11 11.54 0.21 5.75 0.047 
ZIC2 8.22 0.16 5.66 0.001 
CADPS 16.98 0.34 5.63 0.001 
IL6 17.13 0.55 4.97 0.001 
ABI3BP 88.35 4.00 4.46 0.001 
TFAP2A 2.38 0.15 4.03 0.001 
ENSECAG00000038866 7.61 0.53 3.84 0.017 
12h 
ZIC3 0.64 0.00 inf 0.001 
C7H11orf52 0.96 0.00 inf 0.001 
SLC13A4 127.92 2.59 5.63 0.001 
CADPS 13.25 0.36 5.22 0.001 
ZIC2 12.14 0.37 5.04 0.001 
RPL11 13.65 0.43 4.98 0.001 
ENSECAG00000031929 4.10 0.14 4.87 0.001 
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PLA2G2A 6.80 0.25 4.79 0.047 
HOXA13 3.48 0.18 4.28 0.001 
CDH1 4.33 0.26 4.06 0.001 
96h 
ZIC3 0.96 0.00 inf 0.001 
ZIC2 10.23 0.17 5.88 0.016 
ADAMTS15 2.27 0.05 5.46 0.001 
THBS4 19.09 0.51 5.22 0.001 
ENSECAG00000033567 6.91 0.24 4.88 0.006 
ENSECAG00000031929 5.83 0.20 4.85 0.001 
HOXA13 6.68 0.26 4.67 0.001 
ENSECAG00000034282 4.61 0.19 4.63 0.001 
DRA 2.45 0.10 4.57 0.026 
ABI3BP 30.03 1.33 4.49 0.001 
aFPKM, fragments per kilobase of transcript per million fragments mapped read 
bFC, fold change 
cFalse discovery rate adjusted P-value 
dinf; Gene expression was not detected in anlagen cell cultures, therefore resulted in 





Table 3.23. Ten most upregulated differentially expressed genes in anlagen cell cultures 





FPKMa log2FCb adj. P-valuec 
Interzone Anlagen 
0h 
H4C9 0.00 1.08 infd 0.003 
HOXB2 0.00 0.67 inf 0.001 
LRRC4C 0.04 1.04 -4.740 0.023 
HOXC8 0.10 2.52 -4.658 0.003 
CXCL8 8.43 140.48 -4.058 0.001 
IGFBP3 2.82 39.98 -3.824 0.001 
ESM1 0.31 4.25 -3.760 0.001 
MEIS1 0.68 8.83 -3.695 0.001 
NLRP3 0.07 0.83 -3.596 0.011 
ENSECAG00000036672 0.66 7.67 -3.532 0.001 
1.5h 
TRPA1 0.02 0.88 -5.491 0.012 
HOXC8 0.05 2.25 -5.385 0.012 
HOXC6 0.51 10.54 -4.369 0.009 
ESM1 0.19 3.16 -4.074 0.001 
IGFBP3 2.93 39.57 -3.756 0.001 
CXCL8 7.68 102.08 -3.733 0.001 
JAM2 0.49 6.49 -3.716 0.001 
PIP5K1B 0.14 1.60 -3.561 0.014 
ENSECAG00000029063 0.14 1.60 -3.505 0.006 
ENSECAG00000015143 1.43 16.07 -3.490 0.001 
3h 
ENSECAG00000038392 0.00 1.34 inf 0.009 
HOXC6 0.59 12.87 -4.443 0.003 
HOXC8 0.16 2.62 -4.042 0.004 
JAM2 0.47 6.53 -3.780 0.001 
PDGFD 1.08 13.10 -3.595 0.001 
IGFBP3 2.75 32.14 -3.546 0.001 
TRPA1 0.05 0.59 -3.539 0.001 
HOXC4 0.12 1.40 -3.529 0.001 
MEIS1 0.41 4.66 -3.503 0.001 
CXCL8 2.81 29.53 -3.392 0.001 
12h 
HOXB2 0.00 0.96 inf 0.001 
HOXB3 0.00 0.75 inf 0.001 
HOXC6 0.76 25.41 -5.058 0.001 
HOXC8 0.15 3.44 -4.525 0.001 
SMPD3 0.04 0.80 -4.253 0.023 
HOXC4 0.15 2.26 -3.897 0.001 
ENSECAG00000039489 0.06 0.90 -3.891 0.017 
105 
 
NRN1 20.85 246.23 -3.562 0.001 
IRX6 0.05 0.55 -3.551 0.013 
EYA2 0.72 8.14 -3.489 0.001 
96h 
PLAC8B 0.00 1.17 inf 0.001 
HOXB2 0.00 1.46 inf 0.001 
KIF19 0.37 14.41 -5.269 0.001 
HOXC6 0.51 16.09 -4.992 0.001 
HOXC4 0.08 2.46 -4.887 0.006 
SMPD3 0.59 13.81 -4.548 0.001 
IFIT3 0.27 5.74 -4.428 0.018 
HOXC8 0.12 2.40 -4.261 0.001 
FAM20A 0.03 0.60 -4.222 0.022 
DLX6 0.07 1.24 -4.104 0.002 
aFPKM, fragments per kilobase of transcript per million mapped reads  
bFC, fold change 
cFalse discovery rate adjusted P-value 
dinf; Gene expression was not detected in anlagen cell cultures, therefore resulted in 




Figure 3.15. Gene ontology (GO) enrichment analysis on differentially expressed genes (DEGs) 
between interzone and anlagen cell cultures at each time point, plotted by GOCircle plot. The 
GO IDs and corresponding terms are listed in Table 3.24. The inner ring is a bar chart colored 
by z-score, and the height of the bars represents the significance of the GO term determined 
by −log10(adjusted P-value). The outer ring shows dotted plots of the log2 fold change (FC) for 
the DEGs in each term. Upregulated DEGs in interzone cell cultures are shown in red dots 
while upregulated DEGs in anlagen cell cultures are shown in blue dots. Exclusively expressed 
genes in a cell type were excluded because of infinite FC. a) 0h, n=769 DEGs; b) 1.5h, n=769 
DEGs; c) 3h, n=707 DEGs; d) 12h, n=539 DEGs; e) 96h, n=548 DEGS.  
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Table 3.24. Gene ontology (GO) IDs and corresponding terms present in Figure 3.15  
Gene ontology ID Term 0h 1.5h 3h 12h 96h 
GO:0001501 Skeletal system development    12h  
GO:0001503 Ossification    12h  
GO:0001525 Angiogenesis 0h 1.5h   96h 
GO:0001569 Patterning of blood vessels    12h  
GO:0001649 Osteoblast differentiation 0h 1.5h   96h 
GO:0001958 Endochondral ossification     96h 
GO:0002062 Chondrocyte differentiation 0h   12h 96h 
GO:0002063 Chondrocyte development     96h 
GO:0003337 
Mesenchymal to epithelial transition 
involved in metanephros morphogenesis 
0h     
GO:0006260 DNA replication 0h 1.5h 3h   
GO:0006270 DNA replication initiation 0h 1.5h 3h   
GO:0007010 Cytoskeleton organization 0h     
GO:0007018 Microtubule-based movement   3h   
GO:0007059 Chromosome segregation   3h   
GO:0007155 Cell adhesion 0h 1.5h 3h 12h  
GO:0021772 Olfactory bulb development  1.5h    
GO:0030155 Regulation of cell adhesion   3h   
GO:0030198 Extracellular matrix organization  1.5h    
GO:0030199 Collagen fibril organization    12h  
GO:0030335 Positive regulation of cell migration  1.5h  12h  
GO:0030501 Positive regulation of bone mineralization     96h 
GO:0030855 Epithelial cell differentiation    12h  
GO:0034501 Protein localization to kinetochore  1.5h 3h   
GO:0042127 Regulation of cell proliferation 0h  3h   
GO:0042472 Inner ear morphogenesis     96h 
GO:0042733 Embryonic digit morphogenesis     96h 
GO:0044344 
Cellular response to fibroblast growth 
factor stimulus 
   12h  
GO:0050679 
Positive regulation of epithelial cell 
proliferation 
0h     
GO:0050731 
Positive regulation of peptidyl-tyrosine 
phosphorylation 
 1.5h    
GO:0051256 Mitotic spindle midzone assembly   3h   
GO:0051301 Cell division   3h   
GO:0060325 Face morphogenesis    12h  
GO:0070374 
Positive regulation of ERK1 and ERK2 
cascade 
    96h 
GO:0090263 
Positive regulation of canonical Wnt 
signaling pathway 
    96h 
The cells are colored by the z-score scale shown in Figure 3.15. Red colors represent 
upregulation in interzone cells, and blue colors represent upregulation in anlagen cells. 
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Predicted upstream regulators 
Upstream regulators were estimated by analyzing differences of gene expression levels 
between the chondrogenic cell cultures at each time point using the IPA software (Figure 3.16). 
Twelve upstream regulators were predicted to be more activated in interzone cell cultures 
while twenty-three upstream regulators were predicted to be more activated in analgen cell 
cultures over the experimental period. The upstream analysis projected NUPR1 as an 
activated regulator in interzone cell cultures and E2F1 in anlagen cell cultures at 0h, 1.5h, and 
3h. In analgen cell cultures, RUNX2 was expected as an upstream regulator at the baseline, 






Figure 3.16. Prediction of upstream regulators that differentially regulate the chondrogenic pathways between interzone and analgen 
cultures by Ingenuity Pathway Analysis (IPA). The activation status thresholds were activation z-score>|2| and P-value of overlap<0.05. Only 
genes that have log2 fold change (FC)≥|1| in the dataset were presented in the figure. Positive z-scores represent activated upstream 
regulators in interzone cell cultures, and negative values indicate activation in analgen cell cultures. When a predicted activation in a cell 
type matched the regulation pattern analyzed from the dataset (positive log2FC=upregulation in interzone cell cultures; negative 
log2FC=upregulation in anlagen cell cultures), the prediction was accepted. aOthers include enzymes, kinases, and others. bSignal 
transduction includes growth factors, ligands, receptors, and cytokines.  





The present study tested the hypothesis that differentially expressed regulatory genes 
during the first 1.5 hours will initiate chondrogenic divergence between interzone and anlagen 
cell cultures, and further distinctions will accumulate as time passes in culture, represented 
by the activation of different pathways that leads to different ECM profiles. Accepting this 
hypothesis, the transcriptomic analyses in the current chapter demonstrated the kinetics of 
gene expression changes over 96 hours in the experimental and control cell cultures, 
characterized common molecular properties of the two chondrogenic cell lines compared to 
the negative control fibroblasts, and identified cell type-specific signatures in interzone and 
anlagen cell cultures.  
 
Kinetics of gene expression patterns during 96 hours of in vitro chondrogenesis 
TGF-β1 induced chondrogenesis 
It should be mentioned that the upstream regulator prediction analysis projected TGFB1, 
which encodes the experimental stimulus (TGF-β1), as a common activated upstream 
regulator only between the baseline and the first collection point (1.5h) in all three cell types 
(Figure 3.5, 3.9, and 3.13). This result confirms that each one responded to the experimental 
chondrogenic stimulation induced by the TGF-β1 treatment during the first 1.5 hours. Since 
TGF-β1 is auto-regulated and this analysis is based on computational prediction, an important 
question arises: would different chondrogenic factors also activate TGF-β1 pathways during in 
vitro chondrogenesis? A mechanistic study with other chondrogenic inductive stimuli, such as 




In addition, the hub gene analysis identified LTBP3 as a common hub gene in all three cell 
cultures (Figure 3.4, 3.8, and 3.12), and its expression was differentially upregulated at 96h 
compared to 12h in each cell type (log2FC=1.13 in interzone cell cultures; log2FC=1.19 in 
anlagen cell cultures; log2FC=1.45 in fibroblast cultures; FDR adjusted P-value<0.001). This 
gene encodes an ECM component, and one of its important functions is to regulate the activity 
of the TGF-β family (Robertson et al., 2015). By binding to TGF-β propeptides, LTBP3 maintains 
their latent state, being stored in extracellular space. In the experimental setting, all three cell 
cultures were continuously exposed to the TGF-β1 treatment, and thus, the result presenting 
LTBP3 as a common hub gene may indicate that TGF-β signaling mediation commonly 
occurred in all three cell cultures and was highly correlated to the time course.  
 
Overall expression patterns of differentially expressed genes 
All three cell cultures, including the negative control, shared similar expression pattern 
changes of their own DEGs responding to the chondrogenic stimulation during the 96-hour 
experimental period. Fewer DEGs were detected between 0h and 1.5h (106 – 170 DEGs), and 
greater DEGs were detected between 12h and 96h (1,433 – 2,395 DEGs; Table 3.3). In most 
cases, except the upregulated DEGs at 96h from 12h in interzone cell and fibroblast cultures, 
the numbers of DEGs between two consecutive time points within a cell type kept increasing 
throughout the time sequence. This result may imply exponential responses to an upstream 
change in the downstream; a transcription factor can regulate expression of multiple genes, 
a ligand can interact with different receptors, various signaling cascades can be turned on or 
off from the same upstream signal, and all of these processes orchestrate complex gene 




by the increased numbers of DEGs towards the delayed time points.  
 
It is also interesting to note that most of the DEGs upregulated at the earlier time points 
became downregulated at the later time points, and vice versa. Between the baseline and the 
first collection point (1.5h), the DEG expression patterns in all cell types were more correlated 
with biological replicates than time points (Figure 3.2.a, 3.6.a, and 3.10.a). After 3 hours being 
grown in the chondrogenic medium, gene expression profiles were distinctively clustered by 
time point. The chondrogenic stimulation gradually shifted the regulation patterns 
(upregulated and downregulated) of DEGs to the opposite towards the end of the 
experimental period. When comparing the baseline gene expression to that of 96h, a very 
clear trend of upregulated genes and downregulated genes switching the patterns was 
observed in all three cell cultures. 
 
Overrepresented biological processes in the time course 
While the DEG expression pattern changes during the 96-hour in vitro chondrogenesis 
were similar among the cell types, overrepresented biological processes in each cell culture 
were evaluated to further characterize common and cell type-specific responses to the 
chondrogenic stimulation (Table 3.4, 3.5, 3.7, 3.8, 3.10, and 3.11). From the baseline to the 
first collection point (1.5h) after inducing chondrogenesis, the upregulated DEG profiles in all 
cell types were highly related to transcription regulatory events. Between 1.5h and 3h, skeletal 
muscle cell and fat cell differentiation processes were significantly downregulated in all cell 
types under the chondrogenic stimulation. Since mesenchymal stem cells derived from 




osteocytes, as well as chondrocytes, the downregulation of skeletal muscle cell and fat cell 
differentiation processes may confirm that all cell lines were receiving chondrogenic 
stimulation, and this stimulation initiated the downregulation of the other cell lineage 
differentiation pathways. Towards the last collection point (96h), it is noticeable that biological 
processes related to ECM metabolic events and involving ECM genes were overrepresented 
in all cell cultures. Altogether, the gene ontology analysis demonstrated the model of 
molecular event changes that was derived from Chapter 2 in which altered transcriptional 
events would lead to subsequent changes in signaling cascades and eventually in ECM biology. 
 
Chondrogenic characteristics observed in both interzone and analgen cell cultures 
Common chondrogenic characteristics of the two skeletal cell lines were evaluated by 
analyzing the overlapping DEGs from the comparisons of each chondrogenic cell type to the 
negative control at each time point. These common chondrogenic DEGs also include the 
candidate molecular switches that were exclusively turned on or off in both chondrogenic cell 
lines, but not in the negative control fibroblasts (Table 3.16 and 3.17). Along with the DEGs, 
several interesting common hub genes correlated with the time course and projected 
upstream regulators are proposed in this section. 
 
Presumptive chondrogenic molecular switches 
GSC was exclusively expressed in chondrogenic cell lines but not in fibroblast cultures at 
all time points after inducing chondrogenesis (1.5 – 96h). This gene is a marker of mesoderm 
during gastrulation (Blum et al., 1992) and mesenchymal cell lineages in fetal limb buds (Gaunt 




participated in limb formation and patterning through regulating expression of HOXA and 
HOXD clusters (Heanue et al., 1997). In the dataset, HOXD13 expression was also exclusively 
observed in the chondrogenic cell cultures by the last time point (96h). This gene is expressed 
in distal regions of limb buds and regulates digit patterning (Nelson et al., 1996). The exclusive 
expression of GSC and one member of the posterior HOX genes in cluster D might suggest that 
the chondrogenic cell cultures retained some regulatory processes observed during the fetal 
limb formation. 
 
On the other hand, there were greater numbers of genes that were not expressed in the 
chondrogenic cell lines while exclusively expressed in fibroblasts. These genes include several 
central and posterior Homeobox transcription factor genes in cluster B (HOXB4, HOXB5, 
HOXB8, and HOXB9). In addition, EN1 was recorded as a candidate molecular switch turned 
off in the skeletal cell lines at four time points including the baseline (0, 3, and 12h).  
 
Both GSC and EN1 are members of Homeobox transcription factor gene families, acting as 
a transcription repressor, and they were expressed in the opposite way between the 
chondrogenic cell lines and the negative control. Thus, a gain-of-function or loss-of-function 
study might elaborate if these genes are involved in the cellular fate decision whether to 
commit chondrogenic differentiation. Also, further research on the regulatory processes of 
these two genes and their relationship with other HOX gene families as well as other genes 
involved in development might bring important information to understand the regulation of 




Overrepresented biological processes in chondrogenic cell lines 
Gene enrichment analysis identified 128 upregulated and 133 downregulated 
overrepresented biological processes in the chondrogenic cell lines based on the negative 
control across the entire experimental period (Table 3.14). It is notable that a greater number 
of significant biological processes were observed towards the later time points (from 69 
processes at 0h to 120 processes at 96h). This result might suggest that under the 
chondrogenic inductive stimulation, further differences between the skeletal cell lines and the 
non-skeletal fibroblast cultures were developed over time. 
 
Among the biological processes that were upregulated in the chondrogenic cell lines, 
three GO terms were repeatedly observed at all collection points (Table 3.18). Noticeably, 
several central and posterior Homeobox transcription factor genes in clusters A and D were 
consistently upregulated in the chondrogenic cell cultures based on the negative control and 
categorized into these three common biological processes identified at all time points. In the 
meantime, the commonly downregulated DEGs in the chondrogenic cell cultures showed four 
common biological processes that were overrepresented across the whole experimental 
period (Table 3.19).  
 
Before inducing chondrogenesis and also at all post-chondrogenic induction time points, 
the positive regulation of chondrocyte differentiation process was identified as one of the 
overrepresented biological processes from the common upregulated DEG profile in interzone 
and analgen cell cultures compared to the negative control. This process includes the SOX 




transcription factor—and activated S100A1, which inhibits chondrocyte terminal 
differentiation (Saito et al., 2007), and therefore prevented chondrocytes from entering pre-
hypertrophic stages (Smits et al., 2004). At the earlier stages of embryonic development, SOX9 
is expressed in mesenchymal cells and a mesenchymal condensation—the cartilaginous tissue 
prior to hypertrophic differentiation (Decker et al., 2014). When SOX9 was knocked out, it 
resulted in apoptosis (Akiyama et al., 2002) as well as decreased mesenchymal condensation 
and chondrocyte formation (Bi et al., 1999). Also, SOX9 is required for SOX5 and SOX6 
expression (Akiyama et al., 2002) although SOX5 and SOX6 are not essential for chondrogenic 
differentiation unlike SOX9 (Liu and Lefebvre, 2015). Thus, expression profiles of these genes 
in the dataset might demonstrate close relationships between SOX genes and chondrocyte 
differentiation and also confirm chondrogenic differentiation in interzone and analgen cell 
cultures. 
 
Of note, both upregulated and downregulated DEGs in the chondrogenic cell lines resulted 
in anterior/posterior pattern specification as an overrepresented biological process. In this 
process defined by the upregulated DEG profile, HOX genes in clusters A and D were involved. 
On the other hand, the downregulated DEGs in this biological event were HOX genes in 
clusters B and C as well as EMX2, a Hox-related gene. It is noteworthy that some central and 
posterior HOX genes in cluster B were exclusively turned off in the chondrogenic cell lines 
while they were expressed in the negative control (Table 3.17). 
 
Homeobox genes encoding transcription factors are highly conserved between species 




are involved in axial skeleton patterning, the posterior HOX paralogs (HOX9-13) are also 
involved in the development of appendicular skeleton, the limb skeletal elements (Pineault 
and Wellik, 2014). The posterior HOX genes in clusters A and D are expressed in forelimb buds, 
and the posterior HOX genes in cluster C are expressed in hindlimb buds along the 
proximodistal axis. From the dataset, the central and posterior HOX gene clusters A and D 
were upregulated in chondrogenic cell lines while the anterior and central HOX gene clusters 
B and C were either switched off or downregulated. The contrasting HOX gene expression 
patterns between the chondrogenic cell lines and the negative control may confirm the origin 
of the cells. In addition, GSC was turned on in both interzone and analgen cell cultures at all 
time points after inducing chondrogenesis, and this gene is involved in limb formation and 
patterning through regulating expression of HOX clusters A and D, but GSC did not affect 
expression of HOX cluster C (Heanue et al., 1997). Thus, further investigation in regulatory 
events involving the HOX gene families might elaborate the current knowledge of 
chondrogenic differentiation pathways during limb development.  
  
Common chondrogenic hub genes correlated with the time sequence 
The chondrogenic cell lines shared 53 hub genes highly correlated with the time sequence, 
and IGF2, SNAI2, and COMP are examples of them (Figures 3.4 and 3.8). IGF1 is a hub gene in 
only interzone cell cultures and interacts with another hub genes highly related to IGF2 and 
SNAI2 (Figure 3.4). Both IGF isoforms can bind both IGF receptors (IGF1R and IGF2R) and 
activate downstream, but the downstream pathways of these receptors have different effects. 
IGF1R have been reported to induce hypertrophy in skeletal myocyte (Musarò et al., 1999) 




kinase domains, and thus, it is known to result in no downstream signaling events, only 
attenuating the IGF1R pathway by sequestering IGF ligands. However, both IGF receptors were 
not differentially expressed in any comparisons from the dataset. Further research on the IGF 
ligands and receptors would be beneficial to better understand the roles of the IGF signaling 
pathways in chondrogenic differentiation. 
 
Although SNAI2 was a common hub gene highly correlated with the time course in the 
chondrogenic cell lines, SNAI1—another Snail transcription factor involved in epithelial-
mesenchymal transition—was not identified as a hub gene in either of cell cultures. However, 
SNAI1 was differentially upregulated at 1.5h compared to the baseline in both interzone and 
analgen cell cultures (log2FC=3.27 and 2.77 in interzone and analgen cell cultures, respectively; 
FDR adjusted P-value=0.003). SNAI2 and SNAI1 compensate the loss of each other and 
regulate chondrogenic differentiation during limb formation (Chen and Gridley, 2013). Also, 
TGF-β sustained upregulation of both SNAI2 and SNAI1 in human corneal epithelial cell 
cultures (Aomatsu et al., 2011). Therefore, the profiles of Snail transcription factors in the 
chondrogenic cell lines may suggest that SNAI1 might be responsible for the initial responses 
to the TGF-β1 treatment, and SANI2 expression might interact with other molecular responses 
to the chondrogenic stimulation along the experimental period.  
 
COMP, a classic cartilaginous biomarker, was a hub gene in the chondrogenic cell lines, but 
not in fibroblast cultures, and the expression levels were increased over time. Also, its 
expression was significantly higher in the skeletal cell cultures at all post-chondrogenic 




4.85; FDR adjusted P-value<0.01). Thus, the expression profiles of COMP evaluated in the 
study may confirm that interzone and analgen cell cultures indeed underwent chondrogenic 
differentiation, accumulating cartilaginous ECM.  
 
Common chondrogenic upstream regulators 
 While no common chondrogenic upstream regulators were predicted until 3h, inhibition 
of MYC, TBX2, NOTCH1, SMAD7 (involved in transcription regulation), CCL2, CCL11, CSF1, TLP7, 
and MFSD2A (involved in signaling transduction) was projected in the chondrogenic cell lines 
between 3h and 12h. One of the inhibited upstream regulators, SMAD7, represses canonical 
TGF-β pathways regulated by Smad2/3 and Smad1/5/8 (Wang et al., 2014). The SMAD2/3 
involved pathway induces cartilaginous phenotypes. On the other hand, the SMAD1/5/8 
downstream pathway exhibits hypertrophic marker genes, such as COLX and MMP13. 
 
Between the two last collection points (12h and 96h), NKX3-2 activation was predicted in 
both chondrogenic cell cultures. This gene was also a hub gene in anlagen cell cultures, but it 
was not significantly correlated with the time course in interzone cell cultures. In the literature, 
NKX3-2 was not expressed in cells at the surface of developing bones, including cells that 
would differentiate into articular chondrocytes; on the other hand, its expression was 
detected in proliferative chondrocytes at pre-hypertrophic stages (Church et al., 2005). When 
GO enrichment analysis was conducted on the upregulated DEGs in interzone cell cultures at 
96h compared to 12h, endochondral ossification and negative regulation of chondrocyte 
differentiation were significantly overrepresented (Table 3.4). NKX3-2 was one of the players 




However, the expression levels of NKX3-2 were significantly lower in interzone cell cultures 
compared to anlagen cell cultures at all collection points (log2FC ranged from |2.12 – 3.62|; 
FDR adjusted P-value<0.01). Based on the literature, the findings from the current study may 
suggest that interzone cell cultures might obtain pre-hypertrophic characteristics, at least at 
a minimal level, towards the last time point while anlagen cell cultures constantly presented 
greater hypertrophic characteristics over time.  
 
Differential transcriptomic signatures between interzone and anlagen cells  
The transcriptomic signatures in interzone and anlagen cell cultures demonstrated the 
chondrogenic divergence directed towards articular and hypertrophic developmental 
pathways, respectively. The candidate molecular switches that were identified between these 
chondrogenic cell lines may be responsible for the decisions whether to commit one of the 
different chondrogenic programs. Furthermore, predicted upstream regulators within a cell 
type over the time course or between the cell types at each time point provided further 
evidence that interzone and anlagen cells were indeed diverged into their corresponding 
developmental pathways.  
 
Exclusively expressed genes in interzone cell cultures 
Among four exclusively expressed genes in interzone cell cultures over time, 
ENSECAG00000037611 (from 0h – 3h) is a novel gene, and C7H11orf52 (at 12h) encodes an 
uncharacterized protein (Table 3.21). The exclusive expression of ENSECAG00000037611 was 
continuous during the first 3 hours after inducing chondrogenesis, therefore this gene might 




mechanisms, especially in the articular chondrogenic pathway. 
 
Expression of LY6G6C was turned on in interzone cell culture at 3h. This gene is a member 
of a cluster of leukocyte antigen-6 (LY6) and encodes proteins containing Ly6/uPAR (LU) 
domains in integral membrane receptors. The LU domains have various biological functions in 
eukaryotes, and one of their important roles is being the extracellular ligand-binding domain 
in the TGF-β receptor family, including TGF-βR1, BMPR1A, TGF-βR2, and BMPR2 (Leth et al., 
2019). Not only TGF-β1 was the experimental stimulus, but also is a key upstream regulator 
of chondrogenic differentiation pathways. Interacting with different TGF-β receptors, this 
cytokine can activate both canonical and non-canonical pathways and regulate both articular 
and hypertrophic chondrogenic differentiation (Wang et al., 2014). Therefore, localizing this 
specific LU domain encoded by LY6G6C in different TGF-β receptors may better describe its 
role in interzone cell-specific chondrogenic pathways. 
 
Exclusively expressed genes in anlagen cell cultures 
Members of the anterior HOX gene cluster B were exclusively expressed in anlagen cell 
cultures at the baseline (HOXB2) and at delayed time points (HOXB2 and HOXB3 at 12h and 
96h; Table 3.21). Another gene exclusively expressed in anlagen cells is PLAC8B, which was 
turned on by 96h. In addition to HOXB2 that has been reported to regulate self-renewal 
processes (Phinney et al., 2005), PLAC8B is assigned to a GO term of “chromatin binding.” Thus, 
the results may suggest that regulating DNA replication and proliferation might be important 





Differentially regulated biological processes and gene expression between chondrogenic cell 
lines 
During the first 3 hours after inducing chondrogenesis, the DEG profiles between the 
chondrogenic cell lines represented a higher number of biological processes that were 
significantly upregulated in analgen cell cultures (Figure 3.15 and Table 3.24). Similar to what 
the exclusive gene expression in analgen cell cultures may suggest, DNA replication was 
upregulated in anlagen cell cultures between 0h and 3h compared to interzone cell cultures. 
At the baseline, regulation of cell proliferation and positive regulation of epithelial cell 
proliferation were overrepresented by the upregulated DEG profile in anlagen cells compared 
to interzone cells. Also, chromosome segregation and cell division were upregulated in 
anlagen at 3h. Altogether, more proliferative events might occur in anlagen cell cultures at the 
earlier stages after inducing in vitro chondrogenesis. The present findings are aligned with the 
biology; proliferating anlagen chondrocytes enter the hypertrophic final differentiation in a 
developing limb bud.  
 
In contrast, towards the later time points, the DEG profiles between interzone and analgen 
cell cultures represented greater biological processes upregulated in interzone cell cultures. 
Cell adhesion and collagen fibril organization were upregulated in interzone cell cultures at 
12h. Positive regulation of ERK1/2 cascade, embryonic digit morphogenesis, chondrocyte 
development, and chondrogenic differentiation processes involved greater DEGs upregulated 
in interzone cell cultures at 96h. At the same time, DEGs upregulated in anlagen cells 
dominated in a GO term—ossification—at 12h and in endochondral ossification at 96h. The 




lead towards the bone forming processes. 
 
In Chapter 2, FGF1 was upregulated in anlagen cultures from 6 – 48h compared to 
interzone cultures. Along with this previous finding, from this RNA-seq dataset, differential 
expression of FGF1 between the two chondrogenic cell lines was detected at 12h 
(log2FC=|3.43|; FDR adjusted P-value=0.001) and at 96h (log2FC=|1.89|; FDR adjusted P-
value=0.001), and the gene was upregulated in anlagen cells. When human mesenchyme 
stromal cells were co-cultured with chondrocytes from osteoarthritic cartilage, FGF1 
expression was increased in mesenchymal cells and promoted proliferation of osteoarthritic 
chondrocytes (Wu et al., 2013). When FGF1 activity was inhibited, proliferation of 
chondrocytes was also downregulated. In addition, FGF1 expression was detected from the 
proliferative and hypertrophic zones of fetal growth plate but not from the resting zone (Krejci 
et al., 2007). Thus, based on the previous studies, the present finding may suggest that 
anlagen cell cultures might undergo proliferation by 12h after inducing chondrogenesis and 
might become further hypertrophic over time. 
 
Several HOX genes in clusters B and C were either exclusively expressed (HOXB2 and 
HOXB3; Table 3.21) or significantly upregulated (HOXC4, HOXC6, HOXC8, and HOXC9; Table 
3.23) in anlagen cell cultures compared to interzone cell cultures. On the other hand, some 
posterior HOX genes in clusters A and D (HOXA11, HOXA13, HOXD11, and HOXD13) were 
upregulated in interzone cell cultures. It is worth mentioning that other HOX genes in cluster 
B around the central position were not expressed at all in both chondrogenic cell lines (HOXB4, 




were only expressed in anlagen cell cultures but not in interzone cells. In addition, differential 
expression of HOX genes in cluster C around the central region (HOXC4, HOXC6, HOXC8, and 
HOXC9) were differentially upregulated in anlagen cultures compared to interzone cell 
cultures. It is known that the HOX genes’ function is more similar to that of their paralogs in 
different chromosomes relative to that of other HOX genes that are closely located in the 
same chromosome. Therefore, the roles of HOXC4-9 in anlagen cell cultures might be related 
to non-chondrogenic pathways. Further research is required to better describe the 
mechanisms of HOX genes regulating limb development.  
 
Also, one example of an interesting DEG between the two fetal skeletal cell cultures is 
TGFGR3. While multiple TGF-β ligands can interact with multiple TGF-β receptors, the 
downstream events of TGF-β are mediated by different combinations of receptors, resulting 
in different chondrogenic outcomes. Among different TGF- receptor genes, TGFBR3 was 
differentially upregulated in interzone cell cultures at 12h (log2FC=1.01; FDR adjusted P-
value=0.001). TGFBR3 interacts with ALK5 and transduces the noncanonical SMAD-
independent pathway (Iwata et al., 2012), and this receptor provides stable ligands to the 
receptor combination of TGFBR2 and ALK5, which facilitates the SMAD2/3 mediated canonical 
TGF-β pathway (Shi and Massagué, 2003). SMAD2/3 are phosphorylated in this signaling 
cascade and become active transcription regulators, upregulating COL2A1 and ACAN 
expression. In addition, phosphorylated SAMD3 inhibits SMAD1/5/8, which induces 
hypertrophic differentiation, resulting in articular cartilage phenotypes (Chen et al., 2012, 
Wang et al., 2014). Thus, upregulation of TGFBR3 in interzone cell cultures may indicate that 




expression was differentially downregulated in interzone cell cultures at 12h (log2FC= |1.07|; 
FDR adjusted P-value=0.005), and the other TGF-β receptor genes or SMAD genes were not 
differentially expressed between the two chondrogenic cell cultures at any collection time 
points. To better understand TGF-β signaling pathways involved in chondrogenesis may 
require further research on phosphorylation and protein level evaluation. 
 
Upstream regulator prediction 
<Upstream regulators in interzone cell cultures between time points> 
Between the baseline and 1.5h, NOTCH1 and GATA1 involved pathways were predicted to 
be activated upstream of interzone cell cultures (Figure 3.5). Both NOTCH1 and GATA1 
downregulate chondrogenesis. When NOTCH signaling was constitutively activated, 
formation of chondrogenic nodules was significantly reduced in mice fetal limb bud 
mesenchymal cells (Tian et al., 2015). GATA1 was reported to be induced by BMPs and 
correlated with BMPs’ anti-chondrogenic activity, reducing expression of collagen type 2 
(Karamboulas et al., 2010). Predicted activation of NOTCH1 and GATA1 regulatory pathways 
in interzone cell cultures during the first 1.5 hours might represent temporarily paused 
chondrogenesis in interzone tissue during earlier stages of limb development.  
 
The activation of MEOX2 was projected as an upstream event in interzone cell cultures 
between 3h and 12h. Also, this gene was evaluated as a hub gene correlated with the time 
course in interzone cell cultures. Its expression levels were significantly increased between 3h 
and 12h (log2FC=3.73; FDR adjusted P-value=0.015) and between 12h and 96h (log2FC=2.40; 




fetal axial skeleton as an upstream of PAX genes (Mankoo et al., 2003). Therefore, the results 
may suggest that chondrogenesis might resume in interzone cell cultures, 3 hours after 
introducing the TGF-1 stimulation, and MEOX2 might be an interesting gene for further 
investigation to better understand the articular chondrogenic differentiation pathway. 
 
During the last time sequence (12h to 96h), COL9A1 was predicted as an activated 
upstream in interzone cell cultures. This gene encodes an ECM component of hyaline cartilage. 
Also, the null mutation of this gene resulted in increased ossification in mice femoral heads 
and also enhanced invasion of vessels (Heilig et al., 2018). Therefore, this predicted upstream 
between the two last time points in interzone cell cultures, treated with TGF-1, may indicate 
that the cells might be towards the articular chondrogenic pathway in this experimental 
setting.  
 
<Upstream regulators in anlagen cell cultures between time points> 
In analgen cell cultures, SOX10 activation was projected as an upstream event from 1.5h 
to 3h (Figure 3.9). SOX10 was expressed in hypertrophic cutaneous scars (Febres-Aldana and 
Alexis, 2020) and in hypertrophic nerve trunks (Sham et al., 2001). Also, some genes involved 
in hypertrophic differentiation during endochondral ossification—DLX5 and DLX6—were 
predicted as upstream regulators between 3h and 12h in anlagen cell cultures. Both DLX5 and 
DLX6 were involved in hypertrophic differentiation, and DLX5 was able to compensate the 
absence of DLX6 expression (Zhu and Bendall, 2009). Between the two last time points (12h 
and 96h), SP7, a classic marker of bone, was an activated upstream regulator. By cooperating 




(Nishimura et al., 2012). Thus, the results altogether may indicate that analgen cell cultures 
might enter pathways towards hypertrophic differentiation at a relatively earlier time point 
(between 1.5h and 3h) and remain in the pathways leading to bone formation throughout the 
experimental period. 
 
<Upstream regulators between interzone and anlagen cell cultures at each time point> 
Including the baseline, NUPR1 was predicted to be an active regulator in interzone cell 
cultures compared to anlagen cell cultures during the first 3 hours (Figure 3.16). In the 
literature, it downregulated cell survival pathways, inducing chondrocyte apoptosis (Tan and 
Yammani, 2019). The present result agreed with a previous RNA-seq study conducted with 
murine tissues from mandibular condyle articular and mature zones (Zhou et al., 2018). The 
authors also analyzed the data using IPA, and NUPR1 was predicted as an upstream regulator 
distinguishing articular cartilage and the mature zone, which is located between articular 
cartilage and hypertrophic cartilage. 
 
E2F1 was predicted as an active upstream regulator in anlagen cell cultures during the 
earlier time points (from the baseline until 3h). In a previous study, its overexpression 
prevented chondrocytes from hypertrophic differentiation and interrupted endochondral 
ossification (Scheijen et al., 2003). On the other hand, one of the activated upstream 
regulators in anlagen cell cultures at the baseline and 1.5h was SPP1. This gene encoding 
osteogenic glycoprotein attaches osteoclasts to bone matrix and is required for 
biomineralization (Peacock et al., 2011). While SOX9 binds to SPP1 and inhibits transactivation, 




predicted to be an upstream regulator in analgen cell cultures. RUNX2 (at 0h, 1.5h, and 96h) 
and RUNX3 (at 12h), well-established bone biomarkers, were two of the predicted active 
upstream regulators in anlagen cell cultures treated with the TGF-β1 treatment. Thus, the 
results may verify that anlagen cell cultures in the experimental setting might be heading 
towards the bone forming-hypertrophic chondrogenic pathway. 
 
Future direction 
This RNA-seq study identified several important DEGs, candidate molecular switches, and 
upstream regulators that were either common in the chondrogenic cell lines or specific to 
different chondrogenic pathways. Since the current data were generated by measuring mRNA 
levels, a new question arises: if the transcripts were translated to proteins. To be functional in 
biological processes, transcripts need to be translated, and the resulting proteins need to be 
in an active form. Therefore, a cross-validation at a protein level would further confirm the 
biological relevance of the new information obtained from the present study. Also, the 
functional annotations and regulatory mechanisms of transcriptomic signatures that were 
proposed in this chapter could be elucidated by mechanistic studies. In addition, with the 
emergent high-throughput sequencing technologies that have enabled evaluation of gene 
expression at a single cell level, profiling characteristics of subpopulations of each cell 








In summary, the transcriptomic data generated from equine fetal interzone and analgen 
cell pellet cultures during the 96-hour of in vitro chondrogenesis characterized kinetics of gene 
expression of each cell type. In agreement with the study conducted in Chapter 2, 
transcription regulatory responses were initiated by 1.5h after inducing chondrogenesis, 
alterations in signaling transduction were observed throughout the experimental period, and 
ECM-related signatures became more evident towards the latest time point (96h). The study 
provided evidence that the transcriptomic profile of interzone cell cultures might be directed 
to articular chondrogenic pathways, and that of analgen cell cultures might be towards 
hypertrophic pathways, leading to bone formation, while both cell cultures shared some 
common chondrogenic characteristics. Furthermore, this study proposed candidate 
molecular switches, important DEGs, and predicted upstream regulators between interzone 
and anlagen cell cultures, and various Homeobox transcription factor genes are some of the 
examples. The transcriptomic signatures of interzone and analgen cell cultures defined by the 






Chapter 4. A pilot single cell RNA-seq study: Evaluation of chondrogenic divergence between 
equine fetal interzone and analgen cell cultures at the single cell level 
 
Introduction 
Experimental in vitro chondrogenic differentiation models frequently utilize TGF-β 
containing induction media and measure classic cartilaginous biomarkers, such as cartilage-
specific ECM genes or proteins after 14-21 days (McCarthy et al., 2012, Rakic et al., 2018, 
Adam et al., 2019). One such study from our laboratory compared equine fetal interzone and 
analgen cell pellets and demonstrated a clear distinction of histological characteristics (Adam 
et al., 2019). While anlagen cell pellets showed relatively homogenous histology in sagittal 
sections, interzone cell pellets usually exhibited a heterogenous zonal structure.  
 
To investigate these differences further, a preliminary histology analysis was conducted 
on equine interzone and anlagen cell pellets (500,000 cells/pellet) that were grown in the 
TGF-β1 chondrogenic induction medium and collected at three different time points, 1d (24h), 
2d (48h), and 21d (Figure 4.1). In agreement with the previous study (Adam et al., 2019), day-
21 anlagen cell pellets displayed homogenous proteoglycan staining across the entire section 
as well as relatively stable cellular morphology and arrangement. In contrast, and also 
consistent with the previous findings, interzone cell pellets after 21 days presented the 
distinctive zonal configuration. In the periphery region, ECM was rich in proteoglycan, and 
cells were densely arranged parallel to the surface. Across the intermediate zone, 
proteoglycan staining and cell density became decreased towards the core. The histology in 




density and latticed ECM while others showed evidence of cellular necrosis. The cellular 
morphology, orientation, and ECM proteoglycan staining observed in day-21 interzone cell 
pellets have some resemblance to the architecture of articular cartilage—almost suggesting 
an organoid structure.  
 
In contrast to the 21d time point, anlagen pellets at 1d (24h) and 2d (48h) had significantly 
less proteoglycan staining (Figure 4.1). Differences between interzone and analgen cell pellets 
were minimal in terms of cell size and histology at days 1 and 2.  
 
Figure 4.1 Cell pellet proteoglycan staining. Passage 5 equine fetal interzone and analgen cell 
pellets were collected after 1, 2, and 21d of culture in chondrogenic induction medium and 
stained with Safranin-O and Fast Green. Proteoglycan in the extracellular matrix stains red, 
while regions devoid of proteoglycan stains blue-green.  
 
 
The different levels of variation and intensity of proteoglycan staining between 21d 
interzone and anlagen cell pellets may indicate different cell subpopulations and cellular 
heterogeneity. With the complexity of gene expression profiles in kinetic data reported in the 
Time point
Cell type











previous chapters, in which changes induced by TGF-β1 were demonstrated as early as 1.5 
hours after the initiation of in vitro chondrogenic induction, different cell subpopulations 
might be present by the 1d or 2d time points. Since differential expression of ECM effector 
genes was delayed, cell subtype differences may well be present even though histological 
staining characteristics are still similar.  
 
In this pilot study, single cell RNA-seq analysis was conducted to further describe the 
differential chondrogenic pathways between interzone and anlagen cell cultures by profiling 
their cell subpopulations. The hypotheses tested in the study were that 1) interzone cell 
cultures will develop relatively heterogenous cell subpopulations while anlagen cell cultures 
will display less heterogenous subpopulations, and 2) these fetal skeletal cell lines will not 
only share common chondrogenic cell subpopulations but also show unique cell 
subpopulations that distinguish the two cell types.  
 
Materials and Methods 
Cell culture 
Primary interzone and analgen cells collected from a single 45-day equine fetus (Adam et 
al., 2019) were used for the present study. Passage 5 cell pellets were established following 
the protocol described in Chapter 2 and cultured in the TGF-1 chondrogenic induction 
medium. Samples were collected at two time points, 24 and 48 hours. These two time points 
were selected with consideration of gene expression profiles and for logistical considerations 




pellet cultures. Regenerating cell suspensions was feasible until 48h without substantially 
compromising the cell number recovery rate or cell viability. 
 
Single cell suspension preparation  
The preparation of cell suspensions for the single cell cDNA library construction followed 
protocols recommended by the manufacturer (10X Genomics, Pleasanton, CA). Briefly, cell 
pellets, five per cell-type and time point, were washed with PBS to remove the chondrogenic 
medium. The five replicates were then transferred as a group into a cell strainer with a luer-
lock flow controller (pluriStrainer® 5 µm; catalog No. 43-50005-13; pluriSelect Life Science, 
Germany) connected to a 50 ml conical tube. The pellets were incubated for 2.5 hours at 37°C 
in 1.5 ml of a collagenase cocktail, DMEM containing 20% (v/v) FBS, 0.2% (w/v) collagenase II 
(catalog No. LS004177; Worthington Biochem), 0.1% (w/v) collagenase type 4 (catalog No. 
LS004186; Worthington Biochem), and 2mM CaCl2 (catalog No. 10043-52-4; Fisher Scientific). 
The collagenase medium was then drained through the filter by opening the luer-lock. 
Retained cells were washed twice with PBS, retrieved into a fresh 50 ml conical tube, and 
resuspended in DMEM. 
 
The cell counting was conducted by both an automated cell counter (EVE™ Automated 
Cell Counter; catalog No. EVE-MC; NanoEnTek) and a manual hemocytometer with trypan 
blue staining. Cell viability was >95% and the concentration of cells in DMEM adjusted to 1,000 
cells/µl, within the range recommended by 10X Genomics. The targeted number of cells for 
barcoded library construction was 5,000 cells for each sample. Per manufacturer 




Single cell cDNA library construction 
Barcoded gel beads are the key feature in 10X Genomics’ single cell gene expression 
system. These beads comprised 1) an Illumina Read 1 primer site, 2) a 16 bp 10X barcode 
(specific to each cell), 3) a 10 bp unique molecular identifier (UMI; specific to each transcript), 
and 4) an oligo-dT sequence. To construct single cell cDNA libraries using a Chromium Single 
Cell 3’ Library & Gel Bead v2 Kit (cat No. 120267; 10X Genomics) and following the company’s 
protocols, the cell suspensions, barcoded gel beads, partitioning oil, and reverse-transcription 
reagents were channeled through a microfluidic chip using a Chromium controller (cat No. 
110203; 10X Genomics). In this process, individual cells were captured with one barcoded gel 
bead and the RT reagents in the partitioning oil, forming a Gel bead-in-EMulsion (GEM). 
Within each GEM, RNA transcripts were released by cell lysis and then captured by oligo-dT 
sequences on the barcoded bead. A reverse transcription reaction was then conducted using 
a Veriti® 96-Well Thermal Cycler (cat No. 4375786; Thermo Fisher) for 45 min at 53°C and for 
another 5 min at 85°C. Finally, all of the GEM droplets were broken open to generate a pool 
of cell-specific barcoded cDNAs for each experimental group—interzone or anlagen cell type 
and either the 24h or 48h time point. The cDNAs in each sample were then amplified for 12 
cycles in the Veriti® 96-Well Thermal Cycler, followed by an assessment of cDNA quality and 
quantity using the Agilent High Sensitivity DNA Kit (catalog No. 5067-4626; Agilent 
Technologies) reagents and a Bioanalyzer 2100 (Agilent Technologies) instrument. 
 
After the amplification step, cDNA molecules were randomly fragmented. For fragments 
that contained the Read 1 primer sequence, Illumina P5 flow cell binding sequences, Illumina 




i7 Multiplex Kit (cat No. 120262; Table 4.1). Indexing PCR was conducted for 13 cycles in the 
Veriti® 96-Well Thermal Cycler. Final library concentration and quality were evaluated by a 
Qubit® 3.0 Fluorometer (cat No. Q33216; Life Technologies) with a Qubit® dsDNA HS Assay Kit 










Index sequences (four oligonucleotides/sample) 
Interzone cells, 24h SI-GA-A1 GGTTTACT CTAAACGG TCGGCGTC AACCGTAA 
Interzone cells, 48h SI-GA-A2 TTTCATGA ACGTCCCT CGCATGTG GAAGGAAC 
Anlagen cells, 24h SI-GA-A3 CAGTACTG AGTAGTCT GCAGTAGA TTCCCGAC 
Anlagen cells, 48h SI-GA-A4 TATGATTC CCCACAGT ATGCTGAA GGATGCCG 
Chromium i7 Multiplex kit (cat No. 120262) 
 
 
Table 4.2. cDNA library concentration and average size of fragments 
Sample ID Concentrationa, ng/µl Average fragment sizeb, bp 
Interzone cells, 24h 47.6 498 
Interzone cells, 48h 31.2 505 
Anlagen cells, 24h 37.0 515 
Anlagen cells, 48h 41.6 538 
aLibrary concentration was measured by a Qubit® 3.0 Fluorometer (cat No. Q33216; Life 
Technologies) with a Qubit® dsDNA HS Assay Kit (catalog No. Q32854; Life Technologies). 
bAverage fragment size was evaluated by a Bioanalyzer 2100 (Agilent Technologies) using 





Figure 4.2. Automated electrophoresis analyses conducted for 
amplified library quality assessment using a Bioanalyzer 2100 
(Agilent Technologies). IZ = interzone cells; ANL = anlagen cells. 
a) Gel like image; b) Electropherogram 





Aliquots of the four cDNA libraries (100 ng each) were pooled into a single tube totaling 
400 ng in 20 µl (20 ng/µl) and sent to the Roy J. Carver Biotechnology Center (University of 
Illinois at Urbana-Champaign, Urbana, IL, USA). The cDNA libraries were then sequenced 
(NovaSeq 6000, Illumina) on an S4 lane generating paired end reads, 2×150 nucleotides in 
length. Three read files were generated per sample: Read1 (reads for barcodes and UMIs), 
Read2 (reads for the transcripts), and Index1 (sequences of indexes) files. This is why the 
libraries in this system have to be sequenced in paired end reads. Also, the workflow does not 
include a fragmentation step for transcripts before being assigned to the UMIs; rather, poly-A 
tails of transcripts are captured by a gel bead in their full length. Therefore, levels of gene 
expression are expressed in UMI counts, and no further normalization for gene length is 
required.  
 
Data analysis pipeline 
Raw reads data were processed using the Cell Ranger software (v 3.0.2; 10X Genomics). 
In the layout for this software, STAR (v2.7) was used for aligning reads onto the latest horse 
reference genome (EquCab 3.0, GCA_002863925.1; Kalbfleisch et al., 2018), and an ENSEMBL 
equine gene annotation file (v97) was used for expression quantification. Gene expression 
levels were expressed in UMI counts. Fold-change was calculated based on the ratio of the 
normalized mean UMI counts of a gene in each cell cluster relative to all of the other clusters. 





For non-linear dimensionality reduction analysis, uniform manifold approximation and 
projection (UMAP) was conducted using an R package, Seurat v 3.0 (Stuart et al., 2019). Then, 
the results were visualized by the Loupe Cell Browser (v 3.1.1; 10X Genomics). Expression of 
selected chondrocyte biomarkers (COL2A1, COMP, and ACAN), interzone cell biomarkers 
(GDF5, WNT9A, and ENPP2), and biomarkers of chondrocyte hypertrophic differentiation 
(COL10A1, MMP13, and DLX5) were visualized in UMAP graphs to evaluate subpopulations of 
cells with those characteristics. Gene ontology enrichment analysis was conducted by the 
Functional Annotation Tool from DAVID Bioinformatics Resources (v6.8; 








While the targeted number of cells/sample was 5,000 cells, the recovered cell numbers 
ranged from 2,032 – 2,845 cells (Table 4.3). Although the cell number recovery rates were low 
(47 – 54%), other parameters indicated the abundance and high quality of the sequencing 
dataset. Ratios of GEMs containing 100% cell-associated UMIs based on the total cell number 
were greater than 72.5% in all samples, suggesting that most cells formed proper GEMs with 
100% cell-originated UMIs. The percentages of fraction reads in cells, which indicates how 
many of the reads were integrated with barcodes that were associated with cells, ranged from 
91.4 – 93.0%. This result confirmed that the vast majority of reads were associated with cells. 
Also, the mean reads/cell numbers that ranged from 219,117 – 332,136 were more than 
sufficient for a gene expression profiling study, suggested in the manufacturer’s user guide, 
where the recommended minimum mean reads/cell number was 50,000. The average 
mapping efficiency from the four samples was 90.1%, and only reads that were mapped 






Table 4.3. Sequencing results 
Cell type Interzone cell cultures Anlagen cell cultures 
Time point 24h 48h 24h 48h 
Total cell number 2,750 2,633 2,032 2,845 
Number of GEMs containing 100% 
cell-associated UMIsb 
2,255 2,107 1,474 2,094 
Ratio of GEMs with 100% cell-
associated UMIs based on total 
cell number, % 
82.0 80.0 72.5 73.6 
Mean reads/cell 273,499 227,277 332,136 219,117 
Fraction reads in cells, % 92.7 93.0 91.4 92.3 
Mapping efficiency, % 91.8 90.5 88.3 89.9 
Reads mapped confidently to 
genome, % 
88.2 86.7 84.6 86.0 
aGEM, Gel bead-In Emulsion 
bUMIs, Unique molecular identifiers 
 
Cell subpopulations within a sample 
The analysis of each sample yielded 7-8 cell clusters (Table 4.4). Differentially expressed 
genes (DEGs) were identified in each cluster compared to the other clusters within a sample 
(Table 4.5), and the top five DEGs with the greatest fold change in each sample are listed in 
Table 4.6 – 4.9. Although the profiles of each cluster were different, subpopulation diversity 
or homogeneity was not remarkably different between interzone and anlagen samples in 





Table 4.4. Number of cells in each cluster within sample 
Interzone cell cultures Anlagen cell cultures 
24h 48h 24h 48h 
Total 2,750 Total 2,633 Total 2,032 Total 2,845 
Cluster 1 581 Cluster 1 477 Cluster 1 447 Cluster 1 543 
Cluster 2 467 Cluster 2 433 Cluster 2 414 Cluster 2 478 
Cluster 3 378 Cluster 3 412 Cluster 3 332 Cluster 3 431 
Cluster 4 352 Cluster 4 385 Cluster 4 266 Cluster 4 399 
Cluster 5 295 Cluster 5 385 Cluster 5 255 Cluster 5 397 
Cluster 6 278 Cluster 6 372 Cluster 6 166 Cluster 6 357 
Cluster 7 247 Cluster 7 169 Cluster 7 152 Cluster 7 240 





Table 4.5. Number of differentially expressed genes in each cluster within sample 
 Interzone cells, 24h  Interzone cells, 48h 
Cluster # Upregulation Downregulation Cluster # Upregulation Downregulation 
Cluster 1 20 49 Cluster 1 32 70 
Cluster 2 2 89 Cluster 2 74 44 
Cluster 3 1 59 Cluster 3 1 38 
Cluster 4 25 0 Cluster 4 53 0 
Cluster 5 85 8 Cluster 5 4 132 
Cluster 6 16 43 Cluster 6 149 48 
Cluster 7 74 22 Cluster 7 0 0 
Cluster 8 0 0    
 
 Anlagen cells, 24h  Anlagen cells, 48h 
Cluster # Upregulation Downregulation Cluster # Upregulation Downregulation 
Cluster 1 20 162 Cluster 1 67 27 
Cluster 2 0 95 Cluster 2 57 64 
Cluster 3 33 45 Cluster 3 509 0 
Cluster 4 97 34 Cluster 4 13 36 
Cluster 5 458 0 Cluster 5 1 34 
Cluster 6 0 0 Cluster 6 0 27 
Cluster 7 0 0 Cluster 7 0 0 
Differential expression was determined at thresholds where statistical significance and fold 







Table 4.6. Top five upregulated and downregulated differentially expressed genes in each cluster of interzone cell pellet sample at 24h 
 
log2FC = log2(flod change) 
***, P<0.0001; **,P<0.01; *, P<0.05; P-values are adjusted for false discovery rate. 








Table 4.7. Top five upregulated and downregulated differentially expressed genes in each cluster of interzone cell pellet sample at 48h  
 
log2FC = log2(flod change) 
***, P<0.0001; **,P<0.01; *, P<0.05; P-values are adjusted for false discovery rate. 







Table 4.8. Top five upregulated and downregulated differentially expressed genes in each cluster of anlagen cell pellet sample at 24h 
 
log2FC = log2(flod change) 
***, P<0.0001; **,P<0.01; *, P<0.05; P-values are adjusted for false discovery rate. 






Table 4.9. Top five upregulated and downregulated differentially expressed genes in each cluster of anlagen cell pellet sample at 48h 
 
log2FC = log2(flod change) 
***, P<0.0001; **,P<0.01; *, P<0.05; P-values are adjusted for false discovery rate. 






Steady state mRNA levels of established gene biomarkers in three different categories 
(chondrocyte, interzone, and hypertrophic chondrocyte) was visualized in UMAP graphs 
plotted for each sample (Figure 4.3, 4.4, and 4.5, respectively). Each dot in the graphs 
represents each cell and is colored by the maximum expression level (Log2 max feature UMI 
count) of the three biomarker genes in each category. 
 
<Chondrocyte biomarkers> 
In all samples, chondrocyte biomarker genes (COL2A1, COMP, and ACAN) were highly 
expressed in most of the cell subpopulations, although a couple of cell clusters had fewer cells 
expressing these transcripts (Figure 4.3). Expression of these ECM genes were higher at 48h 
compared to 24h in both cell types, interzone and analgen. 
 
<Interzone biomarkers> 
Steady state levels of transcripts from interzone biomarker gene loci (GDF5, WNT9A, and 
ENPP2) were higher in the interzone cell cultures compared to anlagen samples (Figure 4.4). 
The expression of WNT9A was minimally detected in four clusters within the interzone cell 
samples at 24h and 48h (individual data not shown), while no cells from anlagen cell cultures 
at either time point expressed WNT9A. The clusters of cells that expressed greater 







<Chondrocyte hypertrophy biomarkers> 
While COL10A1 was not expressed in any sample, the two other chondrocyte hypertrophy 
biomarker genes (MMP13 and DLX5) were expressed at higher levels in anlagen cell cultures 
compared to interzone cell cultures over the experimental period (Figure 4.5). MMP13 
expression in interzone cell cultures was not detected at 24h and minimal at 48h. In analgen 
cell cultures, expression of MMP13 at both time points were modest compared to expression 




4.3.a) Chondrocyte biomarker gene expression in interzone cell cultures at 24h 
 
4.3.b) Chondrocyte biomarker gene expression in interzone cell cultures at 48h  
 
 
log2 Max Feature UMI counts 




4.3.c) Chondrocyte biomarker gene expression in anlagen cell cultures at 24h 
 
4.3.d) Chondrocyte biomarker gene expression in anlagen cell cultures at 48h 
 
Figure 4.3. Chondrocyte biomarker gene (COL2A1, COMP, and ACAN) expression in each 
sample, plotted by uniform manifold approximation and projection (UMAP) analysis. a) 




4.4.a) Interzone biomarker gene expression in interzone cell cultures at 24h 
 
4.4.b) Interzone biomarker gene expression in interzone cell cultures at 48h 
 
 
log2 Max Feature UMI counts 




4.4.c) Interzone biomarker gene expression in anlagen cell cultures at 24h 
 
4.4.d) Interzone biomarker gene expression in analgen cell cultures at 48h 
 
Figure 4.4. Interzone biomarker gene (GDF5, WNT9A, and ENPP2) expression in each sample, 
plotted by uniform manifold approximation and projection (UMAP) analysis. a) Interzone cells 




4.5.a) Chondrocyte hypertrophy biomarker gene expression in interzone cell cultures at 24h 
4.5.b) Chondrocyte hypertrophy biomarker gene expression in interzone cell cultures at 48h 
 
log2 Max Feature UMI counts 




4.5.c) Hypertrophy marker gene expression in anlagen cell cultures at 24h 
4.5.d) Chondrocyte hypertrophy biomarker gene expression in anlagen cell cultures at 48h 
 
Figure 4.5. Chondrocyte hypertrophy biomarker gene (MMP13 and DLX5) expression in each 
sample, plotted by uniform manifold approximation and projection (UMAP) analysis. a) 




Aggregation of the entire sample set 
To evaluate both common traits and differential signatures across the sample set, the 
single cell RNA-seq data from all samples were aggregated for the differential gene expression 
analysis and the dimensionality reduction analysis. By pooling the data from the four samples, 
the transcriptomic profiles of the entire sample set resulted in 13 cell clusters with 
measurements of 0 – 393 DEGs relative to the other clusters’ gene expression profiles (Table 
4.10). The five most differentially upregulated and downregulated genes in each cluster were 
tabulated (Table 4.11). 
 
The gene expression patterns were visualized into UMAP graphs. Each dot in the graphs, 
representing each cell, is colored by cluster (Figure 4.6.a) or by sample (Figure 4.6.b). The 
UMAP analysis indicated that Cluster 8, 9, and 13 are characterized by commonly regulated 
genes among the samples (Figure 4.6.c and d). On the other hand, Cluster 6 and 12 were 






Table 4.10. Number of differentially expressed genes in each cluster of the aggregate of all 
four samples 
 Upregulation Downregulation 
Cluster 1 5 137 
Cluster 2 28 135 
Cluster 3 28 32 
Cluster 4 37 147 
Cluster 5 18 41 
Cluster 6 15 86 
Cluster 7 121 18 
Cluster 8 0 0 
Cluster 9 311 0 
Cluster 10 0 0 
Cluster 11 60 4 
Cluster 12 1 3 




Table 4.11. Five most upregulated and downregulated differentially expressed genes in each cluster of the aggregate of all four samples 
 
log2FC = log2(flod change); P-values are adjusted for false discovery rate; ***, P<0.0001; **,P<0.01; *, P<0.05 
The five most upregulated DEGs and the five most downreuglated DEGs in each cluster are listed. Positive log2FC values represent 




4.6.a) Colored by cluster 
 






4.6.c) Separated view by sample, colored by cluster 
 
4.6.d) Separated view by cluster, colored by sample 
 
Figure 4.6. Non-linear dimensionality reduction analysis (uniform manifold approximation and 
projection; UMAP) conducted on the aggregate of all four samples. IZ = interzone cell cultures; 
ANL = anlagen cell cultures; a) Colored by cluster; b) Colored by sample; c) Separated view by 





Common gene expression patterns among the interzone and anagen samples 
Among the DEGs from the cell clusters, in which all four samples overlapped, a gene 
ontology (GO) enrichment analysis was conducted on only upregulated DEGs in Cluster 9 and 
13 (Table 4.10). The ten most overrepresented biological processes of Cluster 9 and 13 are 
listed in Table 4.12 and Table 4.13, respectively. In both clusters, cell migration was one of the 
most significant biological processes. The upregulated DEG profile in Cluster 9 showed positive 
regulation of chondrocyte differentiation as an overrepresented biological process, and the 
upregulated DEG profile in Cluster 13 showed positive regulation of epithelial to mesenchymal 
transition, by which mesenchymal progenitor cells for skeletal elements arise within the 
presumptive sites of limbs, as an overrepresented biological process.  
 
In these three cell clusters—Cluster 8, 9, and 13, the relative expression levels of 
chondrocyte biomarkers were lower compared to the other clusters, including the cell type-
specific subpopulations (Figure 4.7.a). Simultaneously, the expression of either interzone 






Table 4.12. Overrepresented biological processed from upregulated differentially expressed 
gene profile in Cluster 9 of the aggregate of all four samples 
GOa ID Term Genes P-Valueb 
GO:0016477 Cell migration 
ARC, PLCG1, PTK7, CDC42BPA, 





dependent cell spreading 
MICALL2, LAMC1, LAMB1, 
EPHB3, MERTK, FN1 
8.64E-05 
GO:0051726 Regulation of cell cycle 
CCNE2, TARDBP, JUND, TSC2, 
PUM1, GADD45B 
0.002 




COL6A1, LAMB1, MMP14, FN1 0.004 
GO:0043517 
Positive regulation of DNA 
damage response, signal 
transduction by p53 class 
mediator 
SPRED2, ANKRD1, ATR 0.004 
GO:0008380 RNA splicing 




Positive regulation of 
chondrocyte 
differentiation 








Positive regulation of fat 
cell differentiation 
ZFP36, SH3PXD2B, CEBPB, ID2 0.012 
aGO, gene ontology 
bModified Fisher Exact P-Value was used to evaluate enrichment of genes in GO annotation 





Table 4.13. Overrepresented biological processed from upregulated differentially expressed 
gene profile in Cluster 13 of the aggregate of all four samples 




HIST1H1E, HIST1H1D, HIST1H1C, 
EPHB3 
4.90E-05 
GO:0006334 Nucleosome assembly 
TSPYL1, H1F0, HIST1H2BB, 
HIST1H1E, HIST1H1D, HIST1H1C, 
HIST1H1B, HIST1H1A 
1.47E-04 
GO:0016477 Cell migration 
ARC, PLCG1, ARF4, PTK7, CSPG4, 
MMP14, NFATC2, SNAI1, USP24 
4.52E-04 
GO:0048538 Thymus development 




Negative regulation of 
transcription from RNA 
polymerase II promoter 
ZFP36, ERF, FZD8, HIST1H1E, 
HIST1H1D, HIST1H1C, HIST1H1B, 
SMAD3, CTNNB1, OSR1, HEXIM1, 




Negative regulation of 
apoptotic process 
ATF5, CDKN1B, PLK2, NUAK2, 
OSR1, ID1, ARF4, PIM3, MYC, 





ZNF703, CTNNB1, VCL 0.006 
GO:0016584 Nucleosome positioning HIST1H1E, HIST1H1D, HIST1H1C 0.008 
GO:0033077 
T cell differentiation in 
thymus 
ZFP36L2, FZD8, MAFB, CTNNB1 0.008 
GO:0010718 
Positive regulation of 
epithelial to 
mesenchymal transition 
ZNF703, SMAD3, EPHB3, SNAI1 0.012 
aGO, gene ontology 
bModified Fisher Exact P-Value was used to evaluate enrichment of genes in GO annotation 






4.7.a) Chondrocyte biomarker gene expression in the aggregate of samples 
 












Figure 4.7. Biomarker gene expression in the aggregate of samples, plotted by uniform 
manifold approximation and projection (UMAP) analysis, with a separated view by sample. 
The areas demarcated by the blue line indicate Cluster 8, 9, and 13, in which all four samples 
overlapped. IZ = interzone cell cultures; ANL = anlagen cell cultures; a) Chondrocyte biomarker 
genes (COL2A1, COMP, and ACAN); b) Interzone biomarker genes (GDF5, WNT9A, and ENPP2); 
c) Chondrocyte hypertrophy biomarker genes (MMP13 and DLX5) 
 
  
log2 Max Feature UMI counts 




Characteristics of interzone cells 
No cluster had a clear distinction between interzone cell cultures at 24h and 48h (Figure 
4.6.d). Cluster 5 and 12 had relatively greater interzone cells at 24h compared to 48h, and 
Cluster 6, 10, and 11 had relatively greater interzone cells at 48h compared to 24h. Among 
these clusters, only Cluster 6 and 12 dominantly consisted of interzone cells with a minimal 
number of analgen cells. Interzone cells at 48h were dominant in Cluster 6, and relatively 
similar proportions of interzone cells at both time points were observed in Cluster 12.  
 
Gene ontology enrichment analysis was conducted with the DEGs from Cluster 6 and 12 
to evaluate interzone cell-specific characteristics. Out of the ten most significant biological 
processes represented by the downregulated DEG profile in Cluster 6 (Table 4.14), eight GO 
terms are related to mitosis: 1) cell division, 2) mitotic nuclear division, 3) mitotic 
chromosome condensation, 4) mitotic cytokinesis, 5) microtubule-based movement, 6) 
mitotic sister chromatid segregation, 7) mitotic spindle organization, and 8) mitotic 
metaphase plate congression. Cluster 6 had only 15 upregulated DEGs, and Cluster 12 had one 
upregulated DEG and three downregulated DEGs; thus, no overrepresented biological 
processes were identified due to the small size of the DEG lists.  
 
The majority of interzone biomarker (GDF5, WNT9A, and ENPP2) expressing cells were 
located within the cell type-specific areas in both interzone and analgen cell cultures at both 




Table 4.14. Top ten overrepresented biological processed from downregulated differentially 
expressed gene profile in Cluster 6 of the aggregate of all four samples 
GOa ID Term Genes P-Valueb 
GO:0051301 Cell division 
SPC24, CCNB1, SPC25, CCNB2, 
TPX2, CKS2, UBE2C, ASPM, REEP4, 
CDCA3 
1.76E-08 
GO:0007067 Mitotic nuclear division 
SPC24, SPC25, CCNB2, PLK1, 





NCAPG, NUSAP1, NCAPD3, SMC4 1.75E-05 
GO:0000281 Mitotic cytokinesis CKAP2, PLK1, NUSAP1, STMN1 1.55E-04 




KIF11, KIF18A, KIF20B, CENPE 0.002 
GO:0000070 
Mitotic sister chromatid 
segregation 




CCNB1, SPC25, STMN1 0.005 
GO:0007080 
Mitotic metaphase plate 
congression 
CCNB1, CDCA8, KIF18A 0.008 
GO:0034976 
Response to endoplasmic 
reticulum stress 
HYOU1, PDIA6, CXCL8 0.018 
aGO, gene ontology 
bModified Fisher Exact P-Value was used to evaluate enrichment of genes in GO annotation 





Characteristics of analgen cells 
Cluster 2 and 4 were mostly composed of anlagen cells at 48h, with these clusters 
containing much fewer analgen cells at 24h or interzone cells at either time point (Figure 
4.6.d). On the other hand, anlagen cells at 24h were dominant in Cluster 5 although several 
interzone cells were also observed in this cluster.  
 
Gene enrichment analyses were conducted with DEGs from Cluster 2 and 4. Seven and 
one significantly overrepresented biological processes were identified from the upregulated 
DEG profiles of Cluster 2 and 4, respectively (Table 4.15 and 4.16). The ten most 
downregulated biological processes in Cluster 2 and 4 are also shown in the tables. In both 
cell clusters, regulatory processes involved in mitotic events were significantly downregulated: 
upregulation of positive regulation of cell cycle arrest (Cluster 2) and downregulation of 
mitotic sister chromatid segregation, microtubule-based movement, microtubule bundle 
formation, mitotic cytokinesis (Cluster 2), mitotic nuclear division (Cluster 4), cell division, and 
mitotic chromosome condensation (Cluster 2 and 4). 
 
Similar to the interzone biomarker gene expression (Figure 4.7.b), most of hypertrophic 
biomarkers (COL10A1, MMP13, and DLX5) were observed in the cell type-specific areas in 




Table 4.15. Top ten overrepresented biological processed from differentially expressed gene 
profile in Cluster 2 of the aggregate of all four samples 
GOa ID Term Genes P-Valueb 
(Upregulatedc) 
GO:0060428 Lung epithelium development HMGA2, ERRFI1 0.009 
GO:0043405 Regulation of MAP kinase activity TRIB3, TRIB1 0.011 
GO:0045892 
Negative regulation of 
transcription, DNA-templated 
ATF5, TRIB3, HMGA2, TGFB1 0.012 
GO:2000679 
Positive regulation of transcription 
regulatory region DNA binding 
HMGA2, TGFB1 0.022 
GO:0008016 Regulation of heart contraction S100A1 0.026 
GO:0001837 
Epithelial to mesenchymal 
transition 
HMGA2, TGFB1 0.035 
GO:0071158 
Positive regulation of cell cycle 
arrest 





NCAPG, NUSAP1, NCAPD3, 
SMC4 
3.83E-05 
GO:0085020 Protein K6-linked ubiquitination UBE2S, UBE2T, BARD1 7.13E-04 
GO:1904668 
Positive regulation of ubiquitin 
protein ligase activity 
PLK1, CDC20, UBE2S 9.93E-04 
GO:0031145 
Anaphase-promoting complex-
dependent catabolic process 
CDC20, UBE2C, UBE2S 0.001 
GO:0000070 
Mitotic sister chromatid 
segregation 
CDCA8, PLK1, KIF18A 0.005 
GO:0007018 Microtubule-based movement 
KIF11, KIF18A, KIF20B, 
CENPE 
0.006 
GO:0001578 Microtubule bundle formation PRC1, PLK1, MAP1B 0.008 
GO:0051301 Cell division 
CDCA8, CDC20, ASPM, 
CDCA3 
0.011 
GO:0000281 Mitotic cytokinesis CKAP2, PLK1, NUSAP1 0.012 
GO:0035519 Protein K29-linked ubiquitination UBE2S, UBE2T 0.014 
aGO, gene ontology 
bModified Fisher Exact P-Value was used to evaluate enrichment of genes in GO annotation 
terms, and all entities listed in the table have P-value<0.05. 
cUpregulated differentially expressed genes resulted in only seven significant biological 
process. 




Table 4.16. Top ten overrepresented biological processed from differentially expressed gene 
profile in Cluster 4 of the aggregate of all four samples 





CCL2, PODNL1, IFNAR1 0.009 
(Downregulated) 
GO:0051301 Cell division 
SPC24, CCNB1, SPC25, CCNB2, 




Negative regulation of 
reactive oxygen species 
metabolic process 
HK2, BNIP3, PINK1, VDAC1 2.37E-04 
GO:0007067 Mitotic nuclear division 
SPC24, SPC25, CCNB2, PLK1, NUF2, 
GEM, ASPM 
2.40E-04 
GO:0001666 Response to hypoxia 




Positive regulation of 
angiogenesis 






SFRP2, P4HA1, LOX, SERPINH1 0.002 
GO:0010629 
Negative regulation of 
gene expression 




Positive regulation of 
transcription from RNA 
polymerase II promoter 
PID1, CKAP2, NAMPT, HMGB2, 
HES1, HDAC5, CDH13, SFRP2, IRF7, 
SIX1, PSIP1, KDM3A, TOP2A 
0.003 
GO:0050829 
Defense response to 
Gram-negative bacterium 




NCAPG, NUSAP1, SMC4 0.004 
aGO, gene ontology 
bModified Fisher Exact P-Value was used to evaluate enrichment of genes in GO annotation 
terms, and all entities listed in the table have P-value<0.05. 







The first single cell RNA-seq study was published in 2009 (Tang et al., 2009), but this 
technology is still emerging and is relatively novel in the field of transcriptome research. In 
this pilot study, while asking scientific questions, this advanced technique was also evaluated 
for use in our laboratory with the experimental settings and typical specimens that the lab 
has been employing.  
 
While the targeted cell number was 5,000 cells/sample, the numbers of recovered cells 
ranged from 2,032 – 2,845 (recovery rates of 47 – 54%). These lower recovery rates might be 
due to the characteristics of the sample type. The specimens studied in this experiment were 
chondrogenic cell pellets, which produced and accumulated ECM over time. To prepare single 
cell suspensions, the cell pellets had to be disaggregated by enzymatic digestion as well as 
filtration through a porous membrane. Even though cell pellets underwent those steps, 
remaining debris might affect the GEM formation.  
 
Despite the lower cell number recovery rates, greater than 91.4% of the total reads were 
associated with cells in all samples. In addition, the total transcripts count/cell in all samples 
surpassed 200,000 reads/cell, which was well above the recommended minimum number of 
reads/cell (50,000 reads/cell) from the manufacturer’s protocol. Thus, the sequencing 





Subpopulations of cells in each sample 
The data do not support the first hypothesis tested in the study that interzone cell cultures 
will develop relatively heterogenous cell clusters while anlagen cell cultures will result in 
relatively homogenous cell clusters. In terms of subpopulation homogeneity, there was no 
significant evidence that either cell lines at either time points had greater heterogeneity (Table 
4.4). Also, chondrocyte biomarker gene expression (COL2A1, COMP, and ACAN) was observed 
from the majority of cell clusters in interzone and analgen cell cultures at 24h and 48h (Figure 
4.3) with a few clusters showing lower levels. In agreement with findings in the previous 
chapters, the expression of these cartilaginous ECM genes was greater at 48h compared to 
24h in both cell cultures, confirming that the cell lines were progressing towards a 
chondrogenic phenotype. 
 
The interzone biomarker genes (GDF5, WNT9A, and ENPP2) selected for visualization are 
regulatory genes, unlike the ECM effector genes chosen for chondrocytes. Interestingly, 
though, the localization was generally concordant (Figures 4.3 and 4.4). This co-localization 
may suggest retention of interzone biomarkers in the subset of cells destined to form articular 
cartilage or downregulation in cell subsets moving towards non-cartilaginous joint tissues. 
Levels were lower in anlagen cell cultures, especially, WNT9A which was not detectable. The 
overall intensity of the interzone marker gene expression was not remarkably different 
between the time points. Since in vivo GDF5 and WNT9A expression drops significantly 
postnatally in mouse limb joints (Koyama et al., 2008), the equine primary cells used in the 





The chondrocyte hypertrophic biomarkers (MMP13, and DLX5) were present at higher 
levels in the anlagen samples (Figure 4.5), consistent with this tissue progressing to 
osteogenesis. Overall, however, COL10A1 and MMP13 were less informative. COL10A1 was 
not detectable and the MMP13 expression limited. In contrast, steady state mRNA levels of 
DLX5, a transcription factor gene, were relatively high in anlagen cell cultures and increased 
over time. These results may indicate that the anlagen cell cultures were at earlier stages of 
hypertrophic differentiation. Similar to the interzone biomarker gene expression, DLX5 was 
also expressed from the cell clusters that expressed the cartilage ECM genes. This finding is 
consistent with both the interzone- and hypertrophic biomarkers being closely linked to 
chondrogenic differentiation in the two skeletal cell lines. 
 
Shared features and unique properties between interzone and analgen cells 
The second hypothesis tested in the current experiments was that interzone and anlagen 
cells will share common chondrogenic characteristics, but also show cell type-specific 
properties. Supporting this hypothesis, the data clearly demonstrate both similarities and 
differences. 
 
Common gene expression patterns between interzone and anlagen cells  
Analyzing gene expression data from the four-sample aggregate, 13 cell clusters were 
identified, and all four samples overlapped in Cluster 8, 9, and 13 (Figure 4.6.c and d). 
Interestingly, the only common overrepresented GO term in these cell subpopulations was 
“cell migration” (Table 4.12 and 4.13). This result is consistent with data reported in Chapter 




lightly centrifuged to aid in pellet formation, which might increase the expression of genes 
that regulate cell migration, regardless of cell types. 
 
Cluster 9 is interesting because it shows an overrepresentation of positive chondrocyte 
differentiation regulators as a significant biological process, while expression of chondrocyte 
ECM biomarkers was relatively low. Perhaps the cells in Cluster 9 were regulating 
chondrogenesis in other cells, or alternatively were just earlier in the differentiation process. 
Among the significant biological processes analyzed from the upregulated DEG profile in 
Cluster 13, positive regulation of epithelial to mesenchymal transition was observed and is 
consistent with cellular processes undoubtedly also occurring during limb bud formation 
(Gros and Tabin, 2014). 
 
Differences between interzone and anlagen cells 
When plotting the gene expression in the aggregate of all samples, the chondrocyte 
biomarker gene expression (COL2A1, COMP, and ACAN) was higher in cell type-specific areas: 
Cluster 2 and 4 for anlagen samples, and Cluster 6 and 12 for interzone samples (Figure 4.7.a). 
Also, expression of interzone (GDF5, WNT9A, and ENPP2) and hypertrophic (MMP13 and DLX5) 
biomarkers had the same pattern especially at the 48h time point. When comparing the 
profiles of the most overrepresented biological processes from the interzone cell-specific 
cluster (Cluster 6) and the analgen cell-specific clusters (Cluster 2 and 4), mitosis-related 
biological events were consistently downregulated. In addition, positive regulation of cell 





There are several examples of genes that may diverge chondrogenic pathways between 
interzone and anlagen cell cultures. Among the DEGs in the analgen cell-specific clusters 
within the aggregate of all samples (Cluster 2 and 4, which were dominated by anlagen cells 
at 48h), DEFB1 was the most downregulated gene (log2FC=-5.62 in Cluster 2; log2FC=-5.99 in 
Cluster 4; P-value<0.0001; Table 4.11). At the same time, DEFB1 was the only upregulated DEG 
(log2FC=1.74; P-value=0.019; Table 4.11) in Cluster 12, in which interzone cells at both time 
points were dominant. This gene encodes a TLR ligand and activates downstream by 
interacting with a receptor, TLR4. Its signal activates RAC1 in MAPK pathways and HSP27 in 
that order (Melas et al., 2014). HSP27, a chaperone involved in proper protein folding, was 
significantly expressed in normal articular cartilage when compared to osteoarthritic cartilage 
(Lambrecht et al., 2010). Along with DEFB1, HSP27 was differentially downregulated in Cluster 
4 (log2FC=-1.22; P-value=0.006). Altogether, these results may suggest that DEFB1 might 
participate in interzone-specific signaling pathways leading to articular cartilage formation, 
and these pathways might be significantly downregulated in anlagen cells.  
 
On the other hand, CXCL8 was a key upregulated gene (log2FC=1.98; P-value=6.96E-06) in 
Cluster 4 within the aggregate of all samples, but this gene was differentially downregulated 
(log2FC=-3.55; P-value=<0.001) in Cluster 6 (Table 4.11). CXCL8 was also an upregulated DEG 
in anlagen cell cultures compared to interzone cell cultures before and after inducing in vitro 
chondrogenesis from the study reported in Chapter 3 (Table 3.23). In a previous study, 
although the expression of CXCL8 was detected in normal articular chondrocyte cultures, 
when its protein was excessively added (10 ng/ml) to the cultures, it increased MMP13 




result from the previous chapter, the data may indicate that anlagen cell cultures showed 
greater levels of hypertrophic potential compared to interzone cell cultures. 
 
Future direction 
By profiling transcriptomic signatures at the single cell level, the present study showed 
that both interzone and anlagen cell cultures at 24h and 48h consisted of several cell 
subpopulations with different gene expression patterns. Although this study characterized cell 
clusters within a sample and within the aggregate of the sample set, spatial arrangement of 
these cell subpopulations and potential paracrine interactions between them are yet to be 
defined. These undefined properties could be further described when a spatial single cell 
RNA-seq is conducted on cell pellet sections. As shown in the histology images generated from 
the preliminary staining experiment (Figure 4.1), different ECM compositions and cellular 
arrangement were observed in a zonal structure on the day-21 interzone cell pellet section. 
In addition, the current dataset revealed that several genes were differentially upregulated in 
some cell clusters while differentially downregulated in other cell clusters within the same 
sample. Thus, the evaluation of spatial gene expression would provide a better understanding 
of the spatial arrangement of cell subpopulations and the molecular interaction between 
them in interzone and analgen cell pellet cultures during chondrogenic differentiation.  
 
Obviously, the current pilot experiments would greatly benefit from additional biological 







This pilot transcriptomic study conducted at the single cell level proposes the single cell 
RNA-seq technology as a highly informative new approach for studying gene expression in 
chondrogenic cell pellet cultures. With the abundant and quality sequencing data generated, 
this study demonstrated subpopulations of cells in both interzone and anagen cell cultures 
grown in a chondrogenic induction medium containing TGF-1 for 24 and 48 hours. Although 
interzone and analgen cell cultures at both time points did not display different degrees of 
heterogeneity in cell subpopulations, the sample set showed common traits as well as cell 
type-specific differences. It is interesting to note that the cell type-specific clusters exhibited 
greater cartilaginous ECM marker expression as well as either interzone-like characteristics or 
hypertrophic potentials compared to the clusters that were overlapped by all four samples. 
On the other hand, the gene expression pattern in the overlapping clusters presented positive 
regulation of chondrocyte differentiation as its significant biological process. Therefore, the 
data may suggest that upstream signal transduction and cartilaginous ECM production might 
be organized by different cell subpopulations during chondrogenesis. In conclusion, the 
present study added further evidence that interzone and analgen cell cultures progress down 





Chapter 5. Overall summary and future directions 
In this dissertation project, two studies and a pilot experiment were conducted to 
investigate chondrogenic divergence of equine fetal interzone and anlagen cells in tissue 
culture using various high throughput gene expression analytic technologies. Tissue culture 
protocols were held constant in all three studies. Interzone and analgen cells collected from 
gestational day 45 equine fetuses were grown in 3-dimensional cell pellet cultures, and the in 
vitro chondrogenesis was induced by TGF-1, which is a well-established chondrogenic factor. 
Kinetics of gene expression changes were evaluated in each chapter over different 
experimental periods using different methods.  
  
In the first study, 93 targeted genes were selected for characterizing expression kinetics 
over 336 hours in Chapter 2. These genes are either involved in biological processes related 
to fetal skeletal development or differentially expressed between equine interzone and 
anlagen tissue lineages. By profiling their expression under the chondrogenic at ten different 
time points (0, 1.5, 3, 6, 12, 24, 48, 96, 168, and 336h), this study yielded important new 
information on changes in steady state mRNA levels between the cell lines, and importantly 
also the timing of those in changes in response to the in vitro chondrogenic induction.  
 
Both shared and cell type-specific differences before and after inducing chondrogenesis 
were observed. Before inducing chondrogenesis, 73 out of 87 targeted genes were not 
differentially expressed between interzone and anlagen cells, while 14 genes already had 
different gene expression levels at the baseline. Among 73 genes that were not differentially 




The first responses to the chondrogenic induction stimulus occurred within the first 1.5 
hours. Interestingly, these initial gene loci all had functional annotation related to either 
transcription regulation or signal transduction. In fact, all transcription regulatory genes that 
were selected for the panel changed their expression patterns within the first 24 hours in the 
two chondrogenic cell lines, while the alterations in signaling events were relatively evenly 
distributed across all time points during the 336-hour experimental period. On the other hand, 
effector genes maintaining ECM composition had more delayed responses. No ECM effector 
genes changed their basal mRNA level at the first collection point (1.5h), with the earliest 
effects in this functional annotation group observed at 3h. Taken together, the results 
accepted the hypothesis that divergent chondrogenic pathways between interzone and 
anlagen cell cultures will become evident within the first 24 hours after inducing in vitro 
chondrogenesis. 
 
From the findings in Chapter 2, five time points, including the baseline, were selected (0, 
1.5, 3, 12, and 96h) for full mRNA transcriptome assessment based on the following reasons. 
By 1.5h, regulatory responses to the chondrogenic stimulation were initiated. At 3h, a peak of 
initial gene expression responses was recorded. A second major peak of first responses in 
transcription regulatory genes occurred at 12h. Finally, most of effector genes regulating ECM 
profiles (85.4%) responded by 96h. The method used to evaluate the transcriptome was RNA-
sequencing.  
 
Data from the Chapter 3 support that chondrogenic differentiation in interzone cell 




are directed more towards a cartilage that will progress through hypertrophic differentiation. 
At the same time, a number of the gene expression changes in response to induced 
chondrogenesis are shared between these two cell lines. This study identified interesting 
DEGs and candidate molecular regulators that may diverge chondrogenic pathways between 
the two skeletal cell lines. In agreement with the Chapter 2 data, the Chapter 3 results support 
accepting the hypothesis that differential responses of regulatory genes start changing 
expression patterns within the first 1.5 hours, and more distinctive transcriptomic signatures 
between interzone and anlagen cells will accumulate as chondrogenesis progresses. 
 
In Chapter 4, a pilot single cell RNA-seq experiment was conducted to characterize cell 
subpopulations in interzone and anlagen cell cultures at 24h and 48h by testing two 
hypotheses. The first hypothesis was that interzone cell cultures will develop relatively 
heterogenous cell subpopulations while anlagen cell cultures will retain more cellular 
homogeneity. However, the data indicated that interzone and anlagen cell cultures at both 
time points resulted in 7 – 8 cell subset clusters, and the distribution of cell numbers in the 
clusters was not notably different among the sample set, rejecting this hypothesis. 
 
The second hypothesis tested in this pilot experiment was that interzone and anlagen cell 
cultures share common chondrogenic characteristics and also show unique traits within a cell 
type. By plotting the expression of well-established cartilage biomarkers, the chondrogenic 
potential of interzone and anlagen cells was confirmed. Visualizing the interzone biomarker 
expression and the hypertrophy biomarker expression demonstrated that interzone cells 




culture. The expression of genes representing common chondrogenic potential and cell type-
specific traits became greater at 48h compared to 24h. It is interesting to note that groups of 
cells that showed either interzone-like or hypertrophic characteristics had greater expression 
of cartilaginous ECM biomarkers compared to cell subsets that were overlapped, suggesting 
the same cell subsets that achieve unique features also accumulate functional outcomes of 
chondrogenic differentiation generally. In sum, the second hypothesis was accepted. 
 
Overall, data in this dissertation research were generated with a balanced sample set 
composed of paired cell types (interzone cells, anlagen cells, and fibroblasts) between the 
biological replicates. The studies conducted provide new information on divergent 
chondrogenic pathways between fetal interzone and anlagen cells at the molecular level from 
the perspective of time course kinetics and have derived a molecular regulatory model (Figure 
5.1). Early regulation of the different chondrogenic pathways may involve activation of NUPR1 
in interzone cells and RUNX2 in analgen cells within the first 3 hours after inducing 
chondrogenesis (Figure 3.16). In interzone cell cultures, chondrogenic differentiation might 
temporarily pause immediately after treating the chondrogenic inductive medium containing 
TGFβ-1, represented by activated NOTCH1 and GATA1 signaling (between 0h and 1.5h; Figure 
3.5). Then, interzone cells may resume chondrogenesis with the activated MEOX2 regulation 
between 3h and 12h. At later stages, the expression of COL9A1, which composes the ECM of 
hyaline cartilage, may indicate that interzone cells are in the chondrogenic pathways forming 
articular cartilage. On the other hand, anlagen cells appear to be directed to hypertrophic 




and DLX6 signals, and subsequently, the activation of SP7 may induce ECM mineralization at 






Figure 5.1. Molecular regulatory model in interzone and analgen cell cultures during in vitro chondrogenesis. Within the first 3 hours, there 
is evidence for the activation of cell type-specific regulators that initiate divergence of the two different chondrogenic pathways (Figure 3.16). 
The interzone cells in culture appear to pause chondrogenesis immediately after treatment with the chondrogenic stimuli, but then resume 
at 3h (Figure 3.5). Analgen cells, in contrast, progress towards a hypertrophic differentiation pathway (Figure 3.9). The distinguishing 



















































New knowledge obtained from the present research lays a foundation for mechanistic 
experiments and perhaps future translational clinical studies. The mechanistic experiments 
will be required to validate the model of molecular regulation (Figure 5.1) and elucidate the 
roles of candidate regulator genes that may dictate the cellular fates of these two fetal skeletal 
cell lines; a loss-of-function or gain-of-function study would add value to the present findings.  
 
Concurrent to the proposed model, genes loci that are of higher biological interest were 
identified: DEGs, including candidate molecular switches between the chondrogenic cell lines, 
hub genes correlated with the time course, predicted upstream regulators, etc. Mechanistic 
studies would elaborate their biological relevance to the divergent chondrogenic pathways of 
interzone and anlagen cells. For example, some genes that were analyzed as potential 
molecular switches between the two cell lines were novel genes without known functional 
annotations at the current moment. Hypotheses to study functional roles in these differential 
chondrogenic pathways could be tested by conducting loss-of-function or gain-of-function 
experiments. Also, molecular interactions or hierarchy in signaling cascades of these 
interesting genes could be evaluated, adding more useful information. Although weighted 
gene co-expression network analysis (WGCNA) demonstrated interactions between some key 
hub genes in co-expression networks, the function of other hub genes have not well 
characterized in scientific literature and therefore could not be fully assessed in co-expression 
networks despite their greater relationship with other hub genes. In the same way, 
computational predictions of upstream regulators based on the differential expression data 





In the present studies, a majority of primary data centered on measurements of steady 
state mRNA levels. Individual transcripts, however, still need to be translated, transported, 
and in some cases modified to be functional in biological processes. Although the expression 
of RNA and protein is correlated with each other via the central dogma, relationships between 
mRNA, protein, and biological activity are not always concordant (Liu et al., 2018). Steady 
state levels of mRNA are a function of both de novo synthesis and transcript degradation, and 
translation requires additional time which can add another source for discrepancy between 
the mRNA and protein levels. Not only do transcription and translation occur in different 
compartments in cells, but intron excision prior to translation also takes at least 5 – 10 minutes 
(Singh and Padgett, 2009) and can be regulated. Furthermore, proteins can exist in various 
forms with activation status regulated through post-translational modifications. Therefore, 
future cross-validation of the current RNA-based observations with protein expression and 
biological function would be valuable in efforts to more fully elucidate the biological 
relationships. 
 
In addition, spatial expression evaluation at the transcript and/or protein levels would 
enrich the current understanding. A new method generating substantial interest in many 
biomedical areas is spatial single cell RNA-seq analyses to elucidate cell subpopulation 
arrangements in situ. In the current application, this would demonstrate morphological 
relationships of cell subgroups (clusters) within the interzone and anlagen cell pellets, with 





In conclusion, this dissertation research confirmed and elaborated differential signatures 
of fetal interzone and anlagen cells. By suggesting important candidate molecular regulators 
that may direct these two skeletal cell lines towards articular cartilage development or 
hypertrophic chondrogenesis, the present studies propose future research directions, with 
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